tribemd-images-cdninfeces-respiratrias-no-brasil-epidemiologia-impacto-clnico-e-estratgias-vacinais.jpegtrue!@-aasasat.---p-p-;as.png175677103889834812025-09-01T23:57:18.941Z"b7e5d650a5279fb9fa8b429f8e3bafc7"14564-esc®-2025-–-beta-bloqueadores-após-infarto-em-fração-de-ejeção-levemente-reduzida.png175657190267736012025-08-30T16:38:22.720Z"942a092d59954542bfc315b619f8d203"946688-esc®️-2025-–-beta-blockers-after-infarction-in-slightly-reduced-ejection-fraction.png175659907953944412025-08-31T00:11:19.583Z"9563ac2a4998ab989972dc4ea2831792"1178665-hero-banner-mobile.jpeg177342957734465112026-03-13T19:19:37.387Z"eeceea6e70a05923782c6a3ee1f4f659"330708-hero-banner-mobile.null177342716199202112026-03-13T18:39:22.025Z"7a3fc90c40655acf10b9b47241fe6b5a"696740-hero-banner-mobile.png177393038235191112026-03-19T14:26:22.460Z"0935acaf673f2600ae64c0171b24432f"1851328-infecções-respiratórias-e-síndrome-gripal--o-papel-do-otorrino--.png175640832368248312025-08-28T19:12:03.728Z"1857191cc4734adbf35f8184b602c339"1602324-kdigo-2026-e-anemia-na-drc-o-que-muda-na-investigao-no-uso-do-ferro-e-na-tomada-de-deciso-clnica.png177072872071024912026-02-10T13:05:20.758Z"c9a3405c1f84505a545e02a017ef8844"1508220-meet-the-expert--breast-cancer-edition---esmo-2025.jpeg176070505661048212025-10-17T12:44:16.672Z"7d0fd603a937a76479237b3bbe0224f2"256726-oceanic-stroke-fase-iii-asundexiana-na-preveno-secundria-do-avc--o-que-representa-um-nnt-de-53-em-1-ano.png177161849091689312026-02-20T20:14:51.034Z"62c044bbf959db581226716d68afcfcd"24205-riscos-respiratórios-associados-ao-uso-contínuo-de-cigarros-eletrônicos.jpeg174869870485019112025-05-31T13:38:24.895Z"732d390fad29725c82a718fb37f2cd22"807909.png176408777036051412025-11-25T16:22:50.400Z"64c6ab0e7e63c34eeb1ca48eb5b6a420"2346414-mitos-sobre-amamentação-que-todo-profissional-de-saúde-deve-conhecer-(e-desconstruir)-.png175466258889981212025-08-08T14:16:28.937Z"6be5683e36a3856f19b48ff5ed38090d"8221101600o-efficacy-and-safety-of-ima203-a-prametargeted-tcell-receptor-tcr-therapy-in-previously-treated-patients-with-advanced-or-metastatic-uveal-melanoma-results-from-a-phase-i-clinical-trial.png176157328353509112025-10-27T13:54:43.584Z"f98263fb3992483eed7297b1c9949949"190438219-de-maio-dia-mundial-da-doença-inflamatória-intestinal---os-desafios-nutricionais-dos-pacientes.jpeg174861329704221012025-05-30T13:54:57.082Z"8d8bba1a0284deaee32dd2dbc2255c91"157653951st-international-clinical-research-summit-icrs.png175759872860724012025-09-11T13:52:08.668Z"10060cd355f3ea6a71dc905f5c29f8fa"4011852026-aha-acc-acute-pulmonary-embolism-guideline--the-new-a-through-e-classification-that-redefines-pe-management-1.png177343262608948912026-03-13T20:10:26.129Z"1441a7909c087dbbe7ce59881b9df8b9"152026-aha-acc-acute-pulmonary-embolism-guideline--the-new-a-through-e-classification-that-redefines-pe-management-2.png177343262693084712026-03-13T20:10:26.968Z"1441a7909c087dbbe7ce59881b9df8b9"152026-ahaacc-acute-pulmonary-embolism-guideline-the-new-athroughe-classification-that-redefines-pe-management.jpeg177343262844686012026-03-13T20:10:28.479Z"ef0726bb0eb706bea4b30cb696981b26"28045426-de-maio:-dia-nacional-de-combate-ao-glaucoma-.jpeg174827934446112712025-05-26T17:09:04.509Z"36b1acd1147e2ce85d7b70b7927178fa"206696278th-world-health-assembly-meets-in-may-to-discuss-challenges-and-establish-strategies-for-strengthening-global-health.jpeg174793607633498912025-05-22T17:47:56.373Z"67a92c2c80ee3e7fbefb888b40c36d2f"27249078º-assembleia-mundial-da-saúde-se-reúne-em-maio-para-discutir-os-desafios-e-estabelecer-estratégias-de-fortalecimento-da-saúde-global.jpeg174791966538082212025-05-22T13:14:25.431Z"67a92c2c80ee3e7fbefb888b40c36d2f"272490915o-kras-g12d-inhibitor-hrs4642-in-patients-with-advanced-solid-tumors-harboring-kras-g12d-mutation-phase-i-study.png176157081125527412025-10-27T13:13:31.322Z"e8989ba75af7199a43ceab401cdcbd88"2575476918o-telisotuzumab-adizutecan-abbv400-temaba-in-patients-with-advanced-solid-tumors-harboring-met-amplification-metamp-results-from-a-phase-i-study.png176124929207471912025-10-23T19:54:52.132Z"59ca665ea68fb3e3aa2366476ee225b4"2004948Agenda TribeMD Bayer Feed.pdf177377289451483022026-03-17T18:41:34.554Z"36c1c2dbdff1378361a420ee90b8d505"421981AnalisisAGPen5pasos.pdf175269482247269822025-07-16T19:40:22.519Z"a31402004fd92ec070be6d2d4ec5ec47"1121463Ascent03 - BARRIOS - gilead_ajustado_28.11.pdf176590403754715822025-12-16T16:53:57.593Z"cf0200533ac0f19a58d3848f9bf20e82"315333ComparativoFreeStyleLibre2vsFreeStyleLibre.pdf175269489808012522025-07-16T19:41:38.178Z"18914519c4b3109ef1851ca504ca8973"1003614Desktop.png177309370167326022026-03-09T22:01:41.713Z"f3425137c36a752a0929ae02b3dbe23d"1302636ExactituddelsistemaFreeStyleLibre2(MARD).pdf175269494279515122025-07-16T19:42:22.848Z"d61285e27f41bcea789a89b9a0e73bfd"1981032GATE Capa.jpg177687471014632922026-04-22T16:18:30.209Z"f4e2789f24e835d8c5818f7361280b23"48678MaterialresumenRWE2025finalll.pdf175269567421186522025-07-16T19:54:34.257Z"cab3921dff54e135b0c200399ead91e2"825747Mobile-acc.png177309373374134022026-03-09T22:02:13.780Z"85fe7aa32238846daf0c4d22a8d3c838"367938NocomplementarioFDA.pdf175269506145320422025-07-16T19:44:21.492Z"e585aa4372bc2bbb9c461e663e71e967"885697SABCS-Banner-Propor.png176288845210662712025-11-11T19:14:12.131Z"1681441676f15887789c872f2c1ea481"276759Tabela (1) (1).png175571925621829522025-08-20T19:47:36.256Z"2b1a099eb93d635bde4cdbd40c475dc1"3288022TribeNews_Site-2.png176591452137775022025-12-16T19:48:41.417Z"84c33c910cd3fa1bf7c1bb45de6cedb5"1809703TribeNews_Site.jpg176591460107622622025-12-16T19:50:01.116Z"b2133d897e6ecab24136c85c39941cab"663919a-asco-atualizou-sua-diretriz-sobre-terapia-sistêmica-para-pacientes-com-câncer-de-próstata-metastático-resistente-à-castração-(mcrpc).jpeg174861457155577612025-05-30T14:16:11.598Z"754e1c07d44fe98a76536bda6716acbc"15463899a-cafeina-vila-ou-aliada-dos-estudantes-de-medicina-863b712c3f8b47f4b0eafe6cab2b6b25.jpeg176945023531434322026-01-26T17:57:15.361Z"60f2ead818eb0999e87108c2870d2dd6"363994a-decisive-step-toward-democratizing-cancer-diagnosis-the-global-potential-of-an-accessible-aipowered-blood-test.png176003652870669912025-10-09T19:02:08.748Z"197670990ea34977e07df1a330a51757"2283915a-evoluo-da-dapagliflozina-impactos-no-cuidado-cardiometablico-e-renal.jpeg177273687694639412026-03-05T18:54:37.006Z"c24b854138f624d046b6b6c3c56a65aa"316277a-evolução-da-dapagliflozina--impactos-no-cuidado-cardiometabólico-e-renal-1.png177273687321146212026-03-05T18:54:33.276Z"3bfc4ef709895691388921f505784eea"58473a-evolução-da-dapagliflozina--impactos-no-cuidado-cardiometabólico-e-renal-2.png177273687439699712026-03-05T18:54:34.461Z"b3c3d4d60ace2599004da8667a36f73b"46950a-evolução-da-dapagliflozina--impactos-no-cuidado-cardiometabólico-e-renal-3.png177273687541178912026-03-05T18:54:35.472Z"7c7401856ecd0a9bba39c5101a06201a"41958a-importancia-da-saude-na-vida-moderna-166c9853f402403d863d916a27bc91ea.jpeg177263101332122022026-03-04T13:30:13.390Z"dccc15b29be4d13401f3d8004b882009"629231a-importância-da-cardiologia.jpeg177247538409672812026-03-02T18:16:24.166Z"70a6d597c6900a3a0448d49ffaa13710"326577a-new-therapeutic-horizon-with-ipsc-derived-nk-cells-in-b-cell-lymphoma.jpeg175371873836761312025-07-28T16:05:38.409Z"2d4a2b737f6997a9aa43942c32812037"816306a-nomogram-predicts-urinary-tract-infection-risk-in-older-adults-with-type-2-diabetes.png176955213757481612026-01-27T22:15:37.618Z"b89e4322da91c8dbdd3fc38f2a6e7b62"6537072a-revolucao-tricolor-alem-das-quatro-linhas-7ae479ede56b45e0b21f1682d5ff4fab.jpeg176935403519332322026-01-25T15:13:55.241Z"2c282af1c491796a6815cf5ec671025c"406520a-revolucao-tricolor-alem-das-quatro-linhas-82b29952649b423db3cfc3ce25c793ab.jpeg176935256297191422026-01-25T14:49:23.011Z"566e3affe78ce1bd63a2d97bea28fee7"571150a-tribute-to-professor-eugene-braunwald-a-paragon-4052.png177703585376192412026-04-24T13:04:13.828Z"59a6c50aae11338fd09400e3abe3cd8d"1028306a-tribute-to-professor-eugene-braunwald-a-paragon-of-medical-scholarship-3368.177699534830825612026-04-24T01:49:08.361Z"13882ce27a235006f707add88a0d0eec"1030207a-year-in-review---cardiologia-2025.png175987058054998412025-10-07T20:56:20.644Z"a192e3ae1445f6c772356483a7ed6c1c"329581a-year-in-review-breast-cancer---destaques-em-cncer-de-mama-2025-.png176590738844447112025-12-16T17:49:48.491Z"06857e4dc0ceac22046763240c5cdbc9"3086885a-year-in-review-breast-cancer---destaques-em-câncer-de-mama-2025-hero-banner.jpeg177092409165095712026-02-12T19:21:31.740Z"4ac1e5670e4c783060a683c1bf779ffc"316452acalabrutinib-combined-with-br-improves-survival-in-treatment-naïve-mantle-cell-lymphoma.png175406564323690312025-08-01T16:27:23.279Z"d913864a1f738223bfe2552ec0e63a6d"489acc-2026--acc-2026--orbita-cto-la-angioplastia-reduce-la-carga-de-angina-y-mejora-la-calidad-de-vida-ms-all-del-efecto-placebo-en-la-oclusin-coronaria-crnica.jpeg177490291525842512026-03-30T20:35:15.299Z"cd1c658499853712a4cc8a17a1533070"252699acc-2026--all-rise-angiography-derived-fractional-flow-reserve-to-guide-pci.pdf177506109755773412026-04-01T16:31:37.602Z"7b87d52e2f17487299de9e398840acce"910751acc-2026--all-rise-reserva-de-flujo-fraccional-derivada-de-la-angiografa-para-guiar-la-intervencin-coronaria-percutnea-icp.jpeg177547891620391812026-04-06T12:35:16.251Z"9f54b0e65e9921d15c2ed2147874a24b"252127acc-2026--all-rise-reserva-de-flujo-fraccional-derivada-de-la-angiografa-para-guiar-la-intervencin-coronaria-percutnea-icp.pdf177547897389851612026-04-06T12:36:13.942Z"c4d26f5d45770553446c1641ee2a183d"910751acc-2026--all-rise-reserva-de-fluxo-fracionada-derivada-da-angiografia-para-guiar-a-interveno-coronria-percutnea-icp-5617.jpeg177497870108687812026-03-31T17:38:21.135Z"f3f824e45b777ee9f91e417288e9d052"253481acc-2026--all-rise-reserva-de-fluxo-fracionada-derivada-da-angiografia-para-guiar-a-interveno-coronria-percutnea-icp.pdf177506106098691512026-04-01T16:31:01.032Z"7b87d52e2f17487299de9e398840acce"910751acc-2026--champion-af-left-atrial-appendage-occlusion-or-anticoagulation-for-atrial-fibrillation.pdf177505645143484712026-04-01T15:14:11.539Z"a264197d653c161c7565e9081ae3f330"1369590acc-2026--champion-af-oclusin-de-la-orejuela-auricular-izquierda-o-anticoagulacin-en-fibrilacin-auricular.jpeg177547413481536512026-04-06T11:15:34.915Z"c89b0bc97f1837bf4f5deaf2e1e027cf"267611acc-2026--champion-af-oclusin-de-la-orejuela-auricular-izquierda-o-anticoagulacin-en-fibrilacin-auricular.pdf177547413767285012026-04-06T11:15:37.770Z"cd2fef1e36a4e9441faa968e5e804e9d"1369590acc-2026--champion-af-ocluso-do-apndice-atrial-esquerdo-ou-anticoagulao-para-fibrilao-atrial-1433.jpeg177481488721697312026-03-29T20:08:07.252Z"f96e1de0a497da3821a0302180b52efe"255951acc-2026--champion-af-ocluso-do-apndice-atrial-esquerdo-ou-anticoagulao-para-fibrilao-atrial.jpeg177547439669979312026-04-06T11:19:56.746Z"c89b0bc97f1837bf4f5deaf2e1e027cf"267611acc-2026--champion-af-ocluso-do-apndice-atrial-esquerdo-ou-anticoagulao-para-fibrilao-atrial.pdf177505722825303912026-04-01T15:27:08.353Z"a264197d653c161c7565e9081ae3f330"1369590acc-2026--chip-bcis3-descompresin-del-ventrculo-izquierdo-en-la-intervencin-coronaria-percutnea-de-alto-riesgo.pdf177547794487003712026-04-06T12:19:04.915Z"2650b9f8d18cc013e9da5ca3ff740629"1491910acc-2026--chip-bcis3-descompresin-del-ventrculo-izquierdo-en-la-intervencin-coronaria-percutnea-de-alto-riesgo.png177547792301407912026-04-06T12:18:43.063Z"4ff9c139035c0f067c319d8ab0ae0d16"2268313acc-2026--chip-bcis3-descompresso-do-ventrculo-esquerdo-em-interveno-coronria-percutnea-de-alto-risco-1080.png177491030802489612026-03-30T22:38:28.057Z"cffdf9d9012148d30a9b29e6c60eedce"2263230acc-2026--chip-bcis3-descompresso-do-ventrculo-esquerdo-em-interveno-coronria-percutnea-de-alto-risco.pdf177506090988934712026-04-01T16:28:29.928Z"b3bc8df7327c0213f86872e23377f25d"1491910acc-2026--chip-bcis3-left-ventricular-unloading-in-high-risk-percutaneous-coronary-intervention.pdf177506094161463212026-04-01T16:29:01.660Z"b3bc8df7327c0213f86872e23377f25d"1491910acc-2026--dig-rhd-digoxina-reduz-desfecho-composto-em-pacientes-com-doena-cardaca-reumtica-3346.jpeg177557587903579312026-04-07T15:31:19.074Z"f49747680d306469f00a663d17b5dfef"397311acc-2026--dig-rhd-la-digoxina-reduce-el-desenlace-compuesto-en-pacientes-con-cardiopata-reumtica.jpeg177557914644975712026-04-07T16:25:46.500Z"717c8e013bb500d4246d3e8ae290b5ad"394452acc-2026--dkcrush-viii-ivus-or-angiography-guidance-for-percutaneous-coronary-intervention-in-complex-coronary-bifurcation-lesions-.pdf177556843974431712026-04-07T13:27:19.855Z"ac48003a1f7cca4d41533e21b840c91f"1652726acc-2026--dkcrush-viii-orientacin-mediante-ivus-o-angiografa-para-la-intervencin-coronaria-percutnea-en-lesiones-coronarias-complejas-de-bifurcacin.pdf177556827263223012026-04-07T13:24:32.672Z"ac48003a1f7cca4d41533e21b840c91f"1652726acc-2026--dkcrush-viii-orientacin-mediante-ivus-o-angiografa-para-la-intervencin-coronaria-percutnea-en-lesiones-coronarias-complejas-de-bifurcacin.png177550002287492012026-04-06T18:27:02.915Z"5454f0508beaf7c60b7094c08a05b55f"2179872acc-2026--dkcrush-viii-orientao-por-ivus-ou-angiografia-para-interveno-coronria-percutnea-em-leses-complexas-de-bifurcao-coronria-4858.png177522346719838512026-04-03T13:37:47.244Z"0c86d785959a0322fa84575401e3c906"2179568acc-2026--dkcrush-viii-orientao-por-ivus-ou-angiografia-para-interveno-coronria-percutnea-em-leses-complexas-de-bifurcao-coronria.pdf177556837010370212026-04-07T13:26:10.149Z"ac48003a1f7cca4d41533e21b840c91f"1652726acc-2026--essence-timi-73b-efecto-de-la-inhibicin-de-apoc3-con-olezarsen-sobre-la-aterosclerosis-coronaria-estudio-de-imagen.png177557363127237012026-04-07T14:53:51.312Z"3fcb837d91a7a0bb8e019cc82289a7f6"1718292acc-2026--essence-timi-73b-efeito-da-inibio-de-apoc3-com-olezarsen-na-aterosclerose-coronariana-estudo-de-imagem-6139.png177557493845210712026-04-07T15:15:38.499Z"a76618978950197088db1e28790bd56a"1718357acc-2026--ez-pave-estratgia-de-ldl-55-mgdl-reduz-desfechos-cardiovasculares-em-pacientes-com-ascvd-em-comparao-a-70-mgdl-2405.jpeg177481106404976712026-03-29T19:04:24.084Z"b91c7ba51ce470dfc910ab9797cd68c1"323282acc-2026--ez-pave-metas-mais-baixas-de-ldl-se-associam-a-menor-risco-cardiovascular-na-preveno-secundria-341.jpeg177481155359160712026-03-29T19:12:33.623Z"b91c7ba51ce470dfc910ab9797cd68c1"323282acc-2026--ez-pave-objetivos-ms-bajos-de-ldl-se-asocian-con-un-menor-riesgo-cardiovascular-en-prevencin-secundaria.jpeg177547672158027512026-04-06T11:58:41.626Z"bb6bb5b3f458d52bff8e987fa69eb0e8"334559acc-2026--fast-iii-angiography-based-physiology-to-guide-coronary-revascularization.pdf177506125551076112026-04-01T16:34:15.556Z"767b1eb94b2e4e17c7e95c219bbb4cd1"1913119acc-2026--fast-iii-fast-iii-fisiologa-basada-en-angiografa-para-guiar-la-revascularizacin-coronaria.jpeg177548025967390412026-04-06T12:57:39.719Z"263a1620184692a9a26eef09235ce045"260904acc-2026--fast-iii-fisiologa-basada-en-angiografa-para-guiar-la-revascularizacin-coronaria.pdf177548029366105412026-04-06T12:58:13.698Z"5478d882a802f1925b8c53e8f27839d5"1913119acc-2026--fast-iii-fisiologia-baseada-em-angiografia-para-guiar-a-revascularizao-coronariana-5350.jpeg177491079598007112026-03-30T22:46:36.012Z"5fec8d1001350fe497c261b41042f3c5"262164acc-2026--fast-iii-fisiologia-baseada-em-angiografia-para-guiar-a-revascularizao-coronariana.pdf177506121963955612026-04-01T16:33:39.678Z"767b1eb94b2e4e17c7e95c219bbb4cd1"1913119acc-2026--hi-peitho-la-tromblisis-dirigida-por-catter-reduce-la-descompensacin-en-la-embolia-pulmonar-de-riesgo-intermedio.jpeg177481045549395112026-03-29T18:54:15.528Z"02400f19f99391ad3d1435fca95c19de"342467acc-2026--hi-peitho-tromblise-dirigida-por-cateter-reduz-descompensao-em-tep-de-risco-intermedirio-8397.jpeg177480927259789512026-03-29T18:34:32.632Z"8557311f720d2dea4d5f492353aaf7c6"338010acc-2026--hi-peitho-tromblise-dirigida-por-cateter-reduz-descompensao-em-tep-de-risco-intermedirio.jpeg177480977685262712026-03-29T18:42:56.944Z"02400f19f99391ad3d1435fca95c19de"342467acc-2026--impedance-hfpef-deteco-precoce-no-invasiva-do-fluido-pulmonar-reduz-morte-e-hospitalizao-7407.jpeg177497190617065012026-03-31T15:45:06.216Z"47b65c238bceaf3e61c41f9efdfc5deb"262587acc-2026--impedance-hfpef-deteco-precoce-no-invasiva-do-fluido-pulmonar-reduz-morte-e-hospitalizao.pdf177506139260743512026-04-01T16:36:32.653Z"2d4aca06b65d9fcc563b991bb8d6aac5"1046017acc-2026--impedance-hfpef-early-noninvasive-detection-of-lung-fluid-reduces-death-hospitalization.pdf177506148765024012026-04-01T16:38:07.697Z"2d4aca06b65d9fcc563b991bb8d6aac5"1046017acc-2026--impedance-hfpef-la-deteccin-precoz-no-invasiva-del-fluido-pulmonar-reduce-la-mortalidad-y-las-hospitalizaciones.jpeg177548130878442312026-04-06T13:15:08.823Z"b52523d0ea6ea56280ce084d74897dac"261037acc-2026--impedance-hfpef-la-deteccin-precoz-no-invasiva-del-fluido-pulmonar-reduce-la-mortalidad-y-las-hospitalizaciones.pdf177548132408389012026-04-06T13:15:24.121Z"3808d313940f0be5de4d1bb8e71370dc"1046017acc-2026--ivus-chip-ultrassonografia-intravascular-guiada-ou-angiografia-guiada-em-interveno-coronria-percutnea-icp-complexa-de-alto-risco-172.jpeg177507069680254112026-04-01T19:11:36.848Z"4fd2cbeae2685e86175053f6c7fe69b8"308671acc-2026--ivus-chip-ultrassonografia-intravascular-guiada-ou-angiografia-guiada-em-interveno-coronria-percutnea-icp-complexa-de-alto-risco.jpeg177548757538921512026-04-06T14:59:35.428Z"cfe106b8c1b7409f27e3efb35027ffab"305995acc-2026--kardinal-antisense-therapy-with-tonlamarsen-in-uncontrolled-hypertension.pdf177505983065323612026-04-01T16:10:30.699Z"06ad90baac9b1d7f945c054fd5efbc6e"347815acc-2026--kardinal-terapia-antisense-com-tonlamarsen-em-hipertenso-no-controlada-4787.jpeg177480708287706412026-03-29T17:58:02.913Z"f5e3422735c306d50bb1838c2f1b66e5"356202acc-2026--kardinal-terapia-antisense-com-tonlamarsen-em-hipertenso-no-controlada.pdf177505975670664412026-04-01T16:09:16.775Z"06ad90baac9b1d7f945c054fd5efbc6e"347815acc-2026--kardinal-terapia-antisentido-con-tonlamarsen-en-hipertensin-no-controlada.jpeg177547596950647412026-04-06T11:46:09.615Z"af3c530f4bddad5bb7626cafdf969491"370378acc-2026--kardinal-terapia-antisentido-con-tonlamarsen-en-hipertensin-no-controlada.pdf177547600691152312026-04-06T11:46:46.957Z"06ad90baac9b1d7f945c054fd5efbc6e"347815acc-2026--orbita-cto-angioplastia-reduz-carga-de-angina-e-melhora-qualidade-de-vida-alm-do-efeito-placebo-em-ocluso-coronariana-crnica-1390.jpeg177490956090312212026-03-30T22:26:00.936Z"3de9e913a2d0e6563737e48bb239f5c0"254385acc-2026--pro-tavi-adiamento-da-interveno-coronariana-percutnea-em-pacientes-submetidos-a-implante-transcateter-da-valva-artica-3212.jpeg177498428962331212026-03-31T19:11:29.668Z"681a754e52a3ae110cbf4cb558f4e861"262260acc-2026--pro-tavi-adiamento-da-interveno-coronariana-percutnea-em-pacientes-submetidos-a-implante-transcateter-da-valva-artica.pdf177506165535025812026-04-01T16:40:55.397Z"ff1113fb209fb6c642c5bbf197471dff"2874401acc-2026--pro-tavi-aplazamiento-de-la-intervencin-coronaria-percutnea-en-pacientes-sometidos-a-implante-transcatter-de-la-vlvula-artica.jpeg177548198352396012026-04-06T13:26:23.564Z"f2175a5452c82d53060ec3987192a9ec"262524acc-2026--pro-tavi-aplazamiento-de-la-intervencin-coronaria-percutnea-en-pacientes-sometidos-a-implante-transcatter-de-la-vlvula-artica.pdf177548210617056712026-04-06T13:28:26.209Z"ff1113fb209fb6c642c5bbf197471dff"2874401acc-2026--pro-tavi-deferral-of-percutaneous-coronary-intervention-in-patients-undergoing-transcatheter-aortic-valve-implantation.pdf177506169203751012026-04-01T16:41:32.152Z"ff1113fb209fb6c642c5bbf197471dff"2874401acc-2026--smart-decision-descontinuao-do-betabloqueador-aps-infarto-no-aumenta-eventos-em-pacientes-estveis-9050.png177507993905480212026-04-01T21:45:39.095Z"de8311e024f0c0e1c7e7f02003152fb2"2254767acc-2026--smart-decision-la-suspensin-del-betabloqueador-tras-infarto-no-aumenta-eventos-en-pacientes-estables.jpeg177507001542528512026-04-01T19:00:15.471Z"2fc2366ed65b75343378a35baf02b217"326488acc-2026--spirit-hf-ausencia-de-beneficio-de-la-espironolactona-en-pacientes-con-insuficiencia-cardaca-con-fraccin-de-eyeccin-preservada-o-levemente-reducida.jpeg177498428165979912026-03-31T19:11:21.705Z"90a1a849af8c8db9730470af8de0462d"225291acc-2026--spirit-hf-ausncia-de-benefcio-da-espironolactona-em-pacientes-com-ic-com-frao-de-ejeo-preservada-ou-levemente-reduzida-2006.jpeg177498364487654212026-03-31T19:00:44.921Z"865a340149e91937481c0a0157eed92a"231193acc-2026--spirit-hf-ausncia-de-benefcio-da-espironolactona-em-pacientes-com-ic-com-frao-de-ejeo-preservada-ou-levemente-reduzida-2519.jpeg177498361986307912026-03-31T19:00:19.903Z"865a340149e91937481c0a0157eed92a"231193acc-2026--stemi-door-to-unload---descompresso-do-ventrculo-esquerdo-em-pacientes-com-infarto-agudo-do-miocrdio-com-supradesnivelamento-do-segmento-st-iamcsst-anterior-sem-choque-3061.jpeg177480323758362812026-03-29T16:53:57.647Z"daa0fab59992626a86296480f025cb40"155624acc-2026--stemi-door-to-unload---descompresso-do-ventrculo-esquerdo-em-pacientes-com-infarto-agudo-do-miocrdio-com-supradesnivelamento-do-segmento-st-iamcsst-anterior-sem-choque.pdf177505130489422012026-04-01T13:48:25.001Z"759b006820e68a149a6fbf1eae5f8fad"2592280acc-2026--stemi-door-to-unload-left-ventricular-decompression-in-patients-with-anterior-stsegment-elevation-myocardial-infarction-stemi-without-cardiogenic-shock-.pdf177506055756860412026-04-01T16:22:37.607Z"f9b5998fd7ac9292e2a22beabf344e66"2592280acc-2026--stemi-doortounload-descompresin-del-ventrculo-izquierdo-en-pacientes-con-infarto-agudo-de-miocardio-con-elevacin-del-segmento-st-iamcest-anterior-sin-shock.jpeg177504553849842212026-04-01T12:12:18.538Z"9ff87dbc95c1b226506fac19ac3cd619"161826acc-2026--vesalius-cv-evolocumab-para-la-reduccin-del-primer-evento-cardiovascular-mayor-en-pacientes-con-diabetes-y-sin-aterosclerosis-significativa-conocida-.jpeg177481376549309812026-03-29T19:49:25.526Z"8619cf6328af21cc0f62160f4b45cba8"390375acc-2026--vesalius-cv-evolocumabe-para-reduo-do-primeiro-evento-cardiovascular-maior-em-pacientes-com-diabetes-e-sem-aterosclerose-significativa-conhecida-7530.jpeg177481329883022612026-03-29T19:41:38.863Z"3bf42aaa1859a831cd5eb57e3aa144f9"359077acc-2026-allrise-angiography-derived-fractional-flow-reserve-to-guide-pci-5789.177497028829047512026-03-31T15:18:08.336Z"d3318cfefc9d6281fdf7abde0379f4cb"252196acc-2026-championaf-left-atrial-appendage-occl-2229.jpeg177489065260416012026-03-30T17:10:52.642Z"896113c34a94eb4edccca4176bfb2a68"294966acc-2026-championaf-left-atrial-appendage-occlusion-or-anticoagulation-for-atrial-fibrillation-173.177481539746963312026-03-29T20:16:37.504Z"64c323f5a98f30c609d050ef04ecfd75"268534acc-2026-chipbcis3-left-ventricular-unloading-in-highrisk-percutaneous-coronary-intervention-5019.177498034206570312026-03-31T18:05:42.104Z"6b9bc94c35c89eb9099a2534636b2606"2268805acc-2026-digrhd-digoxin-reduces-composite-outcomes-in-patients-with-rheumatic-heart-disease-6159.177558186123683512026-04-07T17:11:01.282Z"3b7e48b59eb8af91380ae1ee84565410"395210acc-2026-dkcrush-viii-ivus-or-angiography-guidance-for-percutaneous-coronary-intervention-in-complex-coronary-bifurcation-lesions-1343.177522414760189912026-04-03T13:49:07.649Z"1e12d610ccf7482a3e57474f90d87078"2180043acc-2026-essencetimi-73b-effect-of-apoc3-inhibition-with-olezarsen-on-coronary-atherosclerosis-imaging-study-5672.177557810856027312026-04-07T16:08:28.600Z"a9fa334645431cacd3716dd3e6054563"1717618acc-2026-ezpave-lower-ldl-targets-are-associat-607.jpeg177489083200472812026-03-30T17:13:52.045Z"e3be1a4fe556ba7de795a9a8db45210d"294263acc-2026-ezpave-lower-ldl-targets-are-associat-8951.jpeg177489095640760512026-03-30T17:15:56.449Z"e3be1a4fe556ba7de795a9a8db45210d"294263acc-2026-ezpave-lower-ldl-targets-are-associated-with-reduced-cardiovascular-risk-in-secondary-prevention-8218.177481229652243012026-03-29T19:24:56.554Z"531fb6601e91393baad0d5b9e3120771"339255acc-2026-fast-iii-angiography-based-physiology-to-guide-coronary-revascularization-1625.177497108155335512026-03-31T15:31:21.600Z"291a10134a2258617572ad133ebade29"260949acc-2026-hero-banner-8207.png177446068381155412026-03-25T17:44:43.852Z"f3425137c36a752a0929ae02b3dbe23d"1302636acc-2026-hero-banner-9155.png177446181072190712026-03-25T18:03:30.829Z"f3425137c36a752a0929ae02b3dbe23d"1302636acc-2026-hero-banner-en.png177334228996577312026-03-12T19:04:50.066Z"f3425137c36a752a0929ae02b3dbe23d"1302636acc-2026-hero-banner-mobile-2435.png177453142680786812026-03-26T13:23:46.841Z"65d431172288d52a98301c5d0fd711cc"313852acc-2026-hero-banner-mobile-3380.png177453086284865912026-03-26T13:14:22.890Z"65d431172288d52a98301c5d0fd711cc"313852acc-2026-hero-banner-mobile-3477.png177453144400586512026-03-26T13:24:04.045Z"85fe7aa32238846daf0c4d22a8d3c838"367938acc-2026-hero-banner-mobile-625.png177453088955843012026-03-26T13:14:49.596Z"65d431172288d52a98301c5d0fd711cc"313852acc-2026-hero-banner-mobile-6627.png177453028631336212026-03-26T13:04:46.354Z"65d431172288d52a98301c5d0fd711cc"313852acc-2026-hero-banner-mobile-85.png177446084595592712026-03-25T17:47:25.997Z"85fe7aa32238846daf0c4d22a8d3c838"367938acc-2026-hero-banner-mobile-9155.png177446181964353012026-03-25T18:03:39.736Z"85fe7aa32238846daf0c4d22a8d3c838"367938acc-2026-hero-banner-mobile-9342.png177453113166155212026-03-26T13:18:51.702Z"65d431172288d52a98301c5d0fd711cc"313852acc-2026-hero-banner-mobile-9884.png177453034412068712026-03-26T13:05:44.160Z"65d431172288d52a98301c5d0fd711cc"313852acc-2026-hero-banner-mobile-en.png177334278288816912026-03-12T19:13:02.929Z"65d431172288d52a98301c5d0fd711cc"313852acc-2026-hero-banner-mobile.png177484180900108212026-03-30T03:36:49.101Z"7a3fc90c40655acf10b9b47241fe6b5a"696740acc-2026-hero-banner.png177484180702500412026-03-30T03:36:47.123Z"7a3fc90c40655acf10b9b47241fe6b5a"696740acc-2026-hipeitho-catheterdirected-thrombolysis-reduces-decompensation-in-intermediaterisk-pulmonary-embolism-4463.177480993972334112026-03-29T18:45:39.757Z"8e15a9c99a8b2282d242198ccc25c621"342445acc-2026-impedancehfpef-early-noninvasive-detection-of-lung-fluid-reduces-death-hospitalization-9922.177498106111404612026-03-31T18:17:41.152Z"29b8e67af2b151904383f5911bd3cb0b"260951acc-2026-ivuschip-intravascular-ultrasoundguided-or-angiographyguided-complex-highrisk-pci-936.177506284440969012026-04-01T17:00:44.450Z"a5d73277a12df3139c544d8a2f1e3bb2"305649acc-2026-kardinal-antisense-therapy-with-tonlamarsen-in-uncontrolled-hypertension-7140.177480765076093512026-03-29T18:07:30.796Z"e30bd16d5247aa54484def04a34e9a89"367421acc-2026-orbitacto-angioplasty-reduces-angina-burden-and-improves-quality-of-life-beyond-placebo-in-chronic-coronary-occlusion-4468.177490332831314112026-03-30T20:42:08.352Z"05aaf2b6e33490542fe86fa40352e415"252354acc-2026-protavi-deferral-of-percutaneous-coronary-intervention-in-patients-undergoing-transcatheter-aortic-valve-implantation-4486.177498218481046612026-03-31T18:36:24.851Z"49a97243901821841aad4b3e3d178ae0"261670acc-2026-smartdecision-betablocker-discontinuation-after-myocardial-infarction-does-not-increase-events-in-stable-patients-7428.177506610618931012026-04-01T17:55:06.228Z"1e6e11160fd07c341fb7136f5f039982"325300acc-2026-spirithf-lack-of-benefit-of-spironolactone-in-patients-with-heart-failure-with-preserved-or-mildly-reduced-ejection-fraction-2033.177497972753465812026-03-31T17:55:27.575Z"74c4ccf1b74b09e97ddf91d2ef80fea6"224413acc-2026-stemi-door-to-unload-left-ventricular-decompression-in-patients-with-anterior-stsegment-elevation-myocardial-infarction-stemi-without-cardiogenic-shock-5830.177480489511142212026-03-29T17:21:35.149Z"70fa45d8d3c6bee1d4a2d2d12402e43d"162090acc-2026-vesaliuscv-evolocumab-for-the-reducti-2511.jpeg177489098064813612026-03-30T17:16:20.687Z"29d407359b322f4b33c03e9c6b5251d9"1496517acc-2026-vesaliuscv-evolocumab-for-the-reducti-9911.jpeg177489062480460412026-03-30T17:10:24.844Z"29d407359b322f4b33c03e9c6b5251d9"1496517acc-2026-vesaliuscv-evolocumab-for-the-reduction-of-first-major-cardiovascular-events-in-patients-with-diabetes-and-without-known-significant-atherosclerosis-9502.177481429608517912026-03-29T19:58:16.117Z"01876cfd998c8c37ca926968331ed4ac"372282acc-2026.png177314847786751712026-03-10T13:14:37.969Z"1e22c9d0080e2234e716195e43655bb1"898836acc-2027-hero-banner-mobile.png177334193621354712026-03-12T18:58:56.251Z"8ef92e04d8a2d7b145b5d068ce35bb65"273618acc-2027-hero-banner.png177334193373038112026-03-12T18:58:53.768Z"938c89d73fe70e402539da39685e5b40"170892acc-2028-coverage.png177783571073251612026-05-03T19:15:10.805Z"cfa3d1497e48f0c8029097232b1ce73b"1774535acc-2028.png177764514181001712026-05-01T14:19:01.945Z"cfa3d1497e48f0c8029097232b1ce73b"1774535acc-2029-coverage.png177783590063591012026-05-03T19:18:20.707Z"cfa3d1497e48f0c8029097232b1ce73b"1774535acc-issues-consensus-on-medical-weight-management:-structured,-stepwise-approach-recommended..png175192400708534912025-07-07T21:33:27.132Z"bf3f6b5c23f0b51e16c06167329088fc"1328023acoramidis-and-cardiovascular-mortality:-42-month-results-from-attribute-cm-ole.png175690830088986512025-09-03T14:05:01.002Z"af4af7da6b1657ed92e4004591d5f9f4"1721860ada-2025---benefício-tardio-da-intervenção-no-estilo-de-vida:-look-ahead.png175046694555850312025-06-21T00:49:05.602Z"e0f6ef5e1b0bfbf379be21573a0528ed"1306656ada-2025---novo-agonista-quádruplo-mostra-efeito-na-perda-de-peso-sem-perda-muscular..png175046906058514912025-06-21T01:24:20.625Z"23b808bff707f011ef10bd1b9d891fb2"458720ada-2025---orforglipron-em-dm2-inicial:-achieve-1.jpeg175053796134136112025-06-21T20:32:41.383Z"612ab1c97e7484b1d373a4e6e589d697"13824262ada-2025---perda-de-peso-sustentada-com-tirzepatida-em-pacientes-com-pré-diabetes:-análise-pós-hoc-do-surmount-1.png175046993581440012025-06-21T01:38:55.874Z"a554e063c0d3e89f2a9fdb91004ba659"2398278ada-2025---redução-sustentada-do-tecido-adiposo-epicárdico-após-4-anos-com-dapagliflozina-–-dapaheart.jpeg175047019005325512025-06-21T01:43:10.097Z"bebd44521c98e27925659131ae2c1fe9"93345ada-2025---semaglutida-7,2-mg-mostra-benefício-adicional-na-obesidade.jpeg175053700812632912025-06-21T20:16:48.167Z"bb11f6a91672bc9014203ad1bf3a4dcb"82228ada-2025---sglt2-e-glp-1-ras-na-redução-de-demência.png175045012384860112025-06-20T20:08:43.895Z"ab1029c322aa779d2100b377267b27ae"1168902ada-2025---tirzepatida-na-perda-de-peso:-benefício-consistente,-independente-da-velocidade-de-resposta.jpeg175055187548603112025-06-22T00:24:35.530Z"b7e2611150efa50f7285e080715749f8"535192ada-2025---tirzepatida-vs.-dulaglutida:-sinal-de-maior-benefício-cardiovascular.jpeg175055215301074412025-06-22T00:29:13.054Z"556f0afe7b372482af31390a2faaf9c2"601362ada-2025-–-cagrisema-no-manejo-da-obesidade:-redefine-1.jpeg175059956663218912025-06-22T13:39:26.698Z"340801643aeb84d09ac617f49a8ae498"85315ada-2025-–-finerenona-e-empagliflozina-na-drc-e-dm2:-confidence.jpeg175062033321916912025-06-22T19:25:33.261Z"f3d1c867173ea49d1ad69f21d0ca5829"13192335ada-2025-–-insulina-semanal-para-dm2-sem-insulina-prévia:-qwint-1.jpeg175063676973824512025-06-22T23:59:29.799Z"f5a4100a0437aacbf48764b33ac16f75"93500ada-2025-–-perda-de-peso-com-preservação-muscular:-believe.jpeg175069952939211812025-06-23T17:25:29.434Z"2a18d1c4e92f01b7f7d930c4263429aa"30481ada-2025-–-semaglutida-melhora-capacidade-funcional-na-doença-arterial-periférica-com-diabetes-tipo-2:-stride.jpeg175072679241275012025-06-24T00:59:52.478Z"fee10ce09ca530903158ad2d25c3e9d0"2570066ada-2025-–-semaglutida-oral-reduz-riscos-de-eventos-cv:-soul.png175071016252055012025-06-23T20:22:42.564Z"58dece976fe13a16c60db1396ab7ab9e"1455002ada-2025-–-semaglutida-reduz-risco-renal-e-cardiovascular-independente-do-peso.jpeg175063905304461612025-06-23T00:37:33.091Z"d3e59ace41e7b2b9d3e0f17366950cd2"5478205ada-2025-–-triplo-agonista-promissor-na-nash.jpeg175063835147075012025-06-23T00:25:51.524Z"40a7c6acbe54c82e66b430d1365c1804"80213adapt-af-des-la-monoterapia-con-acod-es-superior-a-la-terapia-combinada-en-pacientes-con-fibrilacin-auricular-despus-del-implante-de-stent-farmacoactivo-.png176270814891615012025-11-09T17:09:08.962Z"0b4a357521f79853ab35e077ca3e395c"1481681adapt-af-des-monoterapia-com-noac--superior--terapia-combinada-em-pacientes-com-fibrilao-atrial-aps-stent-farmacolgico.png176270424027523412025-11-09T16:04:00.327Z"d6b0619dc62fc1da11805fb43f2a6dae"1461727adapt-afdes-acod-monotherapy-superior-postdes-in-af.png176563157191216812025-12-13T13:12:51.970Z"d78845ffa0272ddfafb77620e058bc01"656311adapt-afdes-noac-monotherapy-is-superior-to-combination-therapy-in-patients-with-atrial-fibrillation-after-drugeluting-stent-implantation.png176270846842026812025-11-09T17:14:28.470Z"49cb76415a305a75603886462615faf2"1473539adapt-afdes-noac-monotherapy-superior-postdes-in-af.null176563380420821612025-12-13T13:50:04.322Z"71192e6f313d4478e530b790d86867b3"1481987adapt-afdes-noac-monotherapy-superior-postdes-in-af.png176563374967969112025-12-13T13:49:09.724Z"71192e6f313d4478e530b790d86867b3"1481987adapt-afdes-trial-anticoagulant-monotherapy-outperforms-dual-therapy-beyond-12-months-after-des-in-af-patients.png176295984672142212025-11-12T15:04:06.771Z"b4bda1e30dbd6aa7360d4f290111eb10"2657526adc-de-nueva-generacin-en-el-aacr-2026-payloads-duales-nuevos-blancos-y-combinaciones-que-cambian-la-prctica-clnica-.jpeg177645194423282612026-04-17T18:52:24.292Z"1b4725d1979145c10e518022e03a3388"240004adc4-nurses.png176165260920480712025-10-28T11:56:49.258Z"1b6923dbdefc378b559edfa6e05551d0"3532139adcs-de-nova-gerao-no-aacr-2026-payloads-duplos-novos-alvos-e-combinaes-que-mudam-a-prtica-clnica--7555.jpeg177645601594741412026-04-17T20:00:16.017Z"dda20a31656da01f30456371d64f5e5e"243636adcs-parp-cirurgia-o-novo-mapa-teraputico-est-sendo-desenhado-agora-3479.png177603972349822912026-04-13T00:22:03.585Z"02cd9e7249afd8aa0897fdcd376060f6"2222744adjuvant-chemotherapy-improves-survival-in-older-women-with-triplenegative-breast-cancer-study-finds-6061.177576900644932612026-04-09T21:10:06.508Z"ef27670845535f8d79d50af2801b1fc8"2189356adore-study:-ruxolitinib-+-siremadlin-30-mg-shows-efficacy-in-myelofibrosis..png175632570084728712025-08-27T20:15:00.887Z"9086d94d62b07be624a2afc6c0d342c2"1467852adrisk-study-evaluates-adjuvant-pembrolizumab-combined-with-radiotherapy-and-cisplatin-in-locally-advanced-head-and-neck-cancer.png176080471946969612025-10-18T16:25:19.514Z"61e9025a25ee8aec9ad439be5b139e76"1895256advances-and-ongoing-challenges-in-rare-endocrine-disorders..png175519343206489712025-08-14T17:43:52.113Z"6506dc2faafb0a0adfbfe0b8e9046cea"1936433advances-in-the-management-of-metabolic-dysfunction–associated-steatotic-liver-disease-(masld)..png175519329392983612025-08-14T17:41:33.979Z"44acdb9ff13a5de2e684c18eb5165893"2361764advances-in-understanding-and-managing-long-qt-syndrome-genetics-risk-modifiers-and-evolving-therapies.jpeg176415956918128212025-11-26T12:19:29.222Z"49c7c755392a5f699f47c02881f0e53a"190881aficamten-vs-metoprolol-maplehcm-shows-superiority-of-myosin-inhibition-in-obstructive-hcm.png175880450445765212025-09-25T12:48:24.509Z"342886481ed938dd7ee17f55daf7610e"2677830agomelatina-inovao-na-interface-entre-farmacologia-e-cronobiologia.png175771126482358512025-09-12T21:07:44.883Z"5ac03b84246fcc764c737eaa6e8a0ba6"2242703agomelatine-innovation-at-the-interface-of-pharmacology-and-chronobiology.png175777742931522712025-09-13T15:30:29.383Z"5ac03b84246fcc764c737eaa6e8a0ba6"2242703agonistas-de-glp-1-reduzem-risco-cardiovascular-em-t2d-precoce-comparados--insulina.jpeg175821983118153412025-09-18T18:23:51.223Z"b91e2d30b0c302c73088af9de68dba53"319418agonistas-de-glp-1-sob-nova-regulamentação:-anvisa-exige-retenção-de-receita-a-partir-de-junho.jpeg175009299186941812025-06-16T16:56:31.912Z"ee7f6b0d33c78a3e26733c5bf97711a0"8178689aha-2025.png176045060671476512025-10-14T14:03:26.761Z"9f724840a10c4655574a6d60d6a06cdb"626663aha-2026--do-nutriente-ao-padrão-—-10-mensagens-que-devem-mudar-a-forma-como-pensamos-a-alimentação-na-prática-clínica.png177609095831915612026-04-13T14:35:58.375Z"7390e889d72a9947a89e03454db30d88"1880490aha-2026-do-nutriente-ao-padro--10-mensagens-que-devem-mudar-a-forma-como-pensamos-a-alimentao-na-prtica-clnica-1472.png177576438924815512026-04-09T19:53:09.315Z"5ebe974f6315924612b3390f97c047bb"2139438ai-improves-sensitivity-in-detecting-her2-low-and-her2-ultralow-in-advanced-breast-cancer.jpeg175493617727648612025-08-11T18:16:17.361Z"5bc0b7da8698c8ea36c61b3d42ecc1a2"10408858ai-prime-hero-banner.jpeg176606586367198912025-12-18T13:51:03.711Z"b2f6b1c1bfbc239f2ae0910922401628"835415algoritmos-baseados-em-machine-learning-para-detecção-precoce-e-triagem-de-distúrbios-neurodegenerativos-e-neurocognitivos.jpeg174861388252334412025-05-30T14:04:42.564Z"1a9360bc8b4fef014a0263b95a4c9249"742364alzheimer-em-estágio-avançado--sus-passa-a-ofertar-donepezila-para-quadros-graves.jpeg175286492946680012025-07-18T18:55:29.510Z"51a62e9ae4b2cb17a94366f42f7b0df0"6568605alzheimers-beyond-the-brain-a-review-reframes-ad-as-an-organbrain-immune-network.png176970266815958112026-01-29T16:04:28.207Z"f15e4af1035bc63df20ebd87c9ea8255"6783885amiloidose-al-o-diagnstico-ainda-demora-dois-anos--e-isso-mata-pacientes-2808.jpeg177574312526750012026-04-09T13:58:45.327Z"fffb07c9059e2b1be1da481365778c22"5397104amiloidose-attr-como-o-pcdt-orienta-o-diagnstico-e-o-tratamento.jpeg176969024066149712026-01-29T12:37:20.701Z"0d1023b739a463d2d47908accad5c544"174132amiloidose-do-subdiagnstico-ao-tratamento-precoce-que-muda-a-histria-da-doena.png177072856394101812026-02-10T13:02:43.986Z"502a825b8e66c510386e1ff4512bd123"1085934amivantamablazertinib-improves-overall-survival-in-egfrmutated-advanced-nsclc.png175745489760416012025-09-09T21:54:57.645Z"8c96fa9260e906af0c91557270ce58b8"2641224amplificação-de-fgfr1-define-subtipo-agressivo-de-câncer-colorretal.jpeg175647873108484212025-08-29T14:45:31.127Z"126532be6685e108d8e637b76215c1ef"15258540anlise-crtica-da-eficcia-e-segurana-do-caplacizumabe-no-tratamento-da-prpura-trombocitopnica-trombtica-imune-uma-reviso-sistemtica-atualizada-e-meta-anlise.jpeg177248273637596212026-03-02T20:18:56.445Z"a4d8200c175e308f160da130a08932e7"7151787anlise-de-cinco-anos-do-estudo-polarix-eficcia-e-segurana-de-pola-r-chp-versus-r-chop-no-linfoma-difuso-de-grandes-clulas-b.jpeg177248232048557012026-03-02T20:12:00.555Z"c47d5579f24935bcb54c6d4dbcaf0d3c"13041007anlise-do-estudo-axsana-eubreast-3-estadiamento-axilar-menos-invasivo-aps-quimioterapia-neoadjuvante-.png176600433578790812025-12-17T20:45:35.833Z"1b87dc2799f41b5167b0a9ef3fc70631"1381746ans-avalia-inclusão-de-selpercatinibe-no-rol-para-tratamento-de-carcinoma-medular-de-tireoide-ret+.jpeg175009415069135912025-06-16T17:15:50.740Z"99d73444d603e295153fb9cb1b371d08"7948516anti-amyloid-therapies-show-modest-benefits-in-alzheimer's-disease-meta-analysis-reveals-limited-cognitive-improvements-with-safety-concerns.png175405735382682912025-08-01T14:09:13.881Z"086800b0cb019e38694cb786d9e6078b"2852355anticd300c-antibody-cl7-reduced-tumor-growth-and-improved-survival-in-a-murine-nsclc-model.png176736076542703112026-01-02T13:32:45.466Z"f3bc3ba629a9a8244170e068e8e355f5"6919221anticd300c-antibody-cl7-suppresses-nsclc-tumor-growth-by-remodeling-macrophagedriven-microenvironment.png176736090614922112026-01-02T13:35:06.189Z"f3bc3ba629a9a8244170e068e8e355f5"6919221anticoagulao-isolada--mais-segura-que-terapia-dupla-em-pacientes-com-sndrome-coronariana-crnica.png176597669957222612025-12-17T13:04:59.709Z"bf2ddd353d618a03f3daf855d9b00b21"659864anticoagulação-em-pacientes-com-fibrilação-atrial-após-hemorragia-intracraniana--meta-análise-mostra-benefício-clínico-líquido-mas-devemos-ter-muita-atenção-ao-risco-de-recorrência.jpeg175404950060169512025-08-01T11:58:20.640Z"5069695fdd3c1e757eea5c67dd2a58bb"224897anticorpo-biespecfico-pd-l1-vegf-combinado--quimioterapia-reduz-risco-de-progresso-no-snc-em-47-em-pacientes-com-metstases-cerebrais-aps-falha-de-tki-8950.jpeg177508089458253912026-04-01T22:01:34.628Z"a5fd71414f2c2d1837be9adabc46d0a2"314734anticorpo-biespecfico-pd-l1vegf-combinado--quimioterapia-reduz-risco-de-progresso-no-snc-em-47-em-pacientes-com-metstases-cerebrais-aps-falha-de-tki-1112.jpeg177508084366708912026-04-01T22:00:43.713Z"a5fd71414f2c2d1837be9adabc46d0a2"314734anvisa-aprova-butantan-dv-primeira-vacina-100-nacional-contra-dengue-baseada-em-ensaio-de-fase-3-com-mais-de-16-mil-brasileiros.jpeg176425600937806912025-11-27T15:06:49.426Z"cc08af432430fc078578c5a726d92d19"196875anvisa-aprova-cemiplimabe-adjuvante-no-cec-cutneo-de-alto-risco.jpeg176781641461804012026-01-07T20:06:54.902Z"8777842110f26b9c9271976aceafca96"184658anvisa-aprova-mirvetuximabe,-primeiro-adc-direcionado-ao-receptor-de-folato-alfa,-para-câncer-de-ovário-resistente-à-platina-.jpeg175692293132640812025-09-03T18:08:51.367Z"108805e18416b7e65c84792371246b04"1131054anvisa-aprova-nova-indicao-de-lenacapavir-e-amplia-estratgias-de-preveno-ao-hiv-1-no-brasil.png177073510980950212026-02-10T14:51:49.937Z"ab41d426e9f4ab15e35e66e3f226c199"4145911anvisa-aprova-pembrolizumabe-no-cenrio-perioperatrio-do-cec-de-cabea-e-pescoo.jpeg175822971136289312025-09-18T21:08:31.403Z"ca3878b51ad21409a617e1fc4c8d1de5"4366802anxiety-depression-and-obesity-an-interconnected-challenge-in-clinical-practice.png175778471195843112025-09-13T17:31:52.024Z"429bf8d71a787ffc4b17563639a4fcc6"2204383apoc3-inhibition-with-olezarsen-achieves-significant-and-durable-triglyceride-reduction-in-highrisk-patients.png175984821553145212025-10-07T14:43:35.592Z"af809629ce36c59361e10474eaa646b4"2357823apoio-empático-por-telefone-melhora-controle-glicêmico-em-pacientes-com-diabetes-tipo-2.jpeg174827563252284012025-05-26T16:07:12.568Z"8daaef363c13398a069955dfb5a08941"550298apoio-que-impulsiona-a-ciência--viabilização-da-pesquisa-clínica-no-brasil-.jpeg175707330724158212025-09-05T11:55:07.299Z"d5cc216ae0b160ebd90eea8d70d3c80d"203857apoptosis-linked-plasma-biomarkers-emerge-as-correlates-of-breathlessness-in-long-covid..png175329635950777512025-07-23T18:45:59.556Z"ede5e4d32dcc94e00dc271cade91c6f4"1667982aprendendo-sobre-a-principal-função-do-coração-no-corpo-humano.jpeg177548295163404812026-04-06T13:42:31.672Z"1420351d0286536fb2206d3e24ff58f4"338521aprendendo-sobre-oncologia.png177573400729577012026-04-09T11:26:47.370Z"5eedac2d78bdbde9746067487dd5a2a8"758641are-community-health-workers-costeffective-in-primary-health-care-a-global-systematic-review-of-50-economic-evaluations.png176970209820630012026-01-29T15:54:58.245Z"0f8b14ffd6e592f608f1e18d79c1f8ea"8256368artificial-intelligence-and-hospital-outbreak-prevention:-a-novel-approach-to-identify-vancomycin-resistant-enterococcus-carriers.jpeg175287365960547712025-07-18T21:20:59.671Z"10e4ef0f4a612b4c31cb3f8d394de80c"26669005artificial-intelligence-in-acute-myeloid-leukemia:-diagnostic,-prognostic,-and-therapeutic-perspectives.png175691887551747312025-09-03T17:01:15.560Z"4ffb693d4b7155540f6a3a89ee9b4220"2107417artificial-intelligence-in-clinical-practice:-ethical-dilemmas-and-responsible-implementation-pathways.jpeg175287348657320912025-07-18T21:18:06.637Z"64d830098a704d94570d23419bb63d40"1180741artificial-intelligence-in-computational-pathology-aacr-2026-dedicates-a-plenary-to-the-revolution-reaching-the-diagnostic-bench-.jpeg177686470527770712026-04-22T13:31:45.346Z"6b21025ef65644e09c73c157aa3b4a2f"383875artificial-intelligence-in-computational-pathology-aacr-2026-dedicates-a-plenary-to-the-revolution-reaching-the-diagnostic-bench-1945.177687444096639512026-04-22T16:14:01.028Z"6b21025ef65644e09c73c157aa3b4a2f"383875artificial-intelligence-in-computational-pathology-aacr-2026-dedicates-a-plenary-to-the-revolution-reaching-the-diagnostic-bench-438.177686557681788012026-04-22T13:46:16.887Z"6b21025ef65644e09c73c157aa3b4a2f"383875artificial-intelligence-in-computational-pathology-aacr-2026-dedicates-a-plenary-to-the-revolution-reaching-the-diagnostic-bench-77.177687626727602112026-04-22T16:44:27.338Z"6b21025ef65644e09c73c157aa3b4a2f"383875artificial-intelligence-may-enable-costeffective-population-screening-for-glaucoma.png175934343479646612025-10-01T18:30:34.904Z"b800bd1b34f28801b5c71f8117e1c476"2214076artificial-intelligence-transforms-prediction-of-diabetes-complications.jpeg175822000604716112025-09-18T18:26:46.090Z"96153a626408f75f292e1859d3f7bffa"332501artificial-pancreas-system-lowers-hba1c-by-08-and-increases-time-in-range-by-23-in-adults-with-t1d.jpeg175832243703929012025-09-19T22:53:57.100Z"148e392415d45c16222aa2b3acc686de"315749ascent-04:-nova-combinação-com-sacituzumab-govitecana-melhora-slp-no-tnbc-metastático-pd-l1-positivo.png175226313624028712025-07-11T19:45:36.300Z"3f970aea2866956e1ccae04e8a946ae4"1353236asco-2024.png177783547809876512026-05-03T19:11:18.243Z"cfa3d1497e48f0c8029097232b1ce73b"1774535asco-2025-hero-banner-mobile.png177393093292773812026-03-19T14:35:32.962Z"cfa3d1497e48f0c8029097232b1ce73b"1774535asco-2025-hero-banner.png177393092960410912026-03-19T14:35:29.642Z"7a3fc90c40655acf10b9b47241fe6b5a"696740asco-2026-hero-banner-3430.png177877942687576012026-05-14T17:23:46.939Z"0344d5a72e2389fc5a4537f7bafa5f5a"265725asco-2026-hero-banner-en.png177430151675801412026-03-23T21:31:56.871Z"d4a22bbdf966799117ed94a823477c18"249602asco-2026-hero-banner-mobile-3430.png177877942926918812026-05-14T17:23:49.330Z"72d1ef6cf80c9b86710e0a7d78aee24b"72725asco-2026-hero-banner-mobile-en.png177430151510482012026-03-23T21:31:55.270Z"a88b8a0941eaa057d993887a7e7b24b4"401696asco-gi-2026-atualizaes-relevantes-em-cncer-colorretal-.jpeg176850920892463712026-01-15T20:33:28.963Z"6ccf60ce5221c61ac0f821c49867443d"324490asco-gi-2026-hero-banner-mobile.png177444982752014912026-03-25T14:43:47.560Z"a88b8a0941eaa057d993887a7e7b24b4"401696asco-gi-2026-hero-banner.png177444982530701412026-03-25T14:43:45.410Z"d4a22bbdf966799117ed94a823477c18"249602asco-gi-2026-novas-estratgias-em-imagem-e-qualidade-de-vida-no-cncer-colorretal.jpeg176850502586313412026-01-15T19:23:45.902Z"384b0f88c388f56c259c59bcce5b4aa6"218824asco-gi-2026-novidades-no-tratamento-do-hepatocarcinoma.jpeg176823991155643612026-01-12T17:45:11.671Z"7fa4d44c56d26da737cf39bc758e4e40"214894asco-gi-2026.png176487534643567112025-12-04T19:09:06.481Z"9f1ecc878782d74e1e87b914b85de247"512357asco-gi-principais-destaques-em-cncer-gstrico-e-esofagogstrico.jpeg176823932748571312026-01-12T17:35:27.617Z"68d8daf30396c8acd6d0056a60aad3f4"200992asco-gu---cncer-de-bexiga-ctdna-utdna-no-niagara-e-resultados-finais-do-t-dxd-no-destiny-pantumor02.png177229406788060912026-02-28T15:54:28.019Z"66f99ddec440c662ba92027955577f51"1129545asco-gu---cncer-de-bexiga-ctdnautdna-no-niagara-e-resultados-finais-do-t-dxd-no-destiny-pantumor02.png177187989207546912026-02-23T20:51:32.144Z"eb38bf21acaa4c00824382add30b844e"1127239asco-gu---câncer-de-bexiga--ctdna-utdna-no-niagara-e-resultados-finais-do-t-dxd-no-destiny-pantumor02-1.png177222568705124312026-02-27T20:54:47.131Z"af8353a80e60d29d9a7c3c0334c88fca"26123asco-gu---câncer-de-bexiga--ctdna-utdna-no-niagara-e-resultados-finais-do-t-dxd-no-destiny-pantumor02-2.png177222568820929912026-02-27T20:54:48.284Z"45810c9a41ed17c04dcd280ec0d4adc6"20117asco-gu---prstata-intensificao-precoce-psma-pet-e-combinaes-biomarcadas--os-estudos-que-merecem-ateno.png177229374706321612026-02-28T15:49:07.187Z"cd79e92b5cd53c722edba45f3199eb4f"1381054asco-gu---próstata--intensificação-precoce,-psma-pet-e-combinações-biomarcadas-—-os-estudos-que-merecem-atenção-1.png177222673861373212026-02-27T21:12:18.683Z"771c117683f26a7b95d3f15b454f7187"73210asco-gu---próstata--intensificação-precoce,-psma-pet-e-combinações-biomarcadas-—-os-estudos-que-merecem-atenção-2.png177222673970531712026-02-27T21:12:19.773Z"39bc09f9c3b3826ffeb7ff577eb8a1e7"60799asco-gu---próstata--intensificação-precoce,-psma-pet-e-combinações-biomarcadas-—-os-estudos-que-merecem-atenção-3.png177222674086212712026-02-27T21:12:20.930Z"23d3827b3215f72864da9506d58650ea"62860asco-gu---próstata--intensificação-precoce,-psma-pet-e-combinações-biomarcadas-—-os-estudos-que-merecem-atenção-4.png177222674226757212026-02-27T21:12:22.334Z"cb9e91a72c437930bc75cc6e6ce27f82"61512asco-gu---próstata--intensificação-precoce,-psma-pet-e-combinações-biomarcadas-—-os-estudos-que-merecem-atenção-5.png177222674348559112026-02-27T21:12:23.554Z"9794758655c3bc39e0efd9d288c48610"53882asco-gu---próstata--intensificação-precoce,-psma-pet-e-combinações-biomarcadas-—-os-estudos-que-merecem-atenção-6.png177222674505347012026-02-27T21:12:25.122Z"8268d94af8bb74808b5d4975dc4bbcf9"51128asco-gu--cncer-de-bexiga-ctdnautdna-no-niagara-e-resultados-finais-do-t-dxd-no-destiny-pantumor02.png177187983793609212026-02-23T20:50:38.006Z"eb38bf21acaa4c00824382add30b844e"1127239asco-gu-2026-combinao-de-enzalutamida-e-rdio-223-demonstra-ganho-em-sobrevida-global-no-mcrpc-e-novas-estratgias-com-t-cell-engagers-avanam-no-cenrio-refratrio-.jpeg177228398208392712026-02-28T13:06:22.152Z"081515397b136e6de6120bbb3d3fe533"229364asco-gu-2026-keynote-b15-ev-304-demonstra-benefcio-expressivo-com-enfortumabe-vedotina--pembrolizumabe-no-cncer-de-bexiga-msculo-invasivo-.jpeg177230908432579712026-02-28T20:04:44.425Z"a4db51720cbac6ac45cfe888e73b94fb"361526asco-gu-2026-keynote-b15-ev-304-demuestra-beneficio-significativo-con-enfortumab-vedotina--pembrolizumab-en-cncer-de-vejiga-msculo-invasivo-.jpeg177231043825940212026-02-28T20:27:18.328Z"21f5ee5f606738c77110d0884d169974"352002asco-gu-2026-keynote-b15ev-304-demuestra-beneficio-significativo-con-enfortumab-vedotina--pembrolizumab-en-cncer-de-vejiga-msculo-invasivo-.jpeg177231029829454012026-02-28T20:24:58.377Z"21f5ee5f606738c77110d0884d169974"352002asco-gu-2026-la-combinacin-de-enzalutamida-y-radio-223-demuestra-beneficio-en-supervivencia-global-en-mcrpc-y-nuevas-estrategias-con-t-cell-engagers-avanzan-en-el-escenario-refractario-.jpeg177228746085441412026-02-28T14:04:20.924Z"4fa75381392a58ad5f35becafe70c2d2"216779asco-gu-2026-litespark-011-e-litespark-022-reforam-o-papel-do-belzutifano-no-cncer-renal-avanado-e-adjuvante-.jpeg177231107254998512026-02-28T20:37:52.619Z"ac660e131e552b04a420bbdd92349259"287142asco-gu-2026-litespark-011-e-litespark-022-reforam-o-papel-do-belzutifano-no-cncer-renal-avanado-e-adjuvante-.png177317284689137712026-03-10T20:00:46.922Z"e1ec89024b8e08a3d24adebf3df1d77f"1359718asco-gu-2026-litespark-011-y-litespark-022-consolidan-el-papel-de-belzutifan-en-el-carcinoma-renal-avanzado-y-en-el-escenario-adyuvante-.jpeg177231078414064312026-02-28T20:33:04.209Z"e2756df84017a459c735b1e65d19f41d"268646asco-gu-2026.png176858202083355312026-01-16T16:47:00.939Z"a620fac6bb202f6bd0a76bd882ea2493"359172ascogu-2026.png176858168138718612026-01-16T16:41:21.442Z"a620fac6bb202f6bd0a76bd882ea2493"359172asco®-2025:-highlights-tumores-gastrointestinais-.png174957364533030712025-06-10T16:40:45.382Z"60d0446d985584a42b6967b5a26695dd"544509asco®-2025:-highlights-tumores-gastrointestinais.png174956396152308212025-06-10T13:59:21.577Z"60d0446d985584a42b6967b5a26695dd"544509asco®-2025:-o-que-muda-na-prática-clínica-em-tumores-gênito-urinários-.png174964604186637312025-06-11T12:47:21.980Z"60d0446d985584a42b6967b5a26695dd"544509asdasd.jpeg176892708326107722026-01-20T16:38:03.305Z"80ff27ab1b16c0579737ec338e72ad70"583626ash-2025---atualizao-do-cartitude-4-revela-benefcio-sustentado-do-cilta-cel-no-mieloma-mltiplo-.jpeg176514247416445912025-12-07T21:21:14.271Z"004d1bc7b97e5d00f9b6686d336f5fbb"243143ash-2025---manejo-dos-eventos-oculares-com-belantamabe-mafodotina-no-mieloma-mltiplo-refratrio-dados-dos-estudos-dreamm-7-e-dreamm-8.png176531777491360512025-12-09T22:02:54.964Z"612603113fee619f87a688619753139d"1276891ash-2025--bruin-trial-expande-evidncias-para-pirtobrutinibe-em-macroglobulinemia-de-waldenstrm.jpeg176513807222114512025-12-07T20:07:52.267Z"0408be9c790eff893cd4e9a44861abaf"205819ash-2025--cartitude-4-mostra-benefcio-duradouro-de-ciltacabtagene-autoleucel-em-mieloma-mltiplo-recidivadorefratrio-de-risco-padro-.jpeg176514091737032112025-12-07T20:55:17.478Z"d513e74e0bb45c688d23493a503d5491"252076ash-2025--cartitude-4-mostra-benefcio-duradouro-de-ciltacabtagene-autoleucel-em-mieloma-mltiplo-recidivadorefratrio-de-risco-padro.jpeg176514002997617012025-12-07T20:40:30.115Z"d513e74e0bb45c688d23493a503d5491"252076ash-2025--epcoritamabe-demonstra-respostas-profundas-e-altas-taxas-de-negativao-de-drm-em-primeira-linha-para-dlbcl-fragilizado-.jpeg176514128282513712025-12-07T21:01:22.873Z"8c57af3d03f5ec2227308178c53adbbe"316918ash-2025--regime-zana-atinge-897-de-resposta-completa-com-zanubrutinibe--rituximabe--metotrexato-em-altas-doses-no-pcnsl-recm-diagnosticado-.jpeg176514316190658512025-12-07T21:32:41.953Z"74cd0fcea1af0031ceb4c5dcd3e66356"325104ash-2025-advances-in-myelodysplastic-syndromes-mds.png176614354733245112025-12-19T11:25:47.372Z"0fc2372d34c0d48b1c07834c145923b0"964635ash-2025-avano-no-tratamento-de-primeira-linha-da-llc---resultados-do-estudo-cll17.jpeg176538650902544012025-12-10T17:08:29.073Z"83616462fc0162b45a2c5c7e25a28426"576033ash-2025-avanos-em-terapias-com-car-t-e-anticorpos-biespecficos-.png176608881462003712025-12-18T20:13:34.659Z"b0b5551df2b4f40c7a711e018f8ffc6c"1941946ash-2025-avanos-na-imunoterapia-redefinem-o-tratamento-do-mieloma-mltiplo-recidivado-refratrio-.png176608837647240712025-12-18T20:06:16.511Z"0f6890158bb928bc6a50c1d248c5d0d7"1105056ash-2025-avanos-no-controle-da-hematopoiese-clonal-com-inibidores-de-cdk4-6.jpeg176547366379648412025-12-11T17:21:03.843Z"02796b2247aeb1ec6e04aac43d71f240"221687ash-2025-benefcios-do-uso-precoce-do-cilta-cel-no-tratamento-do-mieloma-mltiplo.png176528691711989912025-12-09T13:28:37.169Z"83be49d968abda379585d4a3df2010c2"1558789ash-2025-breakthroughs-in-aml-treatment-and-transplant.png176623505911224112025-12-20T12:50:59.152Z"b0285d72b11728eabd299d3f0eaf7cad"364593ash-2025-breakthroughs-in-cll-treatment-targeted-therapies.png176609631017063012025-12-18T22:18:30.215Z"bfe1baec3edfb278ff93d55db8fc6185"2436170ash-2025-breakthroughs-in-lymphoma-fixedduration-therapy.png176614277391128412025-12-19T11:12:53.951Z"f3e5b4a6027a3242d3709985caf085de"2159772ash-2025-cartitude-4-mostra-sobrevida-livre-de-progresso-superior-a-80-em-30-meses-para-pacientes-com-risco-citogentico-convencional-tratados-com-cilta-cel-.jpeg177196267957090612026-02-24T19:51:19.695Z"92081a2d0c1acd36d9429abfa34b02d0"242242ash-2025-durao-do-tratamento-com-hipometilantes-impacta-resultados-em-smd-de-baixo-risco.jpeg176547813810318612025-12-11T18:35:38.160Z"790169d129d965a66e5d382ba3f6cba2"271169ash-2025-estudo-cristallo---evidncias-de-longo-prazo-reforam-a-eficcia-do-venetoclax--obinutuzumabe-no-tratamento-da-llc-.jpeg176530883784475412025-12-09T19:33:57.886Z"4e055c3934d95ecf56159c275ba12a97"267556ash-2025-evidncias-de-mundo-real-sobre-o-uso-de-elranatamabe-no-tratamento-do-mieloma-mltiplo.jpeg177222711786769812026-02-27T21:18:37.937Z"01b02a226c2217f9898fc4f044b73d06"418337ash-2025-gmmg-hd7-demonstra-que-isa-vrd-mantm-a-qualidade-de-vida-global-do-paciente-com-melhora-significativa-na-fadiga-dos-pacientes-com-mieloma-mltiplo-recm-diagnosticado-elegvel-ao-transplante-.jpeg176539620605529712025-12-10T19:50:06.100Z"e753eb15f3407fd1cb26364c3a8d1832"231455ash-2025-immunotherapy-in-relapsed-multiple-myeloma.png176623699672169612025-12-20T13:23:16.766Z"040dfa902d413961888f4d006bf7f7dc"1080421ash-2025-new-frontiers-in-cart-and-bispecific-antibodies.png176623292404916212025-12-20T12:15:24.096Z"bca1bd22aa95978c5fac857028f768ea"1965719ash-2025-nova-definio-de-alto-risco-funcional--apresentada-por-dr-luciano-costa-no-ash.jpeg177193892872117812026-02-24T13:15:28.784Z"56170be6fcf71981e2d776a38f45892b"250556ash-2025-novos-dados-consolidam-avanos-em-terapias-dirigidas-drm-e-inibidores-de-btk-no-tratamento-da-leucemia-linfoctica-crnica.png176597468869199812025-12-17T12:31:28.731Z"4ae299d194a7b29cae71cd4a19de8f14"2364002ash-2025-novos-estudos-redefinem-o-tratamento-da-leucemia-mieloide-aguda-da-induo-ao-transplante-.png176608859698982412025-12-18T20:09:57.029Z"4d24e576faf3660bfac4aaae82a1c4f1"390424ash-2025-pirtobrutinibe-versus-ibrutinibe-no-tratamento-da-llc-resultados-do-estudo-bruin-cll-313.jpeg176530920691421112025-12-09T19:40:06.964Z"e9885c8625dae41f2bf31910ddf32a47"263472ash-2025-terapia-car-t-mostra-resultados-promissores-na-amiloidose-al.png176530118104913112025-12-09T17:26:21.096Z"aa45ceeb918b18cf6d28bcdef71cfdcb"1783634ash-2025.png176303900207235512025-11-13T13:03:22.112Z"6dc16edfa21094f05df045fdf214db55"212508ash-highlights-2025-o-que-muda-na-prtica-clnica-do-hematologista mdulo-leucemia.png177222005817378912026-02-27T19:20:58.302Z"2b631c86dd7a8ff483e6c6a0ac5c6dcf"1234992ash-highlights-2025-o-que-muda-na-prtica-clnica-do-hematologista mdulo-linfoma.png177221676684866912026-02-27T18:26:06.974Z"3a6c848bc15761dc858a15c9a14ab446"142611ash-highlights-2025-o-que-muda-na-prtica-clnica-do-hematologista mdulo-mieloma-mltiplo.png177221671365799812026-02-27T18:25:13.797Z"673f9a8342e8def000630940aeae42a0"848834assist-hero-banner-4684.png177446291466224112026-03-25T18:21:54.701Z"5e8bf66c92362ffcd8d7110379692d01"20399assist-hero-banner-7694.webp177625845579976512026-04-15T13:07:35.868Z"b6052a951b292688f5e28bfb04e23d17"152262assist-hero-banner-mobile-4684.png177446291607867812026-03-25T18:21:56.122Z"8ef92e04d8a2d7b145b5d068ce35bb65"273618assist-hero-banner.png177317029844247212026-03-10T19:18:18.551Z"5e8bf66c92362ffcd8d7110379692d01"20399astrazeneca-hero-banner-mobile.png177393182862825012026-03-19T14:50:28.745Z"0935acaf673f2600ae64c0171b24432f"1851328astrazeneca-hero-banner.png177394131409223112026-03-19T17:28:34.205Z"0935acaf673f2600ae64c0171b24432f"1851328atg-ptcy-ou-os-dois-juntos-em-dose-baixa-o-primeiro-fase-iii-randomizado-em-haplo-tcth-com-clulas-perifricas-traz-respostas-1635.jpeg177574272139089212026-04-09T13:52:01.450Z"0e897b1bcb703cf805028e39a4245d49"755003atirando-para-tudo-que--lado-entendendo-os-ajustes-de-multiplicidade--5092.png177644922235069212026-04-17T18:07:02.420Z"2a120b6a47a78ed21952684f8dea06c1"1461021ats:-a-bússola-da-saúde-baseada-em-evidências-.jpeg174827783777340012025-05-26T16:43:57.815Z"df29e324add035c7a051c97e5e7d67aa"1938657attain-1-orforglipron-oral-diario-logr-prdida-de-peso-dependiente-de-dosis-a-72-semanas-en-adultos-con-obesidad-sin-diabetes.png176857931364886112026-01-16T16:01:53.694Z"039db7cc41c0865a32e52258ef518ca7"6946204attain1-oncedaily-oral-orforglipron-produced-dosedependent-weight-loss-over-72-weeks-in-adults-with-obesity-without-diabetes.png176857893454790312026-01-16T15:55:34.595Z"039db7cc41c0865a32e52258ef518ca7"6946204atualizaes-do-asco-gi-2026-avanos-no-tratamento-perioperatrio-do-cncer-hepatobiliar-e-pancretico.jpeg176799215052911412026-01-09T20:55:50.568Z"234e42fc2e2df2d553404fbd66801997"220100atualizaes-do-sabcs-2025-avanos-e-desafios-dos-adcs-anti-trop-2-no-cncer-de-mama.png176615188872317312025-12-19T13:44:48.761Z"7a34726007ea87464e5d46fc5f603237"609325atualizaes-em-cncer-de-mama-metasttico-e-rastreamento-baseado-em-risco-no-sabcs-2025.png176608180687476112025-12-18T18:16:46.914Z"7b11116b5f7343d4231425dcfd53cafa"1736667atualizao-de-5-anos-do-destiny-breast03-confirma-benefcio-durvel-do-t-dxd-no-cncer-de-mama-her2-metasttico.png177323204205598812026-03-11T12:27:22.173Z"dd750cf5c660b4283a05ac6927cdebec"1263513atualizao-do-estudo-bruin-no-ash-2025-destaca-segurana-e-eficcia-do-pirtobrutinibe-no-linfoma-de-clulas-do-manto-9077.jpeg177852283599622212026-05-11T18:07:16.068Z"a789b1b1e39651868da7451a22fa15fa"595297atualizao-do-serena-6-refora-benefcio-do-switch-precoce-guiado-por-ctdna-em-cncer-de-mama-hr-positivo-her2-negativo.png176582839785972012025-12-15T19:53:17.920Z"5901d7b11c98b44a3cefe0399a1510e2"2235011aumento-de-casos-vsr-em-idosos-alerta-para-prevenção-e-desafia-especialistas.png175312318188203112025-07-21T18:39:41.925Z"7ab3d99e7b40e2bc646f56ee2a6255bb"1639069aumolertinibe-em-alta-dose-mostra-benefício-de-sobrevida-prolongada-em-pacientes-com-câncer-de-pulmão-com-metástases-cerebrais-e-variante-egfr:-resultados-do-estudo-achieve.png175138287355951012025-07-01T15:14:33.617Z"8179799851854fb90f084708b55e5d53"675382aumolertinibe-reduz-risco-de-recorrncia-em-cncer-de-pulmo-egfr-mutado-nos-estgios-ii-a-iiib-aponta-estudo-de-fase-3.jpeg177091803339932712026-02-12T17:40:33.438Z"908fbb6ac09150ba3500113d89100770"2850620autocoleta-aumenta-participação-no-rastreamento-do-câncer-do-colo-do-útero.jpeg175163916250347712025-07-04T14:26:02.563Z"175eca22dd286dafd2ed35592deab061"9152869autoimmune-mechanisms-may-underlie-a-subset-of-gestational-diabetes-and-predict-future-type-1-diabetes.png176070482663722812025-10-17T12:40:26.676Z"b89082be82239533f31ea97b17e5dfdc"2463593automated-aid-systems-improve-time-in-range-and-reduce-training-burden-in-pediatric-t1d.jpeg175832230995902412025-09-19T22:51:50.006Z"ebc25c5b71ff9654ccf709b118dd7b6e"268628avaliao-cardiovascular-em-atletas-masters-principais-recomendaes-das-atuais-diretrizes-553.png177757308690842012026-04-30T18:18:06.981Z"dc8aaf9c63b3c1f7a500afef27564af6"2473145avaliao-da-eficcia-e-segurana-do-hrs-5965-em-pacientes-com-hemoglobinria-paroxstica-noturna-hpn-no-tratados-previamente-com-inibidores-do-complemento.jpeg177248115070072712026-03-02T19:52:30.762Z"f88005ec421f7e4a614e2fd12c395cd9"1524731avanos-e-desafios-no-tratamento-dos-linfomas-destaques-do-hemo-2025.png176357496447737312025-11-19T17:56:04.517Z"e1395607c5e81b030649021ba10dd419"2087408avanos-em-dislipidemia-e-novas-terapias-para-reduo-de-triglicerdeos-e-ldl.png176288083772346312025-11-11T17:07:17.765Z"da5e7baaa260270dc369ab31d6383d1c"1776027avanos-em-sndromes-mielodisplsicas-e-leucemias-agudas-novas-perspectivas-no-hemo-2025.png176244515491613512025-11-06T16:05:54.961Z"46a3d6683dfd5aadc1b77b27b2b0f80f"1168034avanos-no-cncer-de-pulmo-novos-alvos-teraputicos-imunoterapia-e-estratgias-emergentes-em-destaque-no-elcc-2094.jpeg177559181660547812026-04-07T19:56:56.643Z"8a9688df82f364d3fe91431cfdfd4e52"251520avanos-no-cncer-de-vias-biliares-dados-de-vida-real-e-terapias-alvo-em-destaque-no-asco-gi.jpeg176833507807999812026-01-13T20:11:18.121Z"2c437793d6a9ed6c9c56c3db22bafb48"238297avanos-no-tratamento-da-llc-resultados-do-estudo-flair-no-ash-2025.jpeg176530848377309312025-12-09T19:28:03.819Z"2f6b43386a04e6220c549328cfc0a78a"356273avanos-no-tratamento-da-mielofibrose-primria-novas-perspectivas-com-momelotinibe-ojjaara.png176314328450054512025-11-14T18:01:24.612Z"2e506b0cc89b5a89a80c99972257cd6e"2823481avanos-no-tratamento-de-cncer-de-pulmo-egfr-mutado-estudo-paloma-2-refora-benefcios-da-administrao-subcutnea-de-amivantamabe.jpeg175770605142826812025-09-12T19:40:51.529Z"4cb603ff97ad34eff894135b3cf26e35"334738avanos-no-tratamento-do-linfoma-difuso-de-grandes-clulas-b-evidncias-do-estudo-polarix-e-aplicao-clnica.png176236897711011512025-11-05T18:56:17.263Z"61c7d98d1e61f3acd6da763b3fe63e57"1870538avanos-no-tratamento-do-linfoma-do-manto-resultados-do-estudo-triangle.jpeg176132853885986712025-10-24T17:55:38.920Z"ae938fc2a57736407a269c7c96659cf2"262141avanos-no-tratamento-do-mieloma-mltiplo-o-papel-da-lenalidomida.jpeg176122766479436612025-10-23T13:54:24.962Z"178693c311deb0d7a3166ec5fdc6e2c8"302500avanos-no-tratamento-e-preveno-do-cncer-colorretal-destaques-no-asco-gi-2026.jpeg176822908651178012026-01-12T14:44:46.613Z"37a8955e9ae7ec8195fbc2b1cbc02d3e"141617avanos-no-tratamento-perioperatrio-do-cncer-de-esfago-e-estmago-perspectivas-dos-estudos-apresentados-no-asco-gi-2026.jpeg176791330468744012026-01-08T23:01:44.751Z"36fc24293e8f9af87e3f8235fb48e190"284807avanço-no-tratamento-da-atrofia-muscular-espinhal-(ame):-sus-incorpora-nova-terapia-gênica-para-bebês-com-ame-tipo-1.jpeg174827905619046912025-05-26T17:04:16.235Z"23b24fd21fc50415cf673281623a09ca"825635avanço-no-tratamento:-sus-expande-uso-da-donepezila-para-alzheimer-em-estágio-grave-.jpeg174922905710405412025-06-06T16:57:37.148Z"69f48f0459041fa26d8c0b71fa40319e"7162199avanços-na-imunização:-vacina-contra-chikungunya-é-aprovada-no-brasil-.jpeg175009281194371112025-06-16T16:53:31.985Z"d6b8e03b06c6585e963cefcf66292428"12180180axicabtageno-ciloleucel-no-dlbcl-recidivado/refratário:-o-impacto-da-linha-de-tratamento-e-dos-biomarcadores-.png175148493368744512025-07-02T19:35:33.791Z"a3e8d3efadb231c72b84b08fc8a5c90c"1169640axsana-study-deescalating-axillary-surgery-in-breast-cancer.png176610250855043812025-12-19T00:01:48.588Z"3f406e343c36fd6f05ca60c716f6341a"1373996az---programa-faz-bem-hero-banner.png176608328617403112025-12-18T18:41:26.220Z"3869cb0a033f5232fdeef1c039f2b522"930201az-faz-bem-hero-banner.png176945140092265312026-01-26T18:16:40.969Z"c18161d83c52b65a6245414120d76a8c"1254121balancing-cure-and-cardiotoxicity-in-adult-hodgkin-lymphoma-2025-jacc-cardiooncology-review.png175934563076440112025-10-01T19:07:10.803Z"7b5781608d2fcdb324edb1e4a6e74e53"1669003banner-ash-01.png177222170933116812026-02-27T19:48:29.396Z"68e95d2fd01cbc0e08a8f58f95c88669"1210771banner-ash-02.png177222173873871422026-02-27T19:48:58.807Z"6730248e11f467823cfdade29929c47a"215247banner-ash-03.png177222173902416122026-02-27T19:48:59.091Z"d17aa912e2295b01fbe6e0586c65421e"1155310banner-hero-espanhol-hero-banner.jpeg176822958627568812026-01-12T14:53:06.320Z"133ab0a3b4c821372ecd7735fb1e68e9"261044banner-hero-ingles-hero-banner-en.jpeg176822791671551012026-01-12T14:25:16.760Z"133ab0a3b4c821372ecd7735fb1e68e9"261044banner-teste-hero-banner.jpeg176772066109327412026-01-06T17:31:01.134Z"133ab0a3b4c821372ecd7735fb1e68e9"261044banner-teste-hero-banner.png176416000484050512025-11-26T12:26:44.985Z"64c6ab0e7e63c34eeb1ca48eb5b6a420"23464banner.jpg176910301567663822026-01-22T17:30:15.717Z"d658f0ab31b6db8b571e0d2723a2e03f"116580bap-brain-bevacizumab--pemetrexedplatino-mejora-el-control-intracraneal-en-nsclc-no-escamoso-con-metstasis-cerebrales-en-primera-lnea.png176883692399744112026-01-19T15:35:24.036Z"f79be54fab45f7780bfe0ff082530920"7949208bap-brain-bevacizumab-plus-pemetrexedplatinum-improves-intracranial-control-in-untreated-nonsquamous-nsclc-with-brain-metastases.png176883692794286012026-01-19T15:35:27.986Z"f79be54fab45f7780bfe0ff082530920"7949208baseline-lipi-identifies-a-poorprognosis-subgroup-in-pdl1lownegative-nsclc-treated-with-firstline-chemoimmunotherapy.png176883604168030112026-01-19T15:20:41.725Z"192b044a015852a8931ec90b51372013"6716035baxdrostat-promotes-a-significant-and-clinically-meaningful-reduction-in-blood-pressure-in-patients-with-resistant-hypertension.jpeg176279636018764712025-11-10T17:39:20.230Z"213a2b0ab86ab88e4ae59d3d1f1a7763"194509baxdrostat-promove-reduo-expressiva-e-clinicamente-significativa-da-presso-arterial-em-pacientes-com-hipertenso-resistente.jpeg176279479615018012025-11-10T17:13:16.199Z"73eb71fb23b664ee33fe9000b00df833"207474baxhtn-baxdrostat-lowers-systolic-bp-in-uncontrolledresistant-hypertension-at-12-weeks.png175923058111014912025-09-30T11:09:41.165Z"d52987be0ca3a5ccb6f195582e44b6ce"2193031belantamabe-mafodotina-novo-avano-no-tratamento-do-mieloma-mltiplo-no-brasil.png176409894103395912025-11-25T19:29:01.071Z"d9c8fe050c08fdb051981aaffb9d6083"2558927belzutifan-en-feocromocitomaparaganglioma-avanzado-litespark-015-fase-2-informa-respuestas-duraderas.png176848970720461212026-01-15T15:08:27.244Z"aebef9640baa25a4f37f5a65a734a130"6349241belzutifan-in-advanced-pheochromocytomaparaganglioma-phase-2-litespark015-reports-durable-responses.png176848957628431312026-01-15T15:06:16.324Z"aebef9640baa25a4f37f5a65a734a130"6349241benign-prostatic-hyperplasia-a-clinical-overview.jpeg175872471012025312025-09-24T14:38:30.170Z"4ce0cfbbd7eca038f13cb5e66118963b"474557betablocker-therapy-after-myocardial-infarction-in-patients-with-preserved-ejection-fraction.jpeg176303931620756412025-11-13T13:08:36.251Z"9da635914f57fe8cce5ad16fcb74a894"127136betablockers-after-myocardial-infarction-without-reduced-ejection-fraction-no-benefit-in-reboot-trial.png175880523338301512025-09-25T13:00:33.438Z"5e964a330e54b5fb4a78efe4f36a96b7"2613297bevacizumab-plus-erlotinib-shows-significant-activity-in-hereditary-and-sporadic-papillary-renal-cell-carcinoma.jpeg175137089247324512025-07-01T11:54:52.531Z"5d54c0199a39c373a75c6c975ddb19a9"5507983bevacizumabe-e-erlotinibe-no-tratamento-do-carcinoma-papilar-renal-hereditário-e-esporádico.jpeg175138272063251812025-07-01T15:12:00.702Z"0d8e07daa46dd41bf9b006a22bf278db"2844482beyond-bmi-novel-adiposity-indices-predict-mortality-in-early-cardiovascularkidneymetabolic-syndrome.png176039128387336812025-10-13T21:34:43.921Z"ebffbe7ac44084e49adc48341a4bc134"2378755beyond-thrombosis:-pulmonary-hypertension-and-heart-failure-in-myeloproliferative-neoplasms.png175691826506161712025-09-03T16:51:05.105Z"0aa6a45419daa54cb1ed6b1a89c62852"1671044bidirectional-interaction-between-heart-failure-and-cancer:-new-insights-in-cardio-oncology..png175632867566472512025-08-27T21:04:35.703Z"e37a7be00d486d2ee619d1857c7cbab2"1824556big-data-analytics e-machine-learning-na-hematologia:-aplicações-transformadoras-e-principais-desafios.jpeg174923441426278512025-06-06T18:26:54.309Z"657ab3f1bb55537972ef285683c93da1"894776biological-age-not-chronological-age-should-be-a-minimum-standard-in-agerelated-disease-research-.jpeg177366575804812312026-03-16T12:55:58.079Z"dac3c02753253aae66d20b4e2fe27dcc"613599biological-age-not-chronological-age-should-be-a-minimum-standard-in-agerelated-disease-research-6033.jpeg177366613336113912026-03-16T13:02:13.407Z"dac3c02753253aae66d20b4e2fe27dcc"613599biological-age-not-chronological-age-should-be-a-minimum-standard-in-agerelated-disease-research-null.jpeg177366608062112612026-03-16T13:01:20.730Z"dac3c02753253aae66d20b4e2fe27dcc"613599biological-age-not-chronological-age-should-be-a-minimum-standard-in-agerelated-disease-research.jpeg177351699608710612026-03-14T19:36:36.129Z"1940fbe6ceb26745d29c085ac2db2411"950169biological-age-not-chronological-age-should-be-a-minimum-standard-in-agerelated-disease-research.null177342741737266712026-03-13T18:43:37.404Z"dac3c02753253aae66d20b4e2fe27dcc"613599biological-age-not-chronological-age-should-be-a-minimum-standard-in-agerelated-disease-research.png177066655785259612026-02-09T19:49:17.899Z"bbbfe0dcabb1b30e7eed065bc30f97ec"7611143biologics-lower-cardiovascular-risk-in-patients-with-psoriasis.jpeg175287308060335912025-07-18T21:11:20.667Z"01d3250098f5350809ed0f79854f176a"429127biológicos-reduzem-o-risco-cardiovascular-em-pacientes-com-psoríase.jpeg174923336026840612025-06-06T18:09:20.309Z"fb6ff2e0f49a641e755be3bddb01b697"1145925bispecficos-t-cell-engagers-en-el-aacr-2026-nuevas-fronteras-en-linfomas-mieloma-y-la-era-del-doble-bloqueo-.jpeg177645356217157612026-04-17T19:19:22.240Z"37c84e582b2bfc6456b79144a51ecea5"246149bispecficos-t-cell-engagers-no-aacr-2026-novas-fronteiras-em-linfomas-mieloma-e-a-era-do-duplo-bloqueio--6710.jpeg177645664838838912026-04-17T20:10:48.458Z"ca2cc7d7d541914e008b08b97edef3e1"248713blablublué-1.png175468027956013912025-08-08T19:11:19.603Z"8dcd35410b4a9bc47248e51d9e734b23"1506404blood-cancer-new-insights-for-us-healthcare-pros.jpeg175803560395966612025-09-16T15:13:24.055Z"eb2a93172f704ae7ad1e572a86954feb"413134brasil-aprova-imunoterapia-subcutânea--atezolizumabe-sc-traz-inovação-na-experiência-do-tratamento-oncológico.png175370531587759312025-07-28T12:21:55.917Z"a4f92a99c092506249fc84879fad321e"2268157brasil-atinge-recorde-de-transplantes-e-anuncia-avanços-que-podem-impactar-práticas-clínicas-e-hospitalares.jpeg175071117717729212025-06-23T20:39:37.222Z"117cb2b83aef31edc851c37f6ebab3b7"18258764brasil-publica-protocolo-inédito-para-diagnóstico-e-tratamento-da-brucelose-humana-no-sus-.jpeg175009548829564612025-06-16T17:38:08.344Z"895b5a8961cfac90c70c74c252f21bd4"224152breaking-the-adenosine-barrier:-ent1-inhibition-as-a-novel-strategy-to-restore-anti-cancer-t-cell-function.png175371994685392812025-07-28T16:25:46.896Z"cbf614129ecc9b7a6cf4b1e8b9d59d2d"2885311breakwater:-nova-combinação-terapêutica-melhora-sobrevida-no-câncer-colorretal-metastático-com-mutação-braf-v600e.jpeg175136993856371212025-07-01T11:38:58.628Z"b8e43c6681a104e0934de18b380a88e1"10029502breakwater:-novel-therapeutic-combination-improves-survival-in-braf-v600e-mutant-metastatic-colorectal-cancer.jpeg175137074627191912025-07-01T11:52:26.313Z"b8e43c6681a104e0934de18b380a88e1"10029502bridging-the-gap:-real-world-brca-testing-and-parp-inhibitor-utilization-in-metastatic-breast-cancer.png175371984326997912025-07-28T16:24:03.313Z"1bffc112c56849a80fbf7a0f360a309d"2603031broncoscopia-com-navegação-é-tão-eficaz-quanto-biópsia-transtorácica-no-diagnóstico-de-nódulos-pulmonares,-com-menos-complicações.jpeg175008419945080512025-06-16T14:29:59.493Z"51db2b9024ce2822d88db8e3c920f4d0"2784145bruin-cll-321-pirtobrutinibe-consolida-se-como-terapia-de-2-linha-na-llc-ps-inibidor-covalente-da-btk.jpeg176591533661419712025-12-16T20:02:16.653Z"0006eee42eec3e73da8c5bb3858f91fe"232619cagrisema-achieves->20%-weight-loss-in-adults-with-obesity..jpeg175197671470175412025-07-08T12:11:54.764Z"d372f546d129470b86e0b026b2a6b0da"1011288cagrisema-promove-perda-de-peso-inédita-em-pacientes-com-sobrepeso-e-obesidade-1-17444.png175589544961039312025-08-22T20:44:09.654Z"4bcf417a56db1a5e669d5882f019adf3"775751cagrisema-promove-perda-de-peso-inédita-em-pacientes-com-sobrepeso-e-obesidade.png175589539860273312025-08-22T20:43:18.644Z"8595f057bb49a85adab0f7bd8197612a"493655camoral-study-confirms-survival-benefit-with-perioperative-camrelizumab-in-locally-advanced-head-and-neck-cancer.png176080544038349012025-10-18T16:37:20.427Z"3653866655ca3460b7968750545528f4"1163371campanha-nacional-alerta-para-falhas-na-prescrição-de-antibióticos-em-hospitais.jpeg175580211219976312025-08-21T18:48:32.249Z"87d50d80ca52872938112f3f40cdfd46"9169344camrelizumabe-associado--quimioterapia-demonstra-benefcio-de-sobrevida-em-5-anos-no-carcinoma-nasofarngeo-recorrente-ou-metasttico.jpeg176971032556881112026-01-29T18:12:05.614Z"4080543be322f630e1727641c1577b91"6199085capacitación-médica-en-cáncer-urotelial-her2-positivo:-diagnóstico-y-tratamiento-personalizado.jpeg174800758711677412025-05-23T13:39:47.216Z"880ec920054addf153fe522932203348"327955capecitabina-adjuvante-melhora-sobrevida-em-câncer-de-mama-triplo-negativo-com-doença-residual-após-quimioterapia-neoadjuvante.jpeg175683594509456012025-09-02T17:59:05.175Z"f1041d4504e25c483dfbd975617589e3"7324000capecitabina-adjuvante-melhora-sobrevida-em-câncer-de-mama-triplo-negativo-com-doença-residual-após-quimioterapia-neoadjuvantejpeg175683580988784812025-09-02T17:56:49.931Z"f1041d4504e25c483dfbd975617589e3"7324000capsaicin-and-nicotine-reduce-parkinsonsrelated-olfactory-dysfunction-by-targeting-neuroinflammation.png176064830280366212025-10-16T20:58:22.913Z"b8af976842ed70d9e7157f5bc895d8d7"1694222car-nk-alognico-no-lpus-refratrio-67-de-remisso-completa-sem-icans-sem-dech--o-que-o-primeiro-estudo-em-humanos-publicado-no-lancet-revelou-2545.jpeg177574582821367112026-04-09T14:43:48.272Z"4fa3656e392c9f2d7b1e2a852b864301"1163399car-t-em-tumores-slidos-o-aacr-2026-marca-a-virada--novos-designs-primeiros-dados-clnicos-e-a-era-do-car-t-in-vivo--2539.jpeg177662425087982712026-04-19T18:44:10.941Z"0c4ce43fa03986de225a799b43bcf866"325313car-t-em-tumores-slidos-o-aacr-2026-marca-a-virada--novos-designs-primeiros-dados-clnicos-e-a-era-do-car-t-in-vivo--431.jpeg177662423822884912026-04-19T18:43:58.312Z"0c4ce43fa03986de225a799b43bcf866"325313car-t-em-tumores-slidos-o-aacr-2026-marca-a-virada--novos-designs-primeiros-dados-clnicos-e-a-era-do-car-t-in-vivo--8618.jpeg177662426691870512026-04-19T18:44:26.978Z"0c4ce43fa03986de225a799b43bcf866"325313car-t-en-tumores-slidos-el-aacr-2026-marca-el-punto-de-inflexin--nuevos-diseos-primeros-datos-clnicos-y-la-era-del-car-t-in-vivo-.jpeg177685762288736212026-04-22T11:33:42.949Z"a2cf0ac8e8dc6d8667bdf5e8617c23fa"324465car-t-no-mieloma-mltiplo-avanos-uso-precoce-e-transformao-na-jornada-do-paciente.jpeg176478177934312712025-12-03T17:09:39.381Z"7714fc743b550e4fc503d9de51584c1f"392830car-t-therapy-achieves-complete-response-in-hairy-cell-leukemia-anti-cd22-car-t-shows-promise-for-rare-b-cell-malignancy.png175371887650803812025-07-28T16:07:56.566Z"7a143b3870f783ee94668860e5cc57d6"3071086carcinoma-espinocelular-de-cabea-e-pescoo-resultados-do-estudo-trilynx.jpeg175770657980998912025-09-12T19:49:39.853Z"272cc595e362044509284cf026650c84"2034645cardiac-conduction-system-regeneration:-a-key-to-preventing-post-infarction-arrhythmias..png175405666946933212025-08-01T13:57:49.511Z"372ac72c1e36cee1d2006f123c71d518"2355216cardiac-troponin-as-a-key-biomarker-in-light-chain-and-transthyretin-amyloidosis.png175880607428926312025-09-25T13:14:34.333Z"1f7ab889dd33ee0a946a9af0965865b9"2435502cardio-update.png177256572986914912026-03-03T19:22:09.938Z"9855ca701b1c9d596e575001b5bd88d8"717761cardiovascular-assessment-in-masters-athletes-6465.null177869490892813012026-05-13T17:55:08.999Z"c9fba0e90630ac20a762575f6b650cb0"2729701cardiovascular-assessment-in-masters-athletes-key-recommendations-from-current-guidelines-3919.177757561949124812026-04-30T19:00:19.551Z"cd3449fd048dce96daf3216b7b4b08e3"2473937cardiovascular-disease-increases-risk-of-cancer-insights-from-a-cohort-of-27-million-individuals.png175745761185358412025-09-09T22:40:11.910Z"3116bfb0093392a1b9369a7b170ec356"2084859cardiovascular-risk-associated-with-pregabalin-use-in-older-adults-with-chronic-pain.jpeg175502354204033212025-08-12T18:32:22.082Z"283e7ffa28c3a6e16f4d7868c09641b9"115058cardiovascular-risk-in-classical-hodgkin-lymphoma-survivors:-impact-of-genetic-and-treatment-factors..png175511151466200812025-08-13T18:58:34.703Z"23f0abbac35be07e75e62943a09a8339"2045964cardiovascular-risk-scores-and-cardiovascular-health-metrics-as-predictors-of-cancer:-evidence-from-a-scoping-review..png175691812947019412025-09-03T16:48:49.575Z"67e9843859d539c5a7233084779785a5"1571044cardiovascular-toxicity-in-cancer-survivors:-persistent-risks-and-emerging-strategies..png175519386993129412025-08-14T17:51:09.980Z"f0dffb84d0a9c876b1aa6ba475e6bf3d"1631786cart-in-solid-tumors-aacr-2026-marks-the-turning-point-novel-architectures-firstinhuman-data-and-the-dawn-of-in-vivo-cart-5171.177685966980980012026-04-22T12:07:49.874Z"ae9bd2842bf71ce81c92bbe8fa39cc82"320498cart-therapy-through-patients-and-caregivers-eyes-lessons-from-lived-experience.png175986151649000212025-10-07T18:25:16.542Z"fbcb8d72f19b83b35ff865ca563e51f7"2600521cartitude-4-mostra-benefcio-duradouro-de-ciltacabtagene-autoleucel-em-mieloma-mltiplo-recidivado-refratrio-de-risco-padro.jpeg176521561199657712025-12-08T17:40:12.076Z"d513e74e0bb45c688d23493a503d5491"252076cartitude-4-mostra-benefcio-duradouro-de-ciltacabtagene-autoleucel-em-mieloma-mltiplo-recidivadorefratrio-de-risco-padro.jpeg176521437488095012025-12-08T17:19:34.921Z"d513e74e0bb45c688d23493a503d5491"252076case-report-reveals-immune-restoration-and-tumor-regression-through-correction-of-defective-t-cell-receptor-signaling..png175493653683598312025-08-11T18:22:16.878Z"98c1516815302cdbc9d9356216033975"1362510cbosm-2025:-diretrizes-atualizadas-para-o-manejo-farmacológico-da-obesidade.jpeg174863622559331612025-05-30T20:17:05.685Z"865e258b503d41fa26bebd6c28997815"311254cd276-b7h3-adaptercar-tcells-show-antitumor-activity-in-small-cell-lung-cancer-and-reduce-cd276driven-fratricide.png176762046900394412026-01-05T13:41:09.051Z"7c737e3ad6b56fef114026cbc745c648"5989626cdk4-6-no-endomtrio-abemaciclibe--letrozol-entrega-controle-de-doena-sem-quimioterapia--3038.jpeg177618793729941212026-04-14T17:32:17.368Z"3eceb51aa1d5a285a94f42aae4cdf03e"238489cdk46-en-endometrio-abemaciclib--letrozol-ofrece-control-de-enfermedad-sin-quimioterapia-.jpeg177619120508204412026-04-14T18:26:45.216Z"be364ea0499048c0162de566216e31c0"235128cdk46-in-endometrial-cancer-abemaciclib-letrozole-delivers-disease-control-without-chemotherapy-2707.177619195186807212026-04-14T18:39:11.937Z"9cefb6b9b44fbaaa2e78f8b1dd6dbce3"235055cemitrio-de-molculas-por-que-a-inovao-farmacutica--cara-e-por-que-a-qualidade-do-ifa-muda-tudo.jpeg175762156880048612025-09-11T20:12:48.844Z"f7fc20f1b1a8c144761ada9b14c3f19e"194376cenrio-atual-do-uso-de-anticorpos-biespecficos-e-terapia-car-t-no-tratamento-de-linfomas-no-hodgkin.jpeg175762116834078512025-09-11T20:06:08.393Z"281dfca36d02c5afc78aafb7bb88c3d1"315056cerebral-embolic-protection-during-tavi:-clinical-evidence-does-not-support-routine-use..png175253199774016812025-07-14T22:26:37.778Z"8b2d28cb92a0d63435d13865d1b4e315"1446790certificadoo-cirurgia.png175760990508884422025-09-11T16:58:25.129Z"f14a2b254b3fe4bfa287020479d6f5eb"333651checkmate-743-biomarcadores-e-car-t-uma-nova-era-para-o-mesotelioma.png176588795541143612025-12-16T12:25:55.451Z"8c91fe1719f5a0afd86d4bd43a9ff90a"890018cilta-cel-em-mieloma-mltiplo-recidivado-resultados-do-cartitude-4-em-pacientes-de-risco-padro.png176608764194769812025-12-18T19:54:01.987Z"e38d62b8efc3341fc3c0db1bfbc88380"1143460cilta-cel-no-mieloma-mltiplo-refratrio--lenalidomida-anlise-atualizada-do-estudo-de-fase-3-cartitude-4-com-incluso-de-dados-de-sobrevida-global.jpeg177248165313338512026-03-02T20:00:53.204Z"e8068d6d79c8040821743c15f06faa67"1720635ciltacel-in-relapsed-multiple-myeloma-cartitude4-results-in-standardrisk-patients.png176625566522788712025-12-20T18:34:25.269Z"266e7dce480aaa8310d2fb9d0d24cb87"1212031ciprofloxacin-alone-proves-as-effective-as-injectable-combination-therapy-for-bubonic-plague..png175502376359174012025-08-12T18:36:03.645Z"4ea2c51a6820587be08d1cd90eec5bce"1411792cirurgia-axilar-em-pacientes-com-cncer-de-mama-e-macrometstases-em-linfonodos-sentinela-resultados-secundrios-do-estudo-insema-.png176600381441759512025-12-17T20:36:54.469Z"533a9fd2e6e73d98d6c6d243647f05c3"1522082cirurgia-cardíaca-pediátrica-com-orientação-remota-marca-avanço-do-sus-na-região-norte.jpeg175071138662273912025-06-23T20:43:06.668Z"4a23c9b31a7c2df18d38170976f9e19c"10489038cistectomia-radical-no-cncer-de-bexiga-insights-prticos-para-a-tomada-de-deciso.jpeg176615451250997612025-12-19T14:28:32.549Z"8ba813df0a931593d3475f0a72113cd9"78456clear-trial-hypertonic-saline-and-carbocisteine-do-not-reduce-exacerbations-in-noncf-bronchiectasis.png175924761653471612025-09-30T15:53:36.575Z"8bdc51be6e419bd9c3281dbe6a7a2000"2143404clesrovimab-reduces-rsv-infections-and-hospitalizations-in-healthy-infants.png175915978705580912025-09-29T15:29:47.105Z"4bf5b1f6c8b192aa167bfa69c89952e1"1164252clesrovimabe-reduz-infeces-e-hospitalizaes-por-vsr-em-lactentes-saudveis.png175882944455369412025-09-25T19:44:04.606Z"4bf5b1f6c8b192aa167bfa69c89952e1"1164252clinical-decision-support-and-pharmacist-outreach-improve-adherence-to-antihypertensives-but-not-overall-cardiometabolic-control.jpeg175310123468384712025-07-21T12:33:54.745Z"ec0d956e1d9e8942688ba744a98558df"486839clinical-outcomes-of-allogeneic-hematopoietic-stem-cell-transplantation-in-sickle-cell-disease-and-transfusiondependent-betathalassemia.png175745520137109212025-09-09T22:00:01.430Z"4030a9d6b93e135d3b138a7bf9bba375"2573126clinician-engagement-as-a-pillar-for-cardiovascular-device-safety..png175511057009517912025-08-13T18:42:50.135Z"c84d48417d204dd4b62928a7e0e6ba9d"2701644closure-af-cierre-de-la-orejuela-auricular-izquierda-en-pacientes-con-fibrilacin-auricular-y-alto-riesgo-de-ictus-y-sangrado.png176270873095619212025-11-09T17:18:51.002Z"c89d2703d2cd43aa36c9db6dce31bf3e"1968840closure-af-ocluso-do-apndice-atrial-esquerdo-em-pacientes-com-fibrilao-atrial-e-alto-risco-de-avc-e-sangramento.png176270748215498812025-11-09T16:58:02.197Z"3cd57ee192c13a802b914e640edad300"1926318closureaf-left-atrial-appendage-closure-in-patients-with-atrial-fibrillation-and-high-risk-of-stroke-and-bleeding.png176270893154204412025-11-09T17:22:11.588Z"21d4964bfadd7b1900ffbcf7a5d2c090"1968942cncer-de-mama-triplo-negativo-estdio-i-rumo--personalizao-8580.png177816925968713812026-05-07T15:54:19.750Z"d847b3954304d6d55e651d6a767c9609"1951896cncer-de-pulmo-a-terapia-alvo-est-mudando-a-prtica-clnica---quiz-6551.png177634610745172912026-04-16T13:28:27.521Z"c38d917ea5a7048ac8af50ba4b6cafae"878655cncer-de-pulmo-como-a-terapia-alvo-est-mudando-a-prtica-clnica---quiz-6056.png177626370818217012026-04-15T14:35:08.252Z"c38d917ea5a7048ac8af50ba4b6cafae"878655cncer-de-pulmo-como-a-terapia-alvo-est-mudando-a-prtica-clnica---quiz-7920.png177634297368781712026-04-16T12:36:13.750Z"c38d917ea5a7048ac8af50ba4b6cafae"878655cncer-de-pulmo-como-a-terapia-alvo-est-mudando-a-prtica-clnica-3198.png177618343223370412026-04-14T16:17:12.313Z"70429127102f3223a71aabd9a1254ed4"380112cncer-de-pulmo-como-a-terapia-alvo-est-mudando-a-prtica-clnica-4247.png177625628859336212026-04-15T12:31:28.660Z"70429127102f3223a71aabd9a1254ed4"380112cncer-de-pulmo-como-a-terapia-alvo-est-mudando-a-prtica-clnica-5528.png177618167640484612026-04-14T15:47:56.465Z"c38d917ea5a7048ac8af50ba4b6cafae"878655cncer-de-pulmo-como-a-terapia-alvo-est-mudando-a-prtica-clnica-6248.png177625425439204212026-04-15T11:57:34.456Z"70429127102f3223a71aabd9a1254ed4"380112cncer-de-pulmo-como-a-terapia-alvo-est-mudando-essa-prtica-clnica-1211.png177619472289007412026-04-14T19:25:22.958Z"70429127102f3223a71aabd9a1254ed4"380112cncer-de-pulmo-como-a-terapia-alvo-est-mudando-na-prtica-clnica-9360.png177619299363760812026-04-14T18:56:33.701Z"70429127102f3223a71aabd9a1254ed4"380112cncer-de-pulmo-de-pequenas-clulas-estudo-chins-avalia-alternativa--radioterapia-convencional.png175770256580426512025-09-12T18:42:45.862Z"c152baef26d27c0c868d9f8b63e20a79"317958cobertura-completa-—-gp-de-são-paulo-f1-2026-coverage.webp177799459849861512026-05-05T15:23:18.560Z"8e96ed9ab31ec787cdd6c5ec4aab0a5b"50968code-of-ethics-and-conduct-tribemd.pdf177576335021876612026-04-09T19:35:50.261Z"d136a972b67bc07175f2ab6dd10af784"1712466codigo-de-etica-e-conduta-tribe.pdf177576321089097612026-04-09T19:33:30.933Z"301c56c8c034ecffd954f238f9340913"1878679codigo-de-etica-y-conducta-tribemd.pdf177576329890215712026-04-09T19:34:58.942Z"4e4d70ccdd2349b1c8ce9c0291908e6d"1760603combate-à-malária-ganha-fôlego-com-novas-tecnologias-e-cooperação-internacional.png174861383690850612025-05-30T14:03:56.953Z"ba4bce5f0bcb8268504dc64044326439"342896combinao-de-enzalutamida-e-rdio-223-aumenta-sobrevida-em-cncer-de-prstata-avanado-aponta-estudo-peace-3.jpeg177213600434470712026-02-26T20:00:04.416Z"2cc534ef4e47b23e5708cee455f9999d"181838combinao-de-osimertinibe-e-quimioterapia-em-primeira-linha-mostra-benefcio-em-sobrevida-global-no-cncer-de-pulmo-egfr-mutado.jpeg177023198804727212026-02-04T19:06:28.096Z"ba7155fdeddefd726ec588f7edf2a651"9944401combination-immunotherapy-in-hcc-clinical-benchmarks-mechanistic-synergy-and-the-biomarker-gap.png176771037044266212026-01-06T14:39:30.495Z"7f720c2fc1e59ceecdd1b3b66b40b878"6102768combination-of-enzalutamide-and-radium223-improves-survival-in-advanced-prostate-cancer-peace3-study-shows-.jpeg177366649286550812026-03-16T13:08:12.892Z"0b8f6bf02d4c1d45818a268187678b02"792876combination-of-enzalutamide-and-radium223-improves-survival-in-advanced-prostate-cancer-peace3-study-shows-3078.jpeg177366736547159312026-03-16T13:22:45.512Z"0b8f6bf02d4c1d45818a268187678b02"792876combination-of-enzalutamide-and-radium223-improves-survival-in-advanced-prostate-cancer-peace3-study-shows.jpeg177212945679099512026-02-26T18:10:56.854Z"9fd9cc5ed6c8852151cb82a01eafd42e"167980combination-of-enzalutamide-and-radium223-improves-survival-in-advanced-prostate-cancer-peace3-study-shows.null177342614273256112026-03-13T18:22:22.774Z"0b8f6bf02d4c1d45818a268187678b02"792876combination-of-finerenone-and-empagliflozin-enhances-albuminuria-reduction-in-ckd-with-type-2-diabetes..png175276427401066512025-07-17T14:57:54.059Z"2442ff7c4bcb341ab74b89eeecd643c9"2567885combinação-de-sintilimabe-e-axitinibe-mostra-resultados-promissores-em-carcinoma-renal-raro-e-agressivo.jpeg175528681388508312025-08-15T19:40:13.925Z"70a6d597c6900a3a0448d49ffaa13710"326577como-a-terapia-alvo-est-mudando-a-prtica-clnica-5405.png177619152409092612026-04-14T18:32:04.154Z"70429127102f3223a71aabd9a1254ed4"380112como-abordar-a-hipercolesterolemia-no-cotidiano-do-consultório?.png175077469307262312025-06-24T14:18:13.167Z"adc06c4fb81d86cf957c7758f2beb9fc"371452comorbidades-importam-no-car-t--mas-no-da-forma-que-voc-imagina-1933.jpeg177574078260640612026-04-09T13:19:42.665Z"4fa91ceadd4314335e97a355c394c5bf"1634114comparative-efficacy-of-ciltacabtagene-autoleucel-versus-standardofcare-treatments-for-patients-with-previously-treated-relapsed-or-refractory-multiple-myeloma.png175745740395902512025-09-09T22:36:43.999Z"9346fd0a619730acf5745dbdae91da1f"3481468complete-revascularization-reduces-cardiovascular-mortality-in-patients-with-acute-myocardial-infarction-and-multivessel-coronary-disease.jpeg176312808586982112025-11-14T13:48:06.002Z"7300cfb1b24b1faca579523e5a475fc6"161698congresso-ada-2025-|-cagrisema-e-a-nova-fronteira-terapêutica-no-controle-metabólico.png175276509214682512025-07-17T15:11:32.195Z"f9650fb7775a8aefeed66e7c1894adf5"1750910congresso-ada-2025-|-diabetes-tipo-2-e-comprometimento-cognitivo:-dados-por-subgrupos-clínicos.png175252533335461112025-07-14T20:35:33.462Z"1c565a9c7f796cab3e5c80832b1549af"754594congresso-ada-2025-|-estudo-demonstra-alta-acurácia-de-cgm-em-tempo-real-em-pacientes-com-diabetes-e-insuficiência-renal-no-cenário-intra-hospitalar.png175104823795100812025-06-27T18:17:17.992Z"f390a07f917f2ef2eee6e65fa7667699"960371congresso-ada-2025-|-neuropatia-periférica-diabética-como-novo-alvo-para-prevenção-de-demência-e-doença-cerebrovascular-em-pacientes-com-dm2.jpeg175104796935779712025-06-27T18:12:49.411Z"8f0eaec39200fa4898bf6f7e71e919eb"6531768congresso-ada-2025-|-novas-combinações-hormonais-no-tratamento-da-obesidade,-com-ou-sem-dm2.png175258503005720412025-07-15T13:10:30.147Z"891f9c0fd827f15868bd7461d6639ee6"2564480congresso-ada-2025-|-novas-fronteiras-no-tratamento-da-obesidade:-agonistas-múltiplos-demonstram-remodelação-adiposa-e-preservação-muscular.jpeg175104810266311912025-06-27T18:15:02.701Z"f4ee017923dfa79feb340fdbbaa913de"1420751congresso-ada-2025-|-orfoglipron--um-novo-agonista-de-glp-1-oral-com-potencial-promissor-no-tratamento-do-dm2-.png175269099021813512025-07-16T18:36:30.259Z"e1a40b9e5386fe96ed488c3c59016b95"897997congresso-ada-2025-|-stop-diabetes:-diagnóstico-precoce-e-intervenção-intensiva-.png175226759470132112025-07-11T20:59:54.742Z"38078d01597a5cea57eb263cc6445a8f"728155congresso-ada-2025-|-stop-diabetes:-diagnóstico-precoce-e-intervenção-intensiva.png175226725187066512025-07-11T20:54:11.985Z"38078d01597a5cea57eb263cc6445a8f"728155congresso-ada-2025-|-terapia-combinada-de-bimagrumabe-e-semaglutida-na-perda-de-peso-com-preservação-de-massa-magra.png175286713901595712025-07-18T19:32:19.056Z"0102d339243fa00c8c4b3e3bbcd7173f"1440914congresso-ada-2025-|-uso-de-monitoramento-contínuo-de-glicose-reduz-complicações-agudas-e-estresse-em-pacientes-com-dm2.jpeg175104833129678112025-06-27T18:18:51.354Z"ac0bad107ba1e30e1129a81b6d6c1666"27639904congresso-brasileiro-de-genética-hero-banner.png177794885549170112026-05-05T02:40:55.575Z"941f9dfbd1ca90c7bc63e503217fe3bf"506928congresso-eha-e-icml-2025:-novos-avanços-em-linfoma-folicular-e-linfoma-difuso-de-grandes-células-b.jpeg175147916337120812025-07-02T17:59:23.415Z"7c955644d17603eb76be1d2a7081d278"513510conitec-abre-consulta-pública-sobre-incorporação-do-wegovy®-ao-sus-para-tratamento-da-obesidade.jpeg175007836800761112025-06-16T12:52:48.079Z"e02d1d98f4dcda40830221c997d3260b"6585650conitec-approves-innovative-strategies-against-respiratory-syncytial-virus-(rsv):-dual-protection-enters-brazil's-public-health-system.jpeg174964865014096912025-06-11T13:30:50.257Z"e68fe75928ff0191deda73f9f9332f32"3046223conitec:-guardiã-da-eficiência-e-segurança-tecnológica-no-sus.jpeg174863595891140912025-05-30T20:12:39.011Z"38f7bb61829159f5069843138b783d0f"1032322consulta-pblica-para-avaliar-a-incluso-de-momelotinibe-no-rol-da-ans-para-o-tratamento-da-mielofibrose-primria-e-secundria-com-anemia.png176298216470834112025-11-12T21:16:04.754Z"2410ae5f44aab3fcc756a06daace5569"1679734conteúdo-aleatório-com-quiz.png177694928264840112026-04-23T13:01:22.712Z"701ad7c1a858a8befafe844a45676bb7"342546continuous-glucose-monitoring-improves-care-in-hospital-settings-and-in-active-adolescents-with-t1d.jpeg175822070131559612025-09-18T18:38:21.357Z"74f5482e2711575ce953529422728833"268278controle-da-hipercalemia-como-estratgia-para-manuteno-da-terapia-com-israa-na-insuficincia-cardaca-e-na-drc.png177005586588344412026-02-02T18:11:05.923Z"a09f5e2bf81347edd98ae3daa81b8c4d"1206114coordenao-de-cuidados-oncolgicos-para-populaes-indgenas-lies-do-programa-ain-em-oklahoma.jpeg175752884799674912025-09-10T18:27:28.098Z"e0a3237e6ed7b2816d67538b27db6a65"19366785core-timi-72a-e-72b-olezarsen-reduz-triglicerdeos-e-risco-de-pancreatite-em-pacientes-com-hipertrigliceridemia-grave.png176271117017581012025-11-09T17:59:30.225Z"825b6957918da7985849d9f0bb3dd0b3"1040478core-timi-72a-y-72b-olezarsen-reduce-los-triglicridos-y-el-riesgo-de-pancreatitis-en-pacientes-con-hipertrigliceridemia-grave.png176271309834037012025-11-09T18:31:38.379Z"568deaac78e9d6a4d551114d9d3084c9"1053842coretimi-72a-and-72b-olezarsen-reduces-triglycerides-and-pancreatitis-risk-in-patients-with-severe-hypertriglyceridemia.png176271329484743212025-11-09T18:34:54.887Z"5907a896543f228b2e9631af573a73d2"1053928correto-hero-banner.jpeg177342228294740012026-03-13T17:18:02.987Z"eeceea6e70a05923782c6a3ee1f4f659"330708corretoassim-hero-banner.jpeg177342265950979212026-03-13T17:24:19.550Z"eeceea6e70a05923782c6a3ee1f4f659"330708cost-per-opioidfree-year-defining-an-emerging-benchmark-in-addiction-health-economics.png176002478775157712025-10-09T15:46:27.811Z"3b0668b46b49c029e8c60e1b1b9bed98"2477865covid-19-e-desregulação-do-sistema-renina-angiotensina-aldosterona:-novos-insights.jpeg175009241245423112025-06-16T16:46:52.495Z"abcc814aa97de3ec570952deace88332"3871456crest-2-el-stent-ms-manejo-mdico-intensivo-redujo-el-riesgo-de-ictus-a-4-aos-en-estenosis-carotdea-asintomtica-de-alto-grado.png176849099777705912026-01-15T15:29:57.815Z"5642eadc2f06d283d22ceb963d832dec"7637651crest2-stenting-plus-intensive-medical-management-reduced-4year-stroke-risk-in-asymptomatic-highgrade-carotid-stenosis.png176849100713257812026-01-15T15:30:07.170Z"5642eadc2f06d283d22ceb963d832dec"7637651ct-radiomics-plus-clinicalsemantic-features-improved-ml-differentiation-of-lung-adenocarcinoma-vs-squamous-cell-carcinoma-in-a-singlecenter-cohort.png176770923912221012026-01-06T14:20:39.173Z"9d753b043895199d6b3d32c89421eb9a"5311781ctdna-after-neoadjuvant-therapy-predicts-metastatic-risk-and-may-support-bladder-preservation-in-mibc-9630.jpeg177366741544159612026-03-16T13:23:35.474Z"7803105d128fdc4caf2f170461212508"299497ctdna-after-neoadjuvant-therapy-predicts-metastatic-risk-and-may-support-bladder-preservation-in-mibc-null.jpeg177366576747413112026-03-16T12:56:07.512Z"7803105d128fdc4caf2f170461212508"299497ctdna-after-neoadjuvant-therapy-predicts-metastatic-risk-and-may-support-bladder-preservation-in-mibc.jpeg177247990802403712026-03-02T19:31:48.086Z"833549e5bd775935441f2a9e8caa7560"158319ctdna-after-neoadjuvant-therapy-predicts-metastatic-risk-and-may-support-bladder-preservation-in-mibc.null177343541343047012026-03-13T20:56:53.539Z"7803105d128fdc4caf2f170461212508"299497ctdna-as-a-therapeutic-decision-guide-aacr-2026-presents-first-prospective-phase-iii-data-in-solid-tumors-7558.177686052468617312026-04-22T12:22:04.748Z"f4d237f7c64ece2908d1b75b47c12548"331698ctdna-como-gua-de-decisin-teraputica-el-aacr-2026-presenta-los-primeros-datos-prospectivos-de-fase-iii-en-tumores-slidos-.jpeg177685834760715412026-04-22T11:45:47.670Z"70dfd9f9f243e0647983bb3f4ccb1e0a"332207ctdna-como-guia-de-deciso-teraputica-o-aacr-2026-apresenta-os-primeiros-dados-prospectivos-de-fase-iii-em-tumores-slidos--9600.jpeg177662383916981512026-04-19T18:37:19.257Z"5e1a8d386ab8f8fb63abfd87a2c98ec3"334860ctdna-ps-neoadjuvncia-prediz-risco-metasttico-e-pode-orientar-preservao-vesical-no-mibc.jpeg177248540752246612026-03-02T21:03:27.585Z"09cc57d058b572c96625f984bd64cd14"173783ctdna-ps-neoadjuvncia-prediz-risco-metasttico-e-pode-orientar-preservao-vesical-no-mibc.png177317279586797712026-03-10T19:59:55.907Z"56c2e528f94604f48bd2f6c4066711ae"869017cuidados-dermatolgicos-profilticos-mostram-benefcio-em-pacientes-com-cncer-de-pulmo-egfr-mutado-destaques-do-cocoon-no-congresso-mundial-2025.jpeg175796124867901612025-09-15T18:34:08.781Z"460c8d5974a75dea724ca7b48a3d8af3"284803cuidados-dermatológicos-profiláticos-mostram-benefício-em-pacientes-com-câncer-de-pulmão-egfr-mutado--destaques-do-cocoon-no-congresso-mundial-2025-1-153142.jpeg175796110194338712025-09-15T18:31:42.000Z"460c8d5974a75dea724ca7b48a3d8af3"284803câncer-de-endométrio-avançado--o-impacto-dos-biomarcadores-na-prática-clínica.png175277327867123812025-07-17T17:27:58.718Z"cdf6ea335833da555289da7c389d32b8"1488219câncer-de-ovário:-um-desafio-silencioso-que-exige-atenção-e-diagnóstico-precoce.jpeg175009199043181712025-06-16T16:39:50.527Z"8b97035fd09737738660030fe7063d9c"8231145da-bancada-ao-paciente-a-longa-jornada-de-um-medicamento.png175771398074417212025-09-12T21:53:00.784Z"c82704e1144c5022b5dbf7598ac3aae3"2324875da-suspeita-ao-diagnstico-como-identificar-a-miastenia-gravis-5804.jpeg177394344548686912026-03-19T18:04:05.520Z"0d001de351f441df100e6ff92769d52d"287078dan-rsv-la-vacuna-rsvpref-reduce-las-hospitalizaciones-respiratorias-relacionadas-con-vrs-en-adultos-60-aos-en-un-ensayo-pragmtico-aleatorizado.png176892203514995012026-01-20T15:13:55.188Z"d889e5305d5c702e8b2c2da497c99c09"7125101danflu-2-la-vacuna-antigripal-de-alta-dosis-no-redujo-significativamente-la-hospitalizacin-por-influenza-o-neumona-en-65-aos.png176736395052307012026-01-02T14:25:50.567Z"f2ced282a22173da6d29f635ed7b44b5"5233733danflu2-highdose-influenza-vaccine-did-not-significantly-reduce-influenza-or-pneumonia-hospitalization-in-adults-65.png176736394365023212026-01-02T14:25:43.698Z"f2ced282a22173da6d29f635ed7b44b5"5233733danilotypeform.jpeg177256722091413612026-03-03T19:47:00.984Z"b2f6b1c1bfbc239f2ae0910922401628"835415danrsv-rsvpref-vaccine-lowers-rsvrelated-hospitalizations-in-adults-60-in-a-pragmatic-randomized-trial.png176892204549511612026-01-20T15:14:05.533Z"d889e5305d5c702e8b2c2da497c99c09"7125101daraxonrasib-and-pancreatic-cancer-a-new-signal-against-a-historically-difficult-target-179.177851817007335812026-05-11T16:49:30.146Z"28844384686ef0cf477997b24bb128fa"2128809daraxonrasib-y-cncer-de-pncreas-una-nueva-seal-contra-un-blanco-histricamente-difcil.png177851817177097312026-05-11T16:49:31.843Z"815729a3bef8de7100a6bca13de8dd5b"2133212daraxonrasibe-e-cncer-de-pncreas-um-novo-sinal-contra-um-alvo-historicamente-difcil-2075.png177851817744246212026-05-11T16:49:37.512Z"7fe90a3712a34d4e13d6abf6dd0370f5"2125617dare-af-avaliando-o-papel-da-dapagliflozina-aps-ablao-de-fibrilao-atrial.jpeg176278337354036112025-11-10T14:02:53.602Z"8442c93c0e38ec666a72c7a8129494db"188095dareaf-evaluating-the-role-of-dapagliflozin-after-atrial-fibrillation-ablation.jpeg176278973451268212025-11-10T15:48:54.647Z"103ea456a0d52feaccbf32fc6927efac"176324datopotamab-deruxtecan-redefine-el-tratamiento-del-cncer-de-mama-hr-el-aacr-2026-consolida-el-posicionamiento-post-cdk4-6i-.jpeg177644816075585012026-04-17T17:49:20.819Z"37b02c549feb16bb14195fd5ff7e1a05"249768datopotamab-deruxtecan-redefine-el-tratamiento-del-cncer-de-mama-hr-el-aacr-2026-consolida-el-posicionamiento-post-cdk46i-.jpeg177644798419546812026-04-17T17:46:24.262Z"37b02c549feb16bb14195fd5ff7e1a05"249768datopotamab-deruxtecan-redefines-hr-breast-cancer-treatment-aacr-2026-consolidates-postcdk4-6i-positioning-4440.177645065774360312026-04-17T18:30:57.814Z"8e87c6166339c737c27d83d4cb985d9e"250040datopotamabe-deruxtecan-redefine-o-tratamento-de-cncer-de-mama-hr-o-aacr-2026-consolida-o-posicionamento-ps-cdk4-6i--9966.jpeg177645350221638712026-04-17T19:18:22.285Z"d5c33b10306280c578f259ec879e97fc"252717debate-sobre-financiamento-da-fda-reacende-discussões-sobre-acesso-e-segurança-de-medicamentos-oncológicos.jpeg175588463994391912025-08-22T17:44:00.001Z"a2586d2ea06f9fcb9989fc78aa5945ab"10611448decaf-caffeinated-coffee-consumption-after-cardioversion-reduces-atrial-fibrillation-recurrence.jpeg176303901116480212025-11-13T13:03:31.277Z"07bfc4cbda19e9f8e1648519de7d0ac6"175581decaf-consumo-de-caf-com-cafena-aps-cardioverso-reduz-a-recorrncia-de-fibrilao-atrial.jpeg176278469143362012025-11-10T14:24:51.476Z"31d976b5bb0457f21376d9e3c15090ca"189033deep-learning-model-outperforms-traditional-methods-in-predicting-bladder-cancer-survival.png176460685302389912025-12-01T16:34:13.069Z"9d65878d0230b849e3dc889c16128350"2706655desafio-clnico-na-menopausa-interaes-entre-hormnios-e-crebro.png177073453121483112026-02-10T14:42:11.337Z"ba0e14bf350bf121db39dd8eac32c6f1"1840903desfechos-clínicos-com-osimertinibe-±-quimioterapia-na-1ª-linha-do-nsclc-com-mutação-egfr--análise-do-estudo-flaura2-por-subtipo-de-egfrm.png175710171964723112025-09-05T19:48:39.690Z"614e10bd6f3f3c027fa7db1e018d0611"1712778destaques-do-eha-2025:-análise-final-do-estudo-captivate.png175128849728522512025-06-30T13:01:37.346Z"b41cbca31b1cf4c1ed7a3fc3ac0f3f99"1451357destaques-do-eha-2025:-principais-avanços-em-leucemia-linfocítica-crônica-(llc).png175128754335889212025-06-30T12:45:43.403Z"a8c4cf791d1540e4fc2d33285094867e"2630346destaques-do-eha-2025:-tratamento-guiado-por-drm-em-llc:-estudo-flair-traz-novos-parâmetros-e-levanta-discussões-sobre-sobretratamento.png175104197857958112025-06-27T16:32:58.619Z"0cfe9346731efed641762f886159699b"2173941destaques-do-icml-2025:-novas-perspectivas-para-o-tratamento-dos-linfomas-folicular-e-leucemia-linfocítica-crônica-(llc).jpeg175148002571135312025-07-02T18:13:45.754Z"c463e95a3f4795549f2da999d4c79250"452620destinybreast11-demonstrates-superiority-of-tdxdthp-over-standard-regimen-in-the-neoadjuvant-treatment-of-highrisk-her2-breast-cancer.jpeg176080658371508012025-10-18T16:56:23.825Z"f393002a1b38f66edd79e74a675b59f8"148484desvendando-o-elo-perdido-como-a-exposio-pr-natal-ao-diabetes-gestacional-afeta-o-desenvolvimento-cerebral-e-contribui-para-a-obesidade-infantil.png177263305993653012026-03-04T14:04:19.999Z"4ef77bb2f8b9d750473b9c41c9952500"750374determinantes-sociais-da-saúde-e-acesso-ao-transplante-na-leucemia-mieloide-aguda.jpeg175451380421508912025-08-06T20:56:44.262Z"42334e5b1a90ce202df6a0626aea48bb"15962224dia-mundial-contra-os-transtornos-alimentares:-o-papel-crucial-das-famílias-e-profissionais-de-saúde.jpeg174889435292616412025-06-02T19:59:12.969Z"4b80489ec9639292dd3e1bb6af30fe3e"1271339dia-mundial-da-hipertensão-arterial:-diretrizes-avançam,-mas-controle-ainda-é-um-desafio.jpeg174791979429184812025-05-22T13:16:34.369Z"4f72bae0ee9b2675c779f4c397e30002"160138dia-mundial-sem-tabaco-2025-destaca-estratégias-da-indústria-e-reforça-papel-dos-profissionais-de-saúde-na-prevenção-ao-tabagismo.jpeg175009499359259212025-06-16T17:29:53.642Z"e70a3c1b5e1ae89da5b8cd066febad93"236183diabetes-amplifies-fracture-risk-in-women-with-endometrial-cancer-an-asian-cohort-shows.png175986118458313912025-10-07T18:19:44.626Z"015367be24b71648b66ede3ddf02091b"2224009diagnóstico-molecular-da-doença-de-chagas-ganha-agilidade-com-nova-metodologia-automatizada.jpeg174923355697506012025-06-06T18:12:37.018Z"7dac812388c245bea5d7e0401c37109c"196980digital-remote-monitoring-in-people-with-multiple-sclerosis.jpeg174964961054067812025-06-11T13:46:50.589Z"86ac07c8c0dd49055a964b2cc40d1169"9204404digitoxin-lowers-risk-of-death-or-heart-failure-hospitalization-in-hfref-digithf-results.png175856486407197112025-09-22T18:14:24.129Z"63a92bcbf9e940a57a0c1832b3049679"1904904digitoxina-reduz-risco-combinado-de-morte-ou-hospitalizao-em-insuficincia-cardaca-com-frao-de-ejeo-reduzida.png175882923047906212025-09-25T19:40:30.563Z"c9e827bc2465e3c2c565b572d36580b7"1246545direto-do-ias-2025:-pré-conferência-reforça-caminhos-promissores-na-cura-do-hiv.jpeg175259069608509712025-07-15T14:44:56.152Z"b1afd0bf01e0f58eeced2134d607da8a"279714diretriz-sbc-2025-estratificao-de-risco-e-tratamento-das-dislipidemias-no-brasil.png175862650169590212025-09-23T11:21:41.769Z"0b170a7b73674e488cf10cf1e0eacdbd"2598588discovery-of-fviii-“aurora”-mutation-opens-new-perspectives-for-hemophilia-a-therapy..png175519364573181112025-08-14T17:47:25.781Z"877c74ffdf92c3bec2a6db414e716e7f"1578289dispositivos-inteligentes-para-detecção-e-monitoramento-de-alterações-biológicas-em-saúde-mental.jpeg174923294544037512025-06-06T18:02:25.482Z"581c76517e306c2661c995805dcf2571"690993dispositivos-vestíveis:-monitoramento-contínuo-e-cuidado-personalizado-em-doenças-crônicas.jpeg174922993341276512025-06-06T17:12:13.459Z"f9b1fd6b9adb4a181b48c7cd644d2a4f"17966099disrupted-deep-sleep-predicts-faster-motor-decline-in-early-parkinsons-disease.png175986301599411812025-10-07T18:50:16.037Z"294a85d4e26134be023da17e11b09975"2743391do-petrleo-ao-comprimido-a-origem-dos-medicamentos-e-o-papel-do-ifa.png175771421475496512025-09-12T21:56:54.795Z"dbd503f65d5b99c759efb707ba59c04a"1873285do-relato-de-caso--meta-anlise-a-pirmide-da-evidncia--5092.png177645054271862012026-04-17T18:29:02.786Z"6bab1dcb0bfc17c2932614c07af3a530"1575097doctorpatient-communication-in-obesity-management.png175778663028962212025-09-13T18:03:50.365Z"02f9d17a2bbd0db70c9d4ffa8229f671"2517010doena-do-enxerto-contra-o-hospedeiro-dech-avanos-teraputicos-e-o-impacto-da-inibio-de-rock2-9715.png177644452488844812026-04-17T16:48:44.950Z"dd19e6bc360aba7d3d0fe7ef60e65231"2336867doena-do-espectro-da-neuromielite-ptica-reconhea-os-sintomas--diagnstico-diferencial--.jpeg177264839305068912026-03-04T18:19:53.122Z"0677d0000d9aca759ad5821067bf7e85"176513doença-mão-pé-boca:-o-que-sabemos-sobre-esse-quadro-viral-na-infância.jpeg174861312257257712025-05-30T13:52:02.616Z"ab9d648c6b4b74eb07408c755d368507"11106187doenças-meio-raras.png177582383703456612026-04-10T12:23:57.101Z"d9524ba4b079d0229353d832409c7026"465202doenças-nada-raras.png177576455421677412026-04-09T19:55:54.276Z"d9524ba4b079d0229353d832409c7026"465202doenças-raras.png177576429388778312026-04-09T19:51:34.014Z"d9524ba4b079d0229353d832409c7026"465202doenças-um-pouco-raras.png177576444736228112026-04-09T19:54:07.419Z"d9524ba4b079d0229353d832409c7026"465202dog-assisted-therapy-enhances-emotional-regulation-in-children-with-down-syndrome-and-autism.jpeg175310101328606312025-07-21T12:30:13.385Z"a917f5f4d6353edcebd58d6f1420557b"8211023donar-sangre--el-regalo-de-vida-que-no-cuesta-nada-1-113812.jpeg177004309460012512026-02-02T14:38:14.648Z"37a8955e9ae7ec8195fbc2b1cbc02d3e"141617donar-sangre-el-regalo-de-vida-que-no-cuesta-nada.png177004222497999412026-02-02T14:23:45.027Z"3d8c5fa1ab31dcb853686be75d452834"2555096donating-blood-the-gift-of-life-that-costs-nothing.png177005785673307412026-02-02T18:44:16.772Z"3d8c5fa1ab31dcb853686be75d452834"2555096dr-ambreen-mohamed-and-dr-c-michael-gibson-discuss-polyhf-a-polypill-strategy-for-heart-failure-with-reduced-ejection-fraction.png176298079720539312025-11-12T20:53:17.252Z"bc896794aeb5041f0af169916e255081"2364824dr-ann-marie-navar-dr-c-michael-gibson-discuss-coral-reef-lipids-oral-pcsk9-inhibition-delivers-injectablelevel-ldlc-lowering.png176400842791186012025-11-24T18:20:27.958Z"c19880ded8b196c771772892eae67c3c"1623936dr-c-michael-gibson-and-dr-allen-taylor-on-ai-plaque-analysis-moving-beyond-risk-scores-and-stress-testing-in-coronary-prevention.png176460611549057712025-12-01T16:21:55.532Z"afec28ff997047467749e18827cd19d0"1227952dr-c-michael-gibson-and-dr-christopher-x-wong-discuss-the-decaf-trial-does-eliminating-coffee-avoid-fibrillation.png176297195184653612025-11-12T18:25:51.897Z"92f907c3ac70e1d175282195c34f0bd0"2926776dr-c-michael-gibson-and-dr-gran-bergstrm-discuss-the-scapis-study-the-added-prognostic-value-of-coronary-ct-angiography-beyond-calcium-scoring.png176297241495263112025-11-12T18:33:35.003Z"e3d1613a03f9404c7c408f2daa0bf07c"2616705dr-c-michael-gibson-and-dr-john-a-dodson-discuss-betterbp-behavioral-economics-and-the-challenge-of-sustained-blood-pressure-control.png176297294026299712025-11-12T18:42:20.313Z"e99a551779685d5c8da57d4d34b48e95"2934016dr-c-michael-gibson-and-dr-shamir-mehta-review-does-complete-revascularization-truly-reduce-cv-death-and-mi.png176307231579024412025-11-13T22:18:35.839Z"01591d26dfd73daa4d28dd4c74430aad"3016108dr-c-michael-gibson-and-dr-sripal-bangalore-discuss-tuxedo2-ticagrelor-vs-prasugrel-in-diabetic-patients-undergoing-pci.png176460557463447812025-12-01T16:12:54.681Z"8e95f6ff4e05911b8862ee729e098409"1278386dr-c-michael-gibson-dr-amrish-deshmukh-on-metaaf-metformin-as-an-adjunct-to-catheter-ablation-of-atrial-fibrillation.png176296682426916812025-11-12T17:00:24.311Z"bc619c66e3efa256bc2084e1b3a769da"2580184dr-c-michael-gibson-dr-atul-verma-on-ocean-do-we-really-need-lifelong-anticoagulation-after-successful-af-ablation.png176296522285989712025-11-12T16:33:42.899Z"6749bf9515891088f42b384e8d72591d"2465642dr-c-michael-gibson-dr-fatima-rodriguez-on-staging-treating-and-tracking-coronary-atherosclerosis-beyond-stenosis.png176400938240433812025-11-24T18:36:22.445Z"3b78b672ac49c4218d0c16a30215bed9"2327038dr-c-michael-gibson-dr-ginger-jiang-on-celebrate-prehospital-zalunfiban-for-stemi-in-snackablehealth.png176297789636500612025-11-12T20:04:56.405Z"8409d407f3ab2631971b1d53313b9126"1928201dr-c-michael-gibson-dr-james-januzzi-discuss-bnp-atrial-fibrillation-and-amyloidosis-what-do-biomarkers-really-tell-us.png176400703739797412025-11-24T17:57:17.485Z"bb79f3b4d6374e7684bbbef48521ddbe"1489532dr-c-michael-gibson-dr-kevin-alexander-on-attributecm-acoramidis-and-mortality-in-pv142i-variant-attrcm.png176296593362497912025-11-12T16:45:33.669Z"2b0a741143eab417649697711f3934bb"1961574dr-c-michael-gibson-dr-pound-discuss-foodhf-randomized-trial.png176298339660324012025-11-12T21:36:36.647Z"edfc9e7b0de532b5b1558606539e5a39"2681615dr-c-michael-gibson-dr-ulf-landmesser-discuss-closureaf-when-left-atrial-appendage-closure-fails-to-beat-doacs.png176296282679421712025-11-12T15:53:46.837Z"6c949a6070ab946e295257cbd1fb9fb4"2858404dr-christie-ballantyne-dr-c-michael-gibson-oral-pcsk9-inhibition-shows-sustained-60-ldl-reduction-in-hefh.png176400986383918412025-11-24T18:44:23.886Z"6b1881656f764c5ee4166a2bd609c0d7"2620321dr-colin-berry-and-dr-c-michael-gibson-discuss-corcmr-noninvasive-endotyping-in-patients-with-angina-and-no-obstructive-coronary-artery-disease-a-randomized-controlled-trial.png176297939922676712025-11-12T20:29:59.276Z"050b9504da3d84ad03eade4e53ba75fa"2954814dr-nicole-cyrille-superville-dr-c-michael-gibson-discuss-who-gets-tafamidis-and-who-benefits-demographic-gaps-in-attrcm-care-across-the-us.png176400880583871412025-11-24T18:26:45.877Z"b0743f30e9334b07399438ef2ce81c1d"2080494dr-sandesh-dev-dr-c-michael-gibson-explore-geographic-disparities-in-attrcm-among-us-veterans.png176400808221091712025-11-24T18:14:42.251Z"2bd085cfc860412926fbac4db3addcd8"2852891dr-stephen-juraschek-and-dr-c-michael-gibson-discuss-gofresh-trial-can-homedelivered-dash-groceries-lower-blood-pressure.png176297671472227112025-11-12T19:45:14.762Z"f8149f818295643cabb8a4c69f7f30f0"2590050dr-stephen-nicholls-dr-c-michael-gibson-discuss-surpasscvot.png176298409050784212025-11-12T21:48:10.550Z"e3ac43147212fb2f0a1ed677e794951d"2753515dr-william-f-fearon-and-dr-c-michael-gibson-discuss-caviar-can-alirocumab-curb-cardiac-allograft-vasculopathy-after-transplant.png176298219769000312025-11-12T21:16:37.732Z"221846eed88d39098ba17eb28f553205"2907711dr10624-agonista-triple-de-los-receptores-fgf21-glucagn-y-glp-1-reduce-significativamente-los-triglicridos-y-la-grasa-heptica.png176271350749215212025-11-09T18:38:27.531Z"e7e109d39da3e193be7921e4a0da8782"1956505dr10624-agonista-triplo-dos-receptores-de-fgf21-glucagon-e-glp-1-promove-redues-expressivas-nos-triglicerdeos-e-na-gordura-heptica-.png176271200583423012025-11-09T18:13:25.877Z"ff52ba3dba95be09db66d41e428856f5"1917810dr10624-triple-agonist-of-fgf21-glucagon-and-glp1-receptors-significantly-reduces-triglycerides-and-liver-fat.png176271363916504112025-11-09T18:40:39.273Z"d4e71e6904e4f17b87d7f1456a4cce32"1956633dreamm-7-e-dreamm-8-novas-evidncias-para-pacientes-com-mieloma-mltiplo-recidivado-refratrio-de-alto-risco-funcional.jpeg176531745716888812025-12-09T21:57:37.217Z"d97ae0591e73ed8383c824f1f9b67bf2"312684dreamm-7-e-dreamm-8-novas-evidncias-para-pacientes-com-mieloma-mltiplo-recidivadorefratrio-de-alto-risco-funcional.jpeg176531736686377412025-12-09T21:56:07.021Z"d97ae0591e73ed8383c824f1f9b67bf2"312684dreamm7-and-dreamm8-studies-demonstrate-the-benefits-of-belantamab-mafodotin-in-patients-with-functional-highrisk-relapsed-or-refractory-multiple-myeloma.png176625586335632112025-12-20T18:37:43.396Z"35fb4f3d6960cb4160b209f4bc004a3f"1953982drug-pricing-why-international-reference-may-not-work-for-the-united-states.png175934174223962912025-10-01T18:02:22.282Z"3d79367ff5f2802d3f4de74b33bf67bc"2289440dual-antiplatelet-therapy-after-cabg-for-acs-no-added-benefit-over-aspirin-alone.png175916043553198012025-09-29T15:40:35.572Z"dab76e43cf8d282aaff7c83cedc77586"2615322dual-target-car-t-kite-363-shows-promising-efficacy-in-relapsed/refractory-b-cell-lymphoma.png175094585205268212025-06-26T13:50:52.095Z"a42325a36e21f2acb8bee648902b5142"1181783dubhe-l-201-cohorte-5-supervivencia-a-largo-plazo-con-ql1706-ms-bevacizumab-y-platinopemetrexed-tras-fracaso-de-egfr-tki-en-cpnm-con-mutacin-egfr.png176771179122007112026-01-06T15:03:11.260Z"d81b220ea60002da1f9145d90be1f1fd"5703382dubhel201-cohort-5-longterm-outcomes-with-ql1706-plus-bevacizumab-and-platinumpemetrexed-after-egfrtki-failure-in-egfrmutant-nsclc.png176771180436323312026-01-06T15:03:24.401Z"d81b220ea60002da1f9145d90be1f1fd"5703382durante-a-palestra-no-teste-2025-um-tema-recorrente-foi-a-import-ncia-da-educa-o-cont-nua-para-os-profissionais-de-hematologia-com-o-r-pido-avan-o-das-tecnologias-e-tratamentos.jpeg176892778123407922026-01-20T16:49:41.278Z"5ea7005bc223ceee73d1f41fd5d2f9e4"446900durvalumab--flot-mejora-significativamente-la-supervivencia-global-en-pacientes-con-adenocarcinoma-gstrico-o-de-la-unin-gastroesofgica-resecable-matterhorn.jpeg176072618195433212025-10-17T18:36:22.010Z"77b13e21b612406e5fcc623704bbece4"214876durvalumab-combined-with-platinum-and-etoposide-shows-intracranial-response-in-sclc-with-active-brain-metastases.jpeg175276630642714612025-07-17T15:31:46.468Z"0a0bf61b7253aedce750c8bcc9e7e06b"3184532durvalumab-flot-significantly-improves-overall-survival-in-patients-with-resectable-gastric-or-gastroesophageal-junction-adenocarcinoma-matterhorn.jpeg176072572190224812025-10-17T18:28:41.945Z"77b13e21b612406e5fcc623704bbece4"214876durvalumabe-com-platina-e-etoposídeo-mostra-resposta-intracraniana-em-cppc-com-metástases-cerebrais-ativas.jpeg175268974221032912025-07-16T18:15:42.250Z"0a0bf61b7253aedce750c8bcc9e7e06b"3184532durvalumabe-é-aprovado-no-brasil-para-tratamento-perioperatório-de-câncer-de-pulmão-não-pequenas-células-(cpnpc)-ressecável-após-resultados-do-estudo-aegean.jpeg175683361331820912025-09-02T17:20:13.367Z"e72fabb70363ae05d83b2a23181f151b"10455904durvalumabe-é-aprovado-no-brasil-para-tratamento-perioperatório-de-câncer-de-pulmão-não-pequenas-células-(cpnpc)-ressecável-após-resultados-do-estudo-aegeanjpeg175682368031268612025-09-02T14:34:40.393Z"e72fabb70363ae05d83b2a23181f151b"10455904durvalumabe-é-custo-efetivo-no-câncer-de-pulmão-estágio-iii?-análise-internacional-traz-resposta-com-foco-no-brasil-.jpeg174923402056663912025-06-06T18:20:20.610Z"a65701eb3d02b691937a97e133f510cb"1788072dynamic-shifts-in-inflammation-markers-predict-outcomes-in-patients-on-immune-checkpoint-inhibitors.png176070674831577312025-10-17T13:12:28.375Z"01d5a7b69b0bfa6faab6bbd524a9df7e"2417434e-book-esc-2025.png175641385012907312025-08-28T20:44:10.166Z"7b0de0dde676a24a66ef32d26f2ca1fe"1773798early-rituximab-monotherapy-significantly-delays-need-for-chemotherapy-in-low-tumor-burden-follicular-lymphoma..png175632710444394812025-08-27T20:38:24.518Z"1cbbb3adc95b46804502f47f2e98d758"1710222early-sotatercept-use-reduces-clinical-worsening-by-76-in-newly-diagnosed-pulmonary-arterial-hypertension-results-from-hyperion.png175984853800702612025-10-07T14:48:58.071Z"b4685d0cd57229030d86792d6d407890"2211818early-tirofiban-administration-improves-functional-recovery-after-thrombolysis-in-noncardioembolic-stroke.png175261267656832512025-07-15T20:51:16.616Z"7f6d7e99a3bc6c1791b344226d9d3f6d"1020785early-tirofiban-infusion-after-thrombolysis-improves-outcomes-in-acute-ischemic-stroke.png175924797992252712025-09-30T15:59:40.046Z"c5cd18e7c14fb20491bc6db58a31fb2b"2594690easd-2023.pdf176798128200040512026-01-09T17:54:42.123Z"e78021bf101b36eb7a513ea248f7b398"1333476easd-2023.png176797919788921812026-01-09T17:19:57.925Z"3d8c5fa1ab31dcb853686be75d452834"2555096ebook-noticia.pdf176591096623738722025-12-16T18:49:26.277Z"e78021bf101b36eb7a513ea248f7b398"1333476edicin-gnica-con-crispr-cas9-dirigida-a-angptl3-promueve-reducciones-significativas-y-sostenidas-de-lpidos-aterognicos.png176271270903153812025-11-09T18:25:09.080Z"75978de0d2749c49dd7dfee467bcb98d"1269916edio-gnica-com-crispr-cas9-em-angptl3-promove-redues-significativas-e-sustentadas-de-lipdios-aterognicos-.png176271050282843112025-11-09T17:48:22.875Z"02a9bbaf133204ae046dbffdd4207c19"1242253efeitos-da-rosuvastatina-+-ezetimiba-na-regressão-da-placa-aterosclerótica.png175024970828514612025-06-18T12:28:28.333Z"3878d9c07c1afb3bf3630b7284533c66"1846996effectiveness-and-safety-of-early-rhythm-control-in-atrial-fibrillation-are-maintained-in-patients-with-obesity-and-diabetes..png175440434663554812025-08-05T14:32:26.697Z"212aa07d8b7470dcf2c2046f22452332"1606272efficacy-and-safety-of-rilzabrutinib-in-the-treatment-of-chronic-immune-thrombocytopenia:-results-from-the-phase-3-luna3-study..jpeg175146480716415012025-07-02T14:00:07.206Z"529c99302ea8ffb6e77e6c87a5024704"9861924efficacy-of-one-versus-three-doses-of-benzathine-penicillin-g-in-early-syphilis.png175863223635229312025-09-23T12:57:16.397Z"940aa92f2a9b4abde70dc42dff5f58ab"267898eficcia-de-uma-versus-trs-doses-de-penicilina-benzatina-na-sfilis-precoce.png175892043673812812025-09-26T21:00:36.783Z"7127e859660e4b386704fe6ea7494b1f"429390eficcia-e-segurana-do-luspatercepte-em-pacientes-com--talassemia-no-dependentes-de-transfuso-resultados-de-longo-prazo-do-estudo-beyond.jpeg177281930549160712026-03-06T17:48:25.604Z"3bcebfe37d3a1d7b16f3bc1c1518d3fd"5274604eficcia-e-segurana-dos-inibidores-de-pd-1pd-l1-em-combinao-com-quimioterapia-ou-clulas-car-t-para-leucemia-linfoide-aguda-refratriarecidivada-um-estudo-multicntrico-de-fase-ii.jpeg177324750844601312026-03-11T16:45:08.546Z"d7c05f37743d46a7e27e5c54bff99e98"236654eficácia-intracraniana-de-datopotamabe-deruxtecana-(dato-dxd)-em-nsclc-avançado-ou-metastático--resultados-do-tropion-lung-01.png175710169200285812025-09-05T19:48:12.064Z"b5dd227c0c694b2fc3bae49983717063"1978675efruxifermin-and-mash-related-cirrhosis:-long-term-hopes-despite-modest-initial-results.jpeg175287387309366312025-07-18T21:24:33.134Z"47bad8be35510b6d253e171ab271fbd4"2335924eha-2025:-estudo-commands---uso-de-luspatercepte-versus-eritropoetina-alfa-em-pacientes-com-síndrome-mielodisplásica-de-baixo-risco-.png175103625872997412025-06-27T14:57:38.788Z"8f1a7c390c9534f0b8b66aad047b4501"1877167eha-2025:-importância-do-escore-icpss-na-recomendação-de-transplante-para-pacientes-com-leucemia-mielomonocítica-crônica-(lmmc).png175096456962346212025-06-26T19:02:49.725Z"e6a5467c6356d59698ee914f38e933f4"1344883eha-2025:-principais-avanços-no-tratamento-do-mieloma-múltiplo-–-car-t-e-novas-combinações.png175102445534291612025-06-27T11:40:55.386Z"3a706b63d09e907a03e2c96a9413cd38"752168eha-2025:-remissão-e-sobrevida-a-longo-prazo-(≥-5-anos)-de-pacientes-com-mieloma-múltiplo-recidivado/refratário-(rrmm)-após-o-tratamento-com-ciltacabtagene-autoleucel-no-estudo-cartitude-1.png175131118627399912025-06-30T19:19:46.331Z"1aa6d2fc5bde534073941b1859d0fa35"2262515eha-2025:-uso-de-bexmarilimabe-e-azacitidina-no-tratamento-de-pacientes-com-síndrome-mielodisplásica-de-alto-risco.png175129383018302912025-06-30T14:30:30.242Z"99a72b605bdc19b5ef6ab3bf6e9a5a18"1941065eha-2025:-uso-de-ibrutinibe-+-venetoclax-para-o-tratamento-da-leucemia-linfocítica-crônica/linfoma-linfocítico-de-células-pequenas---estudo-captivate-.png175130020139643712025-06-30T16:16:41.441Z"ec12b74dca4b63e4564ee03a84a6f9a9"2429714eha®-2025:-cepheus-consolida-combinação-quadripla-com-daratumumabe-no-mieloma-recém-diagnosticado-ineligível-ao-transplante.jpeg175026931685213412025-06-18T17:55:16.909Z"43212ec62424eb0f40f18883359a1438"454696eha®-2025:-cilta-cel-atinge-platô-de-sobrevida-livre-de-progressão-em-33%-dos-pacientes-após-5-anos.png175094257650098512025-06-26T12:56:16.611Z"b814ee34f3e45f0f3e839562fa38cee6"1584594eha®-2025:-combinação-de-teclistamabe-e-talquetamabe-mostra-resposta-robusta-em-mieloma-com-doença-extramedular.png175087547407518512025-06-25T18:17:54.119Z"472aeb1472d19fbdd5d522b236aad3b1"1452031eha®-2025:-epcoritamabe + quimioterapia-convencional-no-linfoma-difuso-de-grandes-células-b-em-recaída:-sinergia-promissora-.png174990807377980912025-06-14T13:34:33.828Z"b096a12203be66b03b46536d8ac906bf"2139154eha®-2025:-estudo-perseus:-adição-de-daratumumabe-leva-a-respostas-mais-profundas-e-prolongadas-no-mieloma-múltiplo-elegível-ao-transplante.jpeg175010229908170212025-06-16T19:31:39.122Z"967b943539f5096399e53541c15624b4"273288eha®-2025:-isa-vrd-e-o-impacto-positivo-no-tratamento-de-pacientes-de-alto-risco-de-mm-inelegíveis-ao-transplante-.png175028137220660112025-06-18T21:16:12.256Z"5e8e22cde000978994358994427e6f65"1644882eha®-2025:-isatuximabe-subcutâneo-e-terapias-guiadas-por-drm:-evidências-atuais-e-perspectivas-futuras-no-mieloma-múltipl.png175028122158726412025-06-18T21:13:41.627Z"a171fe34defeee0644befe5b3e261dec"1996401eha®-2025:-melhora-da-anemia,-independência-transfusional-e-redução-esplênica-são-associados-com-aumento-da-sobrevida-global-em-pacientes-com-mielofibrose-tratados-com-momelotinibe.png175010285657114512025-06-16T19:40:56.673Z"045a6810a0beda646e989f5f978474ea"1168620eha®-2025:-odronextamabe-em-linfoma-folicular-recidivado/refratário:-dados-de-longo-prazo-do-estudo-elm-2.png174990878363096812025-06-14T13:46:23.679Z"1df6fd4eea2aff85a5b2c5b46e28bf99"2047650eha®-2025:-potencial-cura-com-cilta-cel-é-destaque-na-atualização-de-5-anos-do-estudo-cartitude1.jpeg175026434131914412025-06-18T16:32:21.409Z"d30b593e0be05bb4ec1d36384daffc2a"387382eha®-2025:-principais-destaques-em-mieloma-múltiplo-e-linfoma-b.png175087621752046512025-06-25T18:30:17.561Z"6cb547bfc97fe3d9a5e8a14b0f494ad4"746892eha®-2025:-superioridade-de-ibrutinibe-+-venetoclax-em-llc-de-primeira-linha.jpeg175026535514242112025-06-18T16:49:15.192Z"08eaeb5ad19449435a926949c5b94d99"199764eha®-2025:-tratamento-isento-de-quimioterapia-no-dlbcl:-o-papel-promissor-do-rpolaglo-.png174984717060347612025-06-13T20:39:30.644Z"3596a9a4f4b44b28ed810abb19da5cda"1692840el-anticuerpo-anti-cd300c-cl7-reduce-el-crecimiento-tumoral-en-nsclc-al-remodelar-el-microambiente-inmunitario.png176736076288924712026-01-02T13:32:42.930Z"f3bc3ba629a9a8244170e068e8e355f5"6919221el-ctdna-tras-la-neoadyuvancia-predice-riesgo-metastsico-y-puede-orientar-la-preservacin-vesical-en-el-mibc.jpeg177247934000161812026-03-02T19:22:20.071Z"833549e5bd775935441f2a9e8caa7560"158319el-lipi-basal-estratifica-pronstico-en-nsclc-pd-l1-bajonegativo-tratado-con-quimioinmunoterapia-en-primera-lnea.png176883603776052112026-01-19T15:20:37.814Z"192b044a015852a8931ec90b51372013"6716035el-pncreas-artificial-reduce-la-hba1c-en-un-08-y-aumenta-el-tiempo-en-rango-en-ms-de-un-23-en-adultos-con-t1d-.jpeg175832256033564812025-09-19T22:56:00.376Z"b05314b96464e14ca5537e8cc25f23a9"315661elcc-2026-hero-banner-mobile.png177316925645077812026-03-10T19:00:56.493Z"65d431172288d52a98301c5d0fd711cc"313852elcc-2026-hero-banner.png177247315715668512026-03-02T17:39:17.226Z"5b3414ef541754f06472b5ac2f828304"497932elcc-2026-highlights-cambios-de-paradigma-y-nuevas-fronteras-en-el-cncer-de-pulmn.jpeg177496607780796312026-03-31T14:07:57.854Z"cac3f40864ff6dc775d820155fb997e0"465777elcc-2026-highlights-mudanas-de-paradigma-e-novas-fronteiras-no-cncer-de-pulmo-2052.jpeg177497255972076712026-03-31T15:55:59.768Z"ca8606b36586f52950eba106e6eb8ab2"471407ele--mais-forte-do-que-voc-pensa----o-efeito-placebo--5092.png177644988146934712026-04-17T18:18:01.538Z"906ee9e795b5581905d054b71c19c8e7"1358217electrical-storm-diagnosis-and-treatment-4535.177757570639303712026-04-30T19:01:46.456Z"de2bfbe0c5da529062a7879f302f0972"2004859elevategenai-establishing-global-standards-for-responsible-use-of-large-language-models-in-health-economics.png176038934190488512025-10-13T21:02:21.969Z"8c0ddefb86499eed13ffcfb907e9931b"2283420empathy-focused-phone-calls-by-laypeople-improve-glycemic-control-in-patients-with-diabetes.jpeg175310157413093412025-07-21T12:39:34.170Z"d1e0b88b934c18308c8d5b01bd0918e2"261198encuesta-italiana-multicntrica-reporta-255-de-neoplasias-mieloides-tras-inhibidores-parp-en-cncer-de-ovario.png176762140788112212026-01-05T13:56:47.918Z"233dc11620268e4a3ee258a4bbbc80c8"5602086endocrino-quiz.png177610563428731612026-04-13T18:40:34.343Z"0748f8514d50608042ee702825360e9d"68935endometriose-associao-clinicamente-relevante-com-doena-cardiovascular.png177090004429944012026-02-12T12:40:44.346Z"ae59cd9b92159cc7f8cb3549fc0d14fb"1922591enfortumabe-vedotina-mais-pembrolizumabe-no-perioperatrio-reduz-risco-de-recorrncia-e-morte-no-cncer-de-bexiga-msculo-invasivo-inelegvel--cisplatina.jpeg177152907219191612026-02-19T19:24:32.239Z"23645aa7caa3e2ed23066e6d4eac5d84"8015228engasertib-mostr-mejoras-dosis-dependientes-en-epistaxis-con-principalmente-exantema-e-hiperglucemia-en-hht-ensayo-fase-1b.png176761817926627512026-01-05T13:02:59.325Z"8eb76626491adf059631f3b9cc65112e"5415349engasertib-showed-doserelated-epistaxis-improvements-with-mainly-rash-and-hyperglycemia-in-hht-a-phase-1b-trial.png176761861732762712026-01-05T13:10:17.431Z"8eb76626491adf059631f3b9cc65112e"5415349ensaio-clnico-de-terapia-gnica-para-atrofia-muscular-espinhal-ame-tipo-1--autorizado-no-brasil.jpeg176781881248778912026-01-07T20:46:52.618Z"38e53bfcb51e779ea3f8d7b67a217a3a"16037505ensayo-fase-i-de-neratinib-ms-palbociclib-en-tumores-slidos-avanzados-con-alteraciones-de-la-familia-her-seguridad-dosis-y-actividad-preliminar.png176858811347937712026-01-16T18:28:33.516Z"7190135a6839c6c863765a33d08f8cbc"7134950epigenetic-aging-as-a-mediator-of-cardiovascular-and-metabolic-risk-in-childhood-cancer-survivors..png175511130058902012025-08-13T18:55:00.645Z"f366f90fafe25adc576e96a7a30bfc88"1833380eribulin-shows-limited-efficacy-in-braf-v600emutant-metastatic-colorectal-cancer-but-molecular-insights-emerge-from-the-bravery-trial.png176045834759514112025-10-14T16:12:27.641Z"d811317b1d21048abd9e41a9b8f2008b"2290455ericklegalbonito.png177256063651889812026-03-03T17:57:16.581Z"5894d62fd99022242edc35836bb77f0b"491751esc-2025--dual-acs-is-three-months-of-dapt-the-new-sweet-spot.png175736323366809412025-09-08T20:27:13.729Z"339b125d9b542b3dca2359196a315a25"1397136esc-2025--swedepad-1-and-2-drug-coated-versus-uncoated-stents-in-peripheral-artery-disease.png175736291076806712025-09-08T20:21:50.815Z"28e65c057ba694a93ac895d7139e64b5"1646077esc-2025-optionstemi-immediate-or-staged-complete-revascularization.png175752817843945112025-09-10T18:16:18.479Z"265d56bbe5b721747fe069e766634a36"905187esc-2025-–-betami–danblock:-beta-blockers-after-infarction.jpeg175660148343003612025-08-31T00:51:23.475Z"950c42ec594af034b3c8828f3d1fb934"20457esc-2025-–-betami–danblock:-beta-blockers-after-infarction.png175735985249053912025-09-08T19:30:52.518Z"00a434dba048d188fb701a273a24e162"720658esc-2025-–-betami–danblock:-beta-blockers-after-infarction?.jpeg175660136846620212025-08-31T00:49:28.509Z"950c42ec594af034b3c8828f3d1fb934"20457esc-2025-–-beyond-traditional-risk-factors:-the-weight-of-inflammation.png175660067436046712025-08-31T00:37:54.411Z"916e0946be4e5732ed7624fd8dbbf1f0"393953esc-2025-–-consenso-clínico-sobre-saúde-mental-e-doença-cardiovascular-.png175666548827152212025-08-31T18:38:08.316Z"981671127803848e722671a3f7edcd58"1367166esc-2025-–-ensaios-recentes-em-insuficiência-cardíaca--novas-perspectivas-e-desafios.png175656882648539512025-08-30T15:47:06.588Z"486d91b529631098b0598416c918a74e"939330esc-2025-–-estudo-aquatic-traz-evidências-sobre-o-uso-prolongado-de-aspirina-em-anticoagulação-oral-.png175666127866078912025-08-31T17:27:58.718Z"657a9c4f00b28a77a3aac2c8ce6102fb"1376333esc-2025-–-estudo-pulse--angiografia-no-seguimento-pós-intervenção-coronária-percutânea-é-relevante--.png175666312862183912025-08-31T17:58:48.683Z"0954a8daccf252a210402c644e7c6eef"1543349esc-2025-–-estudo-pulse--angiografia-no-seguimento-pós-intervenção-coronária-percutânea-é-relevante-.png175666288606275012025-08-31T17:54:46.106Z"0954a8daccf252a210402c644e7c6eef"1543349esc-2025-–-novas-diretrizes-para-manejo-de-miocardite-e-pericardite-.png175666497008700212025-08-31T18:29:30.132Z"0b5cb4c0b4b6c56418a124519a87c84b"1150470esc-2025-–-option-stemi:-immediate-or-staged-complete-revascularization.png175736004516013812025-09-08T19:34:05.187Z"5729eb7e1ad36e40ff312c7ab126c669"19733esc-2025-–-recent-trials-in-heart-failure:-new-perspectives-and-challenges.png175659816294745912025-08-30T23:56:03.001Z"bc8904088a9d8f734f196f917b48b523"951566esc-2025.png175632424200656712025-08-27T19:50:42.058Z"7b0de0dde676a24a66ef32d26f2ca1fe"1773798esclerose-mltipla-evoluo-dos-conceitos-diagnsticos-e-teraputicos-diante-da-progresso-independente-de-surtos.png177315023868013012026-03-10T13:43:58.792Z"2470dc57ece4e8f1a9ef23bc80235663"2018973esc®-2025-–-além-dos-fatores-de-risco-tradicionais--o-peso-da-inflamação.png175657375359029412025-08-30T17:09:13.633Z"9925bf5dcc5ae17c4e2cb7e3e4287985"867259esc®-2025-–-attribute-cm--benefícios-sustentados-do-acoramidis-na-amiloidose-cardíaca-.png175666596095828012025-08-31T18:46:01.007Z"2d8b0c5cacaca03d051274e3712a351b"994120esc®-2025-–-attribute-cm:-sustained-benefits-of-acoramidis-in-cardiac-amyloidosis.png175734523881634512025-09-08T15:27:18.863Z"2d8b0c5cacaca03d051274e3712a351b"994120esc®-2025-–-baxhtn--baxdrostat-reduz-pressão-arterial-em-pacientes-com-hipertensão-resistente-.png175666405155746812025-08-31T18:14:11.602Z"26108ecd3a4608c2f60ac3f9155ca735"1316503esc®-2025-–-baxhtn:-baxdrostat-lowers-blood-pressure-in-patients-with-resistant-hypertension.png175690676393745812025-09-03T13:39:23.995Z"26108ecd3a4608c2f60ac3f9155ca735"1316503esc®-2025-–-beta-blockers-after-mi.png175690836921009412025-09-03T14:06:09.310Z"af4af7da6b1657ed92e4004591d5f9f4"1721860esc®-2025-–-beta-blockers-after-myocardial-infarction-in-patients-with-mildly-reduced-ejection-fraction.png175734738737471012025-09-08T16:03:07.476Z"0a7ed7812cc43eef9a4bec845a5cb430"1163495esc®-2025-–-betami–danblock--beta-bloqueadores-após-infarto--.png175657327659389212025-08-30T17:01:16.641Z"73c33f78d049d1ffa905416821979b36"705282esc®-2025-–-betami–danblock:-beta-blockers-after-myocardial-infarction?.png175675758705885112025-09-01T20:13:07.099Z"19719aa8b87fa41977c9b72fa1d3bd8e"144855esc®-2025-–-dapa-act-hf-timi-68-avalia-dapagliflozina-em-pacientes-hospitalizados-por-insuficiência-cardíaca.png175683358283924112025-09-02T17:19:42.884Z"113cfca6ececb79c714f0db0703f9fba"1341912esc®-2025-–-dapa-act-hf-timi-68-avalia-dapagliflozina-em-pacientes-hospitalizados-por-insuficiência-cardíacapng175683328122029312025-09-02T17:14:41.260Z"113cfca6ececb79c714f0db0703f9fba"1341912esc®-2025-–-dual-acs--três-meses-de-dupla-antiagregação-como-novo-sweet-spot--.png175666191710623912025-08-31T17:38:37.146Z"339b125d9b542b3dca2359196a315a25"1397136esc®-2025-–-ensaios-recentes-em-insuficiência-cardíaca--novas-perspectivas-e-desafios.png175657008533765312025-08-30T16:08:05.441Z"486d91b529631098b0598416c918a74e"939330esc®-2025-–-lacross--primeiros-resultados-do-registro-latino-americano-de-fibrilação-atrial-.png175683674008142512025-09-02T18:12:20.105Z"a071096221434fdd2db193daee26fdd7"1492121esc®-2025-–-neo-mindset-desafia-o-padrão-da-terapia-antiplaquetária-dupla-após-icp-em-sca--é-cedo-para-abandonar-a-aspirina--.png175666352318718312025-08-31T18:05:23.231Z"142c417582f413eb69d011763eb4fa79"1266207esc®-2025-–-novas-diretrizes-para-manejo-de-dislipidemias-trazem-novos-algoritmos-para-predição-de-risco-cardiovascular-.png175683354322079512025-09-02T17:19:03.262Z"8d4b2a5e972d3f1767353677eb585d46"1250121esc®-2025-–-novas-diretrizes-para-manejo-de-dislipidemias-trazem-novos-algoritmos-para-predição-de-risco-cardiovascular-png175683321328974012025-09-02T17:13:33.347Z"8d4b2a5e972d3f1767353677eb585d46"1250121esc®-2025-–-novas-diretrizes-para-manejo-de-doença-cardiovascular-e-gravidez.png175683370965058812025-09-02T17:21:49.689Z"435a63bd80d66240da645aece42cb881"978004esc®-2025-–-novas-diretrizes-para-manejo-de-doença-cardiovascular-e-gravidezpng175683368263403912025-09-02T17:21:22.735Z"435a63bd80d66240da645aece42cb881"978004esc®-2025-–-novas-diretrizes-para-manejo-de-doença-cardíaca-valvar.png175657263477913112025-08-30T16:50:34.824Z"c0f3b099fc3255c06b6b41fe386b488c"1053399esc®-2025-–-option-stemi--revascularização-completa-imediata-ou-estagiada-.png175666246128594412025-08-31T17:47:41.330Z"265d56bbe5b721747fe069e766634a36"905187esc®-2025-–-parachute-hf--evidência-inédita-em-cardiopatia-chagásica-.png175734913100197712025-09-08T16:32:11.101Z"c2dc67aa62ae38101efbb93436bbec76"2441541esc®-2025-–-parachute-hf--novo-marco-para-o-tratamento-da-insuficiência-cardíaca-na-doença-de-chagas-.png175672508530211812025-09-01T11:11:25.357Z"67a97fb9182b62ed1f6d3bfcba26f92a"1790882esc®-2025-–-parachute-hf:-unprecedented-evidence-in-chagas-cardiomyopathy.png175735325241898012025-09-08T17:40:52.466Z"226e0a0ca97a82e942320bc56ca076ee"1923493esc®-2025-–-physiosync-hf--estimulação-fisiológica-vs.-trc-biventricular-.png175675073593528012025-09-01T18:18:56.009Z"64a013dd187aeffb87bc708d8e073960"1530328esc®-2025-–-recent-trials-in-heart-failure:-new-perspectives-and-challenges.png175735154398124212025-09-08T17:12:24.028Z"486d91b529631098b0598416c918a74e"939330esc®-2025-–-swedepad-1-e-2--uso-de-stent-farmacológico-versus-não-farmacológico-em-doença-arterial-periférica-.png175666067304428112025-08-31T17:17:53.088Z"28e65c057ba694a93ac895d7139e64b5"1646077esc®-2025-–-updated-dyslipidemia-guidelines-introduce-new-risk-prediction-algorithm.png175690801850203812025-09-03T14:00:18.543Z"d01d43d1b143966bf76f090c5d8eb003"2218919esc®️-2025-–-betami–danblock:-beta-blockers-after-infarction?.jpeg175659978781797312025-08-31T00:23:07.920Z"950c42ec594af034b3c8828f3d1fb934"20457esc®️-2025-–-beyond-traditional-risk-factors:-the-weight-of-inflammation.png175675324255623012025-09-01T19:00:42.657Z"4583164d49dc4a85eec97cbf4c7d8394"890111esc®️-2025-–-recent-trials-in-heart-failure:-new-perspectives-and-challenges.png175659889195083812025-08-31T00:08:12.052Z"bc8904088a9d8f734f196f917b48b523"951566esketamine-monotherapy-demonstrates-efficacy-and-safety-in-treatment-resistant-depression..png175329841323035712025-07-23T19:20:13.281Z"7f82965a674a8e7a2c3fe9f2178435de"1478333esmo-2025-avanos-cientficos-que-marcam-o-incio-do-congresso.jpeg176072663884979312025-10-17T18:43:58.888Z"643838c75efb1e5b6a8166395fd8fecd"273477esmo-2025-avanos-e-insights-que-moldam-a-prtica-clnica.jpeg176072690532930312025-10-17T18:48:25.387Z"753c6d0e6d87cd179d6723321b6def0f"276534esmo-2025-evidncias-que-moldam-a-prtica-clnica.jpeg176072706145318812025-10-17T18:51:01.492Z"52a92e6ce43a920fa1cacb73bb3d09ce"324454esmo-2025-insights-finais-e-novas-perspectivas-para-o-cuidado-ao-paciente.jpeg176106521150715412025-10-21T16:46:51.660Z"cda44efb8fbfbe6bc959a3771c4866e2"243257esmo-2025.png176011560079429712025-10-10T17:00:00.852Z"b04ca7bb93fcaa5a5050e3fe69bc597e"912938esmo-bc-2026-hero-banner-2714.jpeg177564902389678012026-04-08T11:50:23.943Z"4c4f95237a2676f6192b4fb9b8ef780b"238471esmo-bc-2026-hero-banner-9841.jpeg177556633264546812026-04-07T12:52:12.688Z"65da667c1a54858e908f96e758902938"144822esmo-bc-2026-hero-banner-en.jpeg177565213721828912026-04-08T12:42:17.263Z"c1cd447bea5bb8c953357797e71caccc"152196esmo-bc-2026-hero-banner-mobile-2714.jpeg177564902535208112026-04-08T11:50:25.398Z"bcb4babc7d9017d20c4da5fa1c8d3d0d"100370esmo-bc-2026-hero-banner-mobile-8388.jpeg177556636151529812026-04-07T12:52:41.553Z"726fa76091e4d68d756ce50bcc2a801f"89935esmo-bc-2026-hero-banner-mobile-9841.jpeg177556633420278112026-04-07T12:52:14.241Z"726fa76091e4d68d756ce50bcc2a801f"89935esmo-bc-2026-hero-banner-mobile-en.jpeg177565213564690412026-04-08T12:42:15.697Z"4f6d8ff64fa38a69ccd4cff656cc27af"98099esmo-bc-2026-hero-banner.jpeg177556678817362912026-04-07T12:59:48.266Z"5b2d13e4128f20bbd39c4166d50c19d9"153629esmo-consensus-recommendations-for-cardio-oncology-in-cancer-care..png175519408970816212025-08-14T17:54:49.751Z"5b98750a1a5b930ab9fe8a4defaebfdf"2071494especialistas-discutem-avanos-e-controvrsias-no-tratamento-do-linfoma-de-clulas-do-manto-durante-o-hemo-2025.png176357546421640212025-11-19T18:04:24.259Z"b00746c854fcc74ae706a10be9757e2d"363886estratgias-atuais-para-reduo-do-ldl-c-o-lugar-da-terapia-combinada.jpeg177100922259869212026-02-13T19:00:22.644Z"510a10ef86174b2ff492bde5b8385f90"251041estratgias-de-tratamento-para-a-leucemia-mieloide-crnica-com-foco-na-remisso-livre-de-tratamento-comparao-entre-nilotinibe-de-primeira-linha-e-imatinibe-com-switch-precoce-para-nilotinibe.jpeg177333074630604512026-03-12T15:52:26.347Z"47faf05768436703bb70350058460e6c"8621701estratégia-do-sus-amplia-cobertura-vacinal-contra-hepatite-a-e-mira-adultos-em-uso-de-prep.jpeg174861479382835112025-05-30T14:19:53.868Z"4f7f220ad1f084ebc14c7bbd3b67689c"9716745estudo-accord-aponta-benefício-de-imunoterapia-combinada-com-quimiorradioterapia-adjuvante-em-colangiocarcinoma-extra-hepático-e-câncer-de-vesícula-biliar-ressecáveis.jpeg175225663167914812025-07-11T17:57:11.726Z"3995078e5d66555e93265c692618dbe8"968270estudo-alliance-a011104-no-demonstra-benefcio-da-ressonncia-magntica-pr-operatria-no-controle-locorregional-do-cncer-de-mama-inicial.png176590664782605812025-12-16T17:37:27.866Z"da17d3ea98fe9708d8f3cce51b999672"898994estudo-alycante-revoluciona-o-tratamento-de-2ª-linha-no-lgcb--resposta-completa-com-axi-cel-atinge-82,3%-em-pacientes-não-candidatos-ao-transplante.png175569137125916612025-08-20T12:02:51.311Z"c9113af876a777796ab24eb6a0a6cb22"1421889estudo-aponta-avanço-alarmante-nas-mortes-por-overdose-de-jovens-envolvendo-apenas-fentanil.jpeg175071228872888012025-06-23T20:58:08.771Z"015606948b28973cc06580e26024e5d3"6571178estudo-aponta-benefício-da-canagliflozina-em-desfechos-cardiovasculares-e-renais-em-pacientes-com-diabetes-tipo-2.jpeg175007864776358512025-06-16T12:57:27.803Z"6a87accfb9ef2076909b6a3260bedba0"5566116estudo-axsana-refora-segurana-oncolgica-de-abordagens-menos-invasivas-na-axila-aps-quimioterapia-neoadjuvante.png176597949260466112025-12-17T13:51:32.644Z"6a249bfda5f8f3c9a083413f5c8b6842"1180984estudo-benefit-refora-eficcia-e-segurana-da-combinao-isa-vrd-com-altas-taxas-de-drm-sustentada.jpeg176539381083819212025-12-10T19:10:10.886Z"601c6370159f2f9d2267233c90574dc3"434246estudo-brasileiro-avalia-prevalência-de-mutações-em-nódulos-tireoidianos-e-reforça-papel-do-braf-v600e-no-diagnóstico-de-câncer.jpeg175572161251757112025-08-20T20:26:52.560Z"5bce16a255a513770fb305a2f48c9202"977774estudo-brasileiro-demonstra-benefcio-da-combinao-de-pembrolizumabe-e-quimioterapia-em-carcinoma-espinocelular-peniano-avanado.jpeg175873848068899412025-09-24T18:28:00.768Z"e0f3477507c7b9d4df0b913d780018e5"889918estudo-breakwater:-encorafenibe-+-cetuximabe-+-mfolfox6-como-novo-padrão-de-tratamento-para-câncer-colorretal-com-mutação-brafv600e-em-primeira-linha.png175070129201544712025-06-23T17:54:52.079Z"1b6a8a587caf0ec00d357e8ac781caf3"1684065estudo-com-decitabina-e-rhg-csf-como-terapia-de-manutenção-pós-alo-hsct-em-neoplasias-mieloides-de-alto-risco-.jpeg175441278237238212025-08-05T16:53:02.473Z"edc943ebb757717ad98de55d424c9abf"4258972estudo-commands-comparou-o-uso-de-luspatercepte-com-epoetina-alfa-no-tratamento-de-pacientes-com-síndromes-mielodisplásicas.png175129517980890812025-06-30T14:52:59.866Z"3cf578f995ef21765c463d3901a61f49"913276estudo-confirma-que-combinao-com-pembrolizumabe-mantm-qualidade-de-vida-em-pacientes-com-cncer-gstrico-avanado-her2-positivo.jpeg176003846868310512025-10-09T19:34:28.729Z"bda6cc810a30761e8c6d48f5b0179e84"12318524estudo-de-fase-1-destaca-eficácia-do-zongertinibe-em-câncer-de-pulmão-de-não-pequenas-células-her2-mutado.jpeg175165032895952112025-07-04T17:32:09.000Z"69bf32b260407d539439e8b84249ef05"6562132estudo-demonstra-benefcio-de-sobrevida-global-com-amivantamabe-lazertinibe-em-cncer-de-pulmo-nsclc-avanado-com-mutao-egfr.jpeg175769689236745512025-09-12T17:08:12.414Z"7425b8ae1b89d2364c52031ca18d427e"5230633estudo-dreamm-7-mostra-superioridade-do-belantamabe-mafodotina-em-relao-ao-daratumumabe-no-tratamento-do-mieloma-mltiplo.png176426728723848912025-11-27T18:14:47.295Z"222683d4f4a1c1c5e4a83e9cd1730e0b"2240716estudo-impala-2-aponta-novo-padrão-terapêutico-para-a-pap.jpeg175579913654184812025-08-21T17:58:56.583Z"41d937678c019b943eb90a6fedb0a6ef"13352667estudo-inavo120-demonstra-benefício-de-sobrevida-global-com-inavolisibe-em-câncer-de-mama-hr+/her2–-com-mutação-em-pik3ca.jpeg175226222502532412025-07-11T19:30:25.084Z"c8bc9686284cc0fc5e70457d4e1274db"7843125estudo-inédito-revela-diversidade-genética-da-população-brasileira-e-suas-implicações-para-a-saúde-pública..jpeg174923510290298112025-06-06T18:38:22.957Z"626efea8e63426d972b9809cce36e581"12436434estudo-itabera-primeiros-resultados-do-estudo-brasileiro-randomizado-em-rastreamento-de-cncer-de-mama-apresentados-na-asco-2025.jpeg175890691226712712025-09-26T17:15:12.308Z"c95376613247884eb147bf55c8ba7d90"223863estudo-longitudinal-revela-impactos-significativos-da-covid-19-em-pacientes-com-câncer.jpeg175277646725570112025-07-17T18:21:07.297Z"98f762ef4a8a004de6abb3f1080b55bd"10522566estudo-loretta-no-confirma-segurana-da-omisso-cirrgica-com-tamoxifeno-isolado-em-dcis-de-baixo-risco.png176590625730997312025-12-16T17:30:57.351Z"3f2ee3b1d395cec59d54cbe2598b79ab"1300989estudo-mostra-impacto-negativo-do-her2-em-pacientes-com-cncer-colorretal-metasttico.jpeg175770505748435512025-09-12T19:24:17.525Z"6f4598046fd52e91617754b29c26aa47"2900343estudo-projeta-eliminação-do-câncer-do-colo-do-útero-na-coreia-do-sul-a-partir-de-2034-com-estratégias-otimizadas-de-triagem-e-vacinação.jpeg175509513199112212025-08-13T14:25:32.032Z"5536a0c10732d3fd77240aaa5be9c108"150465estudo-recente-mostra-resultados-promissores-do-uso-do-inibidor-de-menina-enzomenibe-na-lma-recidivada-refratria.png176557284071532312025-12-12T20:54:00.752Z"d2cec155c50356b950849f76790a611b"2534385estudo-revela-alta-incidência-de-metástases-cerebrais-em-cpnpc-her2-mutado-e-destaca-benefícios-de-terapias-inovadoras.jpeg175007880676391212025-06-16T13:00:06.805Z"69bcd145dc1963994d4289442a44f86c"5476184estudo-revela-que-sobreviventes-de-câncer-de-pâncreas-com-diabetes-enfrentam-mais-fadiga-e-têm-pior-autocuidado-.jpeg175007901932973712025-06-16T13:03:39.378Z"e6cdb1bfce3826762e4e29e68460f8dd"3508598estudo-ruby-redefine-o-manejo-do-câncer-de-endométrio-avançado-ou-recidivado-com-benefícios-consistentes-em-sobrevida-.png175251444648317512025-07-14T17:34:06.523Z"48f7c5b113108f2301c04d98e8ea5ea5"1574835estudo-sierra-amplia-o-uso-do-regime-stride-para-pacientes-com-chc-avançado-fora-dos-critérios-do-himalaya.png175457636622844412025-08-07T14:19:26.267Z"67280177c923f8caf757a3a6c215247e"396137estudo-tourmaline-reforça-flexibilidade-no-uso-de-durvalumabe-em-tumores-biliares-avançados.png175493986893177012025-08-11T19:17:48.996Z"b8b7dfe590c7b4ba9e1e12f8727ebe0b"1995263estudo-triangle-avalia-o-uso-ibrutinibe-associado--poliquimioterapia-como-alternativa-ao-transplante-autlogo-de-medula-ssea-em-pacientes-com-linfoma-de-clulas-do-manto.jpeg176459405154907512025-12-01T13:00:51.596Z"9aeed93bda944636b57e67716b87dcc2"545470estudos-dreamm-7-e-dreamm-8-mostram-benefcios-do-belantamabe-mafodotina-em-pacientes-com-mieloma-mltiplo-recidivado-ou-refratrio-de-alto-risco-funcional-.png176608722936545212025-12-18T19:47:09.404Z"dab7eeede426633411bd1aecd8de2ad7"1870618evento-acc-2026-hero-banner-mobile.png177384328666116112026-03-18T14:14:46.775Z"7a3fc90c40655acf10b9b47241fe6b5a"696740evento-atualizações-sobre-o-cenário-do-diabetes-tipo-2.png174929483851502212025-06-07T11:13:58.630Z"ea031c71604410c75dcefd7e3e9f094d"90119evento-debate-desafios-e-avanços-no-diagnóstico-e-tratamento-dos-tumores-neuroendócrinos-(tnes).jpeg175520349175063012025-08-14T20:31:31.801Z"b1d918f4adec29b4c8603c7bd18cb029"4577838evento-esmo-hero-banner-2710.jpeg177559255534686412026-04-07T20:09:15.386Z"0e2f7f346db08e81b638415dfca5b738"260710evento-esmo-hero-banner-mobile-2710.jpeg177559255701834512026-04-07T20:09:17.055Z"0e2f7f346db08e81b638415dfca5b738"260710evento-esmo-hero-banner-mobile.jpeg177559171072700412026-04-07T19:55:10.773Z"d41d8cd98f00b204e9800998ecf8427e"0evento-esmo-hero-banner.jpeg177559170912445012026-04-07T19:55:09.237Z"0e2f7f346db08e81b638415dfca5b738"260710evento-generico-3-hero-banner.png177333699885416012026-03-12T17:36:38.888Z"4ef77bb2f8b9d750473b9c41c9952500"750374evento-genérico-banner-genérico-teste-hero-banner.png176402382135279112025-11-24T22:37:01.392Z"1681441676f15887789c872f2c1ea481"276759evento-genérico-banner-genérico-teste.png176408810059476712025-11-25T16:28:20.687Z"64c6ab0e7e63c34eeb1ca48eb5b6a420"23464evidncias-acumuladas-posicionam-a-dapagliflozina-no-cuidado-cardiorrenal-integrado.jpeg177342705852141412026-03-13T18:37:38.553Z"f59654ea4705d76bfac0ee7084b3810a"265657evidncias-de-vida-real-e-impacto-econmico-do-tratamento-com-inibidores-de-btk-no-contexto-brasileiro.png176348790562736112025-11-18T17:45:05.677Z"654424b25d72ef161b9f4abbcbea5853"2302792evidências-acumuladas-posicionam-a-dapagliflozina-no-cuidado-cardiorrenal-integrado-1.png177342705325783312026-03-13T18:37:33.295Z"13c662533f12cc034be90a674d7ff5c4"63338evidências-acumuladas-posicionam-a-dapagliflozina-no-cuidado-cardiorrenal-integrado-2.png177342705490710312026-03-13T18:37:34.944Z"c2efb4db88f9047a00f06e71d8aab302"49076evidências-acumuladas-posicionam-a-dapagliflozina-no-cuidado-cardiorrenal-integrado-3.png177342705678145212026-03-13T18:37:36.812Z"f8fae43cfda2d10203a192e416dfae7e"47155evolocumab-in-highrisk-primary-prevention-vesaliuscv-delivers-practiceshifting-evidence.png176295651880554112025-11-12T14:08:38.857Z"9c6c1c75dbe16e5a79c3c8db629f2b58"2526020evolocumab-reduces-cardiovascular-events-in-primary-prevention-preliminary-results-from-the-vesaliuscv-stud.png176010312272595712025-10-10T13:32:02.766Z"19c2cc25401a1a880fcdbf47f094816e"134047exames-hematologicos-ferramentas-essenciais-para-o-diagnostico-clinico-3dd6d3f984fb45e09399783116c537da.jpeg176962514836415222026-01-28T18:32:28.423Z"e885c66a2c1dc7da3b9795004d105360"379906exames-hematologicos-ferramentas-essenciais-para-o-diagnostico-clinico-7cb1a6bfb3be4b0f8efd37d86772b6a0.jpeg176962518375127722026-01-28T18:33:03.805Z"1f2926e0bdf6fb87bfebe9b3c46680b4"349388exercise-extends-survival-in-colon-cancer:-challenge-trial-prompts-call-to-action..jpeg175253381423854012025-07-14T22:56:54.284Z"8bc35ff4d9556ad1f9cd65537c89d060"222494exome-sequencing-uncovers-new-genes-linked-to-congenital-hypopituitarism.png176117692373903112025-10-22T23:48:43.819Z"d213b53fe82de20961d7f0dc593595e1"2439792expanding-semaglutide-access-in-medicare-modeling-shows-billions-in-health-gains-and-potential-cost-savings.png176002516169447812025-10-09T15:52:41.740Z"4baf7a5c9187634667541922dece775e"2538755expanso-rpida-de-car-t-e-risco-de-neurotoxicidade-no-mieloma-mltiplo-insights-do-ash-2025.jpeg176538861885324412025-12-10T17:43:38.893Z"85f2ce88891dbc5cf78668d312f2ff8b"212301expansão-do-atendimento-oncológico-no-sus:-novo-equipamento-beneficia-pacientes-em-recife.jpeg174804318999658212025-05-23T23:33:10.037Z"625f5f83f42139600180c29103c37be4"213016expressão-genética-do-glp1r-e-risco-renal:-evidência-genética-sugere-efeito-protetor-além-da-glicemia.jpeg174861408692185112025-05-30T14:08:06.962Z"8a63f69e6358d6c0aab91025db4492c0"349059extending-aromatase-inhibitor-therapy-reduces-recurrence-in-hr+-breast-cancer.png175562312221190012025-08-19T17:05:22.268Z"2b3b0b51a3ff2ca54804a1656538b600"432717extensão-da-terapia-com-inibidores-de-aromatase-reduz-recorrência-em-câncer-de-mama-rh+--nova-meta-análise-do-ebctcg.png175517883787715212025-08-14T13:40:37.918Z"6d4e5362a392b0e9c00a4c1be35fbcfe"497100ezetimibe-further-lowers-longterm-cancer-risk-when-added-to-statins-10year-korean-cohort-reveals.png176117655276781712025-10-22T23:42:32.808Z"c5c26209973cba6830a767a02d3bc1a3"2373853f1-2026.png177791448838763312026-05-04T17:08:08.452Z"ed6d0e9250fcf95820dd4e4af6dc2044"269088famous-trial-estratgias-de-seguimento-aps-cirurgia-de-revascularizao-miocrdica-em-pacientes-com-doena-arterial-coronariana-multivascular-.jpeg176278614620610512025-11-10T14:49:06.246Z"a006f950bd6e9ed59442311a3ee0b8c7"163289famous-trial-followup-strategies-after-coronary-artery-bypass-surgery-in-patients-with-multivessel-coronary-artery-disease-ar.jpeg176279620179563512025-11-10T17:36:41.841Z"f24f34681cd1204bca743e3c577ef10d"149856fares-ii-trial:-prothrombin-complex-concentrate-matches-ffp-in-cardiac-surgery-bleeding-control.png175130134999962212025-06-30T16:35:50.043Z"6325e297a62204c3237dd151cd6963c7"1362316fda-amplia-indicao-de-vonvendi-para-profilaxia-e-tratamento-em-todas-as-idades-com-doena-de-von-willebrand.jpeg175762204959190512025-09-11T20:20:49.633Z"228e8aa6a2947d4e1737e18e60e04023"451440fda-approves-first-blood-test-for-alzheimer’s-diagnosis.jpeg174964920129964012025-06-11T13:40:01.348Z"da75b4bb7bf71f85c85f4fb29f84cc72"594024fda-approves-new-antibody–drug-conjugate-for-non-squamous-non–small-cell-lung-cancer-with-c-met-overexpression.jpeg174964897098374212025-06-11T13:36:11.034Z"501d2a75d5e58458dc32aefe087aefe7"8895480fda-approves-sir-spheres®-y-90-for-unresectable-hepatocellular-carcinoma:-expanding-therapeutic-options-in-liver-oncology.png175329678795377512025-07-23T18:53:08.015Z"6af7a9ffe4ed38ccb341616f7873119a"1518904fda-approves-teal-wand™,-the-first-at-home-self-collection-device-for-cervical-cancer-screening-in-the-u.s..jpeg175130525870385412025-06-30T17:40:58.763Z"3fd48b0cfa0b45c7906715ee24f8e2f2"104826fda-aprova-esquema-mensal-de-amivantamabe-subcutneo-para-cncer-de-pulmo-com-mutao-em-egfr.jpeg177152182346188012026-02-19T17:23:43.515Z"e0825c69827cb50cd6d3b415bb69f16f"4623285fda-aprova-primeiro-exame-de-sangue-para-diagnóstico-do-alzheimer.jpeg175009475763775912025-06-16T17:25:57.682Z"e9c4b0cb94fe060449bf7c016af097e4"9360420fda-aprova-radioembolização-com-sir-spheres®-y-90-para-carcinoma-hepatocelular-irressecável-.jpeg175277546023405412025-07-17T18:04:20.281Z"837ac4b493f0cdae5e1e7e67da9a5be1"3917736fda-aprova-sunvozertinibe-para-cpnpc-avançado-com-mutação-de-inserção-no-éxon-20-do-egfr.jpeg175457180534746812025-08-07T13:03:25.385Z"70aaf13514ef7b6c3392181553dbc15a"13551394fda-aprova-teal-wand™,-primeiro-dispositivo-de-auto-coleta-domiciliar-para-triagem-do-câncer-cervical-nos-eua.jpeg175008577024013312025-06-16T14:56:10.303Z"b247d5fb60916151572541552026dc34"5608664fda-aprova-zongertinibe-para-cpnpc-não-escamoso-com-mutações-ativadoras-em-her2-tkd.jpeg175571931324853212025-08-20T19:48:33.288Z"48e40c32935ec7ce707834db9ad6667f"2819520fda-concede-designações-fast-track-a-novas-terapias-oncológicas-em-junho-de-2025.jpeg175138256587276012025-07-01T15:09:25.914Z"7148acf0473891fd90e8517032175fce"3731276fda-grants-accelerated-approval-to-datopotamab-deruxtecan‑dlnk-(datroway)-for-egfr-mutated-nsclc.jpeg175080069216974512025-06-24T21:31:32.213Z"14934d09a9214e4e3e1de5db9306678c"140241febre-maculosa:-doença-grave-transmitida-por-carrapatos-exige-diagnóstico-precoce.jpeg174861413040613012025-05-30T14:08:50.448Z"d0dc6beeb726b5e800003563de3ad29c"8683521fetal-programming-shapes-lifelong-disease-risk-through-metabolic-epigenetic-and-inflammatory-pathways.png176070527799044912025-10-17T12:47:58.034Z"4a9762f137d9cc1ac00e2fb626e568bd"1725275fibrilao-atrial-ps-operatria-uma-arritmia-transitria-ou-marcador-de-vulnerabilidade-atrial-1452.png177818479468282812026-05-07T20:13:14.743Z"5ba6a94ffdad6303bf2a69cb2e1b2450"1596392file.json174784148301091012025-05-21T15:31:23.035Z"561991b252ef82af263902c362bd41c0"35596final-results-from-the-phase-iii-matterhorn-study-show-a-consistent-overall-survival-benefit-and-a-positive-association-between-pathological-response-and-eventfree-survival.jpeg176073561231813712025-10-17T21:13:32.361Z"77b13e21b612406e5fcc623704bbece4"214876finearts-hf:-finerenona-demonstra-potencial-para-reduzir-readmissões-precoces-por-insuficiência-cardíaca.jpeg174803352430744712025-05-23T20:52:04.342Z"10bee036b50da19f1fa8c773c699922b"10938913finerenone-improves-health-status-and-reduces-hf-events-in-patients-with-hfmref/hfpef.png175095793946878512025-06-26T17:12:19.513Z"a17eb9a3bc13f082cfa23f09021a494c"1296982finerenone-reduces-cardiovascular-risk-across-adiposity-levels-in-ckm-diseases.png175856386031206812025-09-22T17:57:40.357Z"7e9a362a936688e82b117343ca5864c3"2377503first-in-human-in-vivo-base-editing-for-cps1-deficiency-demonstrates-feasibility-of-patient-customized-crispr-therapy..png175329664583285712025-07-23T18:50:45.877Z"5c55dd04b8b4be8ddb8a9c380a961ae3"2204063fisiopatologia-da-doena-do-espectro-da-neuromielite-ptica-nmosd-e-papel-do-sistema-complemento.jpeg177074512031404212026-02-10T17:38:40.354Z"f764f9b3e2843da5b02a2d55b1a93a6f"227244fisiopatologia-da-miastenia-gravis-e-o-papel-do-sistema-complemento.jpeg176960810424482412026-01-28T13:48:24.291Z"16854cb0d988b420bbf1ec03c662ea7c"193887for-the-first-time-immunotherapy-changes-survival-in-platinumresistant-ovarian-cancer-8887.177618881801937112026-04-14T17:46:58.090Z"9651ba1b373218364e1e819eecdf6e81"218142fracaso-postcar-t-en-lbcl-validacin-en-vida-real-del-ndice-pronstico-post-car-pc-pi.png176892802837223812026-01-20T16:53:48.412Z"5c24945f65bbf113be426e34bb14ac6b"7004703franks-sign-um-achado-clnico-simples-que-pode-sinalizar-risco-cardiovascular-subjacente.png177072813863144612026-02-10T12:55:38.677Z"1b544dfdeba7a7ae07f100a387700c8d"2065298from-bench-to-patient-the-long-journey-of-a-drug.png175777800506461812025-09-13T15:40:05.106Z"5c9269567938260c3b920de7f304d728"1975116from-oil-to-pill-the-origin-of-medicines-and-the-role-of-apis.png175777840146531512025-09-13T15:46:41.522Z"dbd503f65d5b99c759efb707ba59c04a"1873285from-pediatric-to-adult-care-the-neglected-bridge-for-adults-with-childhoodonset-rare-diseases.png176117730730693212025-10-22T23:55:07.352Z"e71a2c53487bee9ba9c5be243148d5bc"2576148future-hf:-viabilidade-e-segurança-de-sensor-implantável-para-monitoramento-de-veia-cava-inferior-na-insuficiência-cardíaca.jpeg174803374899644612025-05-23T20:55:49.032Z"3888c550d2ae41024f44679486c35725"4736659galectin3-as-a-sexspecific-biomarker-for-cancer-and-heart-failure.png175880547221754012025-09-25T13:04:32.260Z"5bd56b7b5156a7a7328b9b956f4e517e"2596210generics-and-the-truth-about-bioequivalence.png175777853347319812025-09-13T15:48:53.515Z"468e4d20d251a0ac2b38bde951baf894"1714512genetic-determinants-of-cardiovascular-disease-risk-in-cancer-survivors..png175511137806028212025-08-13T18:56:18.108Z"3c33756e55884244c16ee05e5f6727b3"2540477genricos-similares-e-a-verdade-sobre-a-bioequivalncia.png175771435522599212025-09-12T21:59:15.270Z"468e4d20d251a0ac2b38bde951baf894"1714512genômica-no-câncer-colorretal-de-início-precoce--um-perfil-mutacional-distinto-ganha-forma.jpeg175458748369365912025-08-07T17:24:43.762Z"7a5ceb12125de21a77dd1f2d59583cf9"4868377germline-dna-damage-response-gene-variants-are-lin-4726.jpeg177428472715891012026-03-23T16:52:07.191Z"a16cdfa0b8fd81a6b3cd1a108e7d5a55"1054007germline-dna-damage-response-gene-variants-are-lin-9073.jpeg177429648415756612026-03-23T20:08:04.197Z"803bcf3cd1b6f17593bbf85d6e9cdf6b"58472germline-dna-damage-response-gene-variants-are-lin-9472.jpeg177429645562842612026-03-23T20:07:35.666Z"803bcf3cd1b6f17593bbf85d6e9cdf6b"58472germline-dna-damage-response-gene-variants-are-linked-to-multiple-myeloma-risk-and-survival.png176955043857443612026-01-27T21:47:18.622Z"804b49f756f78e793a12277b5619de6a"7920449germline-dna-damage-response-variants-were-linked-to-multiple-myeloma-riskand-worse-survival-for-tp53atm-carriers.png176892964849657712026-01-20T17:20:48.542Z"773479da1a1a4813a82ba2f8c3da4a2b"7908051global-burden-of-nervous-system-disorders-from-1990-to-2021.jpeg175511122218565212025-08-13T18:53:42.239Z"df694fb3f90a63973406488a4138b2ba"392612global-cardiovascular-risk-burden-forecast-to-2050:-hypertension-and-obesity-lead-the-way..png175276377893972412025-07-17T14:49:38.990Z"1557f96a60fccd0bcac952ec599f8416"1641345global-syndemic-of-cardiovascular-risk-factors-projections-to-2050.png175924694953789012025-09-30T15:42:29.659Z"7ede207a84ebf03bced383079d0b6767"2318127glp-1-and-endometrial-cancer-sgo-2026-debates-the-role-of-metabolic-modulation-in-gynecologic-oncology-.jpeg177636541230912512026-04-16T18:50:12.372Z"e38fff38d83980291ab2590e25325204"273611glp-1-e-cncer-endometrial-o-sgo-2026-debate-o-papel-da-modulao-metablica-na-oncologia-ginecolgica--9322.jpeg177637014813321912026-04-16T20:09:08.197Z"1dbdfcedd4a8313c99e53e29998ca4a8"276630glp-1-ras-reduzem-em-47-a-necessidade-de-dilise-e-em-19-a-ocorrncia-de-injria-renal-aguda-em-t2d-sem-drc-prvia.jpeg175830923045921912025-09-19T19:13:50.499Z"d8bbc8d6a0b45159be4600358787beb0"292696glp-1-y-cncer-endometrial-el-sgo-2026-debate-el-papel-de-la-modulacin-metablica-en-la-oncologa-ginecolgica-.jpeg177636625331537112026-04-16T19:04:13.378Z"e38fff38d83980291ab2590e25325204"273611glp1-and-endometrial-cancer-sgo-2026-debates-the-role-of-metabolic-modulation-in-gynecologic-oncology-4199.177636656350381412026-04-16T19:09:23.567Z"15687ec73b4e299fe9f5af34c94dc6ed"274143glp1-ras-reduce-cardiovascular-risk-versus-insulin-in-earlyonset-type-2-diabetes.jpeg175821724779320812025-09-18T17:40:47.835Z"195934ff19657d6eab80495348044800"319619glp1-ras-reduce-dialysis-need-by-47-and-acute-kidney-injury-by-19-in-t2d-without-baseline-ckd.jpeg175832285474223412025-09-19T23:00:54.783Z"89351cbaac2c291376b2447ab783195d"292907grupo-de-discussao.webp176312885758760022025-11-14T14:00:57.628Z"ddf8d93d730b93ace4a34776b337e19b"222164guidance-for-patients-taking-glp-1-medications-for-weight-loss:-nutrition,-hydration,-and-lifestyle-strategies..png175440442560678312025-08-05T14:33:45.650Z"afe6fb72f8e995ddf1f2042c735e79db"1351976guideline-aha-acc-2026-de-embolia-pulmonar-aguda.jpeg177343285778217812026-03-13T20:14:17.820Z"ef0726bb0eb706bea4b30cb696981b26"280454h-espao-para-o-uso-dos-agonistas-do-receptor-de-glp-1-na-doena-aterosclertica-independentemente-da-hiperglicemia-ou-obesidade-7477.png177811282164441812026-05-07T00:13:41.714Z"98e23992ab18620513eb01fb430f1df5"1704302h-espao-para-o-uso-dos-agonistas-do-receptor-de-glp-1-na-doena-aterosclertica-independentemente-da-hiperglicemia-ou-obesidade-8914.png177811450186934312026-05-07T00:41:41.953Z"98e23992ab18620513eb01fb430f1df5"1704302h-espao-para-o-uso-dos-agonistas-do-receptor-de-glp-1-na-doena-aterosclertica-independentemente-da-hiperglicemia-ou-obesidade-9041.png177811239215319112026-05-07T00:06:32.214Z"d2540254f24cc33082562df62a0c2bdc"2795440harmoni-ivonescimab-demuestra-fuerte-actividad-intracraneal-en-nsclc-con-mutacin-de-egfr-.jpeg177506398795574612026-04-01T17:19:47.995Z"69cea0c8602d7f0fa39b494c0b5bea86"307283harmoni6-confirms-significant-clinical-benefit-of-ivonescimab-combined-with-chemotherapy-in-the-firstline-treatment-of-advanced-squamous-nsclc.png176090104711746412025-10-19T19:10:47.209Z"c648b7332999f1c17ec761312adb8b00"1051072heart-failure-2026-back-to-the-future-decision-recoloca-a-digoxina-no-debate-da-insuficincia-cardaca-moderna-4398.png177852832284053212026-05-11T19:38:42.903Z"872e49d9efc30d4feacee97c331f14a1"1548168heart-failure-2026-back-to-the-future-decision-recoloca-a-digoxina-no-debate-da-insuficincia-cardaca-moderna-5170.png177852828512454912026-05-11T19:38:05.188Z"872e49d9efc30d4feacee97c331f14a1"1548168heart-failure-2026-back-to-the-future-decision-recoloca-a-digoxina-no-debate-da-insuficincia-cardaca-moderna-841.png177852823167309512026-05-11T19:37:11.735Z"872e49d9efc30d4feacee97c331f14a1"1548168heart-failure-after-myocardial-infarction-promotes-mammary-tumor-growth-via-ngftrka-pathway.png175880582138526712025-09-25T13:10:21.442Z"2bf1d13c3d02dba5ad7b9c1e789f4483"2631002helios-b:-benefícios-do-vutrisirana-na-attr-cm.png174803243275823612025-05-23T20:33:52.813Z"cf97d9443eb3429eef7a448b653cbbd4"345791hematologia-15afbc229d4348a49403e62e67cf66c7.jpeg177262968070831322026-03-04T13:08:00.771Z"e6047914491fae6ac72a827b68cbb2cf"352114hematologia-teste.png177256643743343712026-03-03T19:33:57.503Z"6e1254b2f4d31e9f3e994c8909c19917"682102hematologic-malignancies-and-newonset-diabetes-m-412.jpeg177428459709921112026-03-23T16:49:57.141Z"f25a99e558bb75dd14d7bd600c2d1527"1039328hematologic-malignancies-and-newonset-diabetes-metaanalysis-finds-higher-incidence-vs-controls.png176963361907056012026-01-28T20:53:39.117Z"255626416e26e8332f7207a67f9b6a5d"6793112hematopoiese-o-processo-de-formacao-das-celulas-sanguineas-c479070fd3f644ef92c24d4625568c19.jpeg177262973797037622026-03-04T13:08:58.039Z"1e755ee4a3f887c8d31af07f0071c4c2"406689hemo-2025---expanso-e-desafios-do-transplante-de-medula-ssea-no-brasil.png176244677478737412025-11-06T16:32:54.825Z"5de978abf20c049502e5131fae37e919"1729864hemo-2025---principais-avanos-e-novas-perspectivas-no-tratamento-da-leucemia-linfoctica-crnica.png176236796765526812025-11-05T18:39:27.702Z"466f433cf2f00cb8b78e0b9a6a55129c"2462676hemo-2025-avanos-no-manejo-dos-linfomas-de-zona-marginal-e-de-clulas-t.png176254239448299912025-11-07T19:06:34.531Z"e92a62672410b8343cd5f460c27da4f6"2775714hemo-2025-especialistas-discutem-os-ltimos-avanos-no-tratamento-da-leucemia-linfoctica-crnica.png176357593965827512025-11-19T18:12:19.698Z"b4a362cb26cd467c47d7d9abbd83439e"2373099hemo-2025-ltimas-novidades-sobre-o-uso-da-terapia-celular-transplante-e-inteligncia-artificial-no-contexto-da-hematologia.png176278276773305812025-11-10T13:52:47.784Z"00a887cad237d2c73835211ace6a538f"1971824hemo-2025.png176035532348383112025-10-13T11:35:23.530Z"4ca22b1a43e920bf1057c8884d5ba511"234145hemomeeting--sul-hero-banner.png177738716658180412026-04-28T14:39:26.644Z"3fc5a3d5dddd25198fdca0a0f480ad12"108958hemomeeting-norte-e-nordeste-2025.png175987052343272112025-10-07T20:55:23.532Z"a00dba1a3b01f0aa59a74e29f91cc1a0"491817hemomeeting-norte-e-nordeste.png175986506155682912025-10-07T19:24:21.598Z"f2ec2b92d94b826d6eb8730990ab0076"561596hemomeeting-spi-hero-banner-1200.png177697226733736212026-04-23T19:24:27.418Z"b53a11a72106e9853c88565a2d01da7b"140422hemomeeting-spi-hero-banner-mobile-1200.png177697226875130712026-04-23T19:24:28.812Z"879c9fbb5b2114926892e21c756dbd4a"138490hemomeeting-sul-2026-hero-banner-5523.png177791649074779312026-05-04T17:41:30.821Z"fe1c4cf7f5a6d909a51880efe4d7d731"272408hemomeeting-sul-2026-hero-banner-7632.png177791665289267612026-05-04T17:44:12.964Z"e953f91f1bb22774b5b37427a0694e42"268287hemomeeting-sul-2026-hero-banner-mobile-5523.png177791649233710912026-05-04T17:41:32.408Z"a48b7fd6fe34e63202f46b8f87fa65ad"295035hemomeeting-sul-2026-hero-banner.png177791232167729612026-05-04T16:32:01.749Z"e9c1c45c965ca2100d9c6faa68a31967"121758hemomeeting-são-paulo-interior.png175562658012834612025-08-19T18:03:00.168Z"99ffcff6b4cf6bb7ce2ea06429409b6c"507169hepatocarcinoma-em-debate-na-asco-gi-2026-entre-a-antecipao-da-imunoterapia-e-os-desafios-da-adjuvncia.jpeg176850869688409112026-01-15T20:24:56.923Z"361eff9148da56590ba01aa91c08f7f1"201554hepatócitos-com-resistência-insulínica-inata.jpeg175055234522896212025-06-22T00:32:25.270Z"74bb03cd5805f24b42532ef8ac47b586"2801969her2climb-05-tucatinib-ampla-el-beneficio-de-la-mantenimiento-en-el-cncer-de-mama-metastsico-her2.png176548733871505912025-12-11T21:08:58.769Z"67591c8e529b01d555aacb4bb6cec3a9"1588067her2climb05-tucatinib-expands-maintenance-benefit-in-her2-metastatic-breast-cancer.png176548374569477712025-12-11T20:09:05.735Z"67591c8e529b01d555aacb4bb6cec3a9"1588067hesitao-vacinal-e-o-impacto-na-imunizao-infantil-.png176399320529177912025-11-24T14:06:45.334Z"4f1bd37be97a4ee81a7bf956c0a85c0b"2005169hf-2026-back-to-the-future-decision-reignites-the-debate-on-digoxin-in-modern-heart-failure-7543.png177852918084156412026-05-11T19:53:00.914Z"cd3b97dbd8f602fa1724206f531f507a"1532263hf-2026-cardio-oncologia--um-dos-destaques-do-congresso-europeu-de-insuficincia-cardaca-1434.png177888132797154012026-05-15T21:42:08.034Z"ecd5b68fcbd06107e8d34db5f923d14d"1564385hf-2026-cardiooncology-as-one-of-the-highlights-of-the-european-heart-failure-congress-258.177888153172721912026-05-15T21:45:31.799Z"a6d944aa8e76329e104d189e4b39ec98"1564512high-dose-aumolertinib-shows-prolonged-survival-benefit-in-lung-cancer-patients-with-brain-metastases-and-egfr-variant:-results-from-the-achieve-study.png175191978284132712025-07-07T20:23:02.884Z"9a1375de9d9eaed39d07a32b33edd3b6"456345highlights-do-congresso-sgo-2025.png174861554287162512025-05-30T14:32:22.912Z"ab7295c95f2cfddf20219bbd25cff49a"336383highlights-ias-2025--avanços-em-cura,-prevenção-e-novas-diretrizes-marcam-a-13ª-conferência-em-kigali.jpeg175399030494254312025-07-31T19:31:45.071Z"d5a069aeecd6e5529c56e8850d6e8ba0"177440highlights-laçamento-tirzepatida-brasil-–-parte-3-.jpeg175156185145535812025-07-03T16:57:31.498Z"f0ec85a1204b118413f231c9624f9fb1"202108highlights-wclc-2025.png175744341229772112025-09-09T18:43:32.337Z"614e10bd6f3f3c027fa7db1e018d0611"1712778highlights-world-symposium-2026-avances-en-el-diagnstico-y-tratamiento-de-las-enfermedades-lisosomales.png177073057424621512026-02-10T13:36:14.293Z"1512a09389a53272456785f499fba4cd"762307highlights-world-symposium-2026-avanos-em-diagnstico-e-tratamento-de-doenas-lisossmicas.png177072746334408112026-02-10T12:44:23.390Z"8d777b03fb1f4c00a3df333341ce5a92"762352hipercalemia-um-obstculo-silencioso--terapia-ideal-na-insuficincia-cardaca.jpeg177005717235965912026-02-02T18:32:52.408Z"ebab1c2cea0c055c84d2540339964d53"248762hipertensão:-foco-na-atenção-primária-é-chave-para-prevenir-mortes-evitáveis,-diz-opas.jpeg175008564185325312025-06-16T14:54:01.901Z"53835d6ffb9e69adb0f5fb6f32b20f32"4535845hipro-trial-extended-lowdose-apixaban-prevents-recurrence-in-provoked-vte-with-enduring-risk-factors.png175856474251775712025-09-22T18:12:22.582Z"bf3e11ed5530abfede7830730ae749e8"1861455httpstrellocomc4hp6rgmi564-18-12-estudos-dreamm-7-e-dreamm-8-mostram-benefc3adcios-do-belantamabe-mafodotina-em-pacientes-com-mieloma-mc3baltiplo-recidivado-ou-r.png176608714906180412025-12-18T19:45:49.101Z"dab7eeede426633411bd1aecd8de2ad7"1870618httpstrellocomchzej5zar26-09-12-c3a0-12-12-evento-sabcs-oncologia.png176600420850718612025-12-17T20:43:28.552Z"1b87dc2799f41b5167b0a9ef3fc70631"1381746hyperinsulinemia-and-cancer-risk:-a-potential-link-highlighted..png175562497982527812025-08-19T17:36:19.870Z"b265b2ffab1fa260c004a9e08091178e"1458002hypertrophic-cardiomyopathy-new-insights-from-genetics-to-therapy.png175880496907374412025-09-25T12:56:09.114Z"fe9c5c260269484e23641c348ec417db"2957082há-espaço-para-o-uso-dos-agonistas-do-receptor-de-glp-1-na-doença-aterosclerótica,-independentemente-da-hiperglicemia-ou-obesidade--1.png177811237227500112026-05-07T00:06:12.370Z"7da55b6d7595ec22cc146baf129e4b09"17468há-espaço-para-o-uso-dos-agonistas-do-receptor-de-glp-1-na-doença-aterosclerótica,-independentemente-da-hiperglicemia-ou-obesidade--2.png177811237343474212026-05-07T00:06:13.494Z"0c59a97d3d9dbf94d4713d5805737a3a"23558há-espaço-para-o-uso-dos-agonistas-do-receptor-de-glp-1-na-doença-aterosclerótica,-independentemente-da-hiperglicemia-ou-obesidade--3.png177811237455853912026-05-07T00:06:14.621Z"8eec161cb88d5e84249e962f5bc12346"14203iCGMNews.pdf175267594517508522025-07-16T14:25:45.220Z"082f7db10b508dad8352d726131e0224"858147ia-aumenta-sensibilidade-na-detecção-de-her2-low-e-her2-ultralow-em-câncer-de-mama-avançado.jpeg175493589356915212025-08-11T18:11:33.630Z"5bc0b7da8698c8ea36c61b3d42ecc1a2"10408858ias-2025--a-equidade-como-chave-para-o-sucesso-da-profilaxia-pré-exposição-(prep)-de-longa-duração.jpeg175312488560169412025-07-21T19:08:05.665Z"ce9e63882670a83b278098a88056d440"200099ias-2025--benefícios-e-desafios-do-doxiprep-para-prevenção-de-infecções-bacterianas-sexualmente-transmissíveis.jpeg175321272287658912025-07-22T19:32:02.918Z"fe87fb1cc155e035082944a55bba9238"181027ias-2025--desafios-emergentes-e-perspectivas-da-terapia-antirretroviral.jpeg175329989228928812025-07-23T19:44:52.329Z"6c27b8f289a8762799bbcb369e194ac6"268854ias-2025--países-de-baixa-e-média-renda-assumem-protagonismo-na-resposta-ao-hiv.jpeg175278311086865512025-07-17T20:11:50.979Z"3a891b66f8cefae2f5d1070d89dd72a0"191554ias-2025-debate-estratégias-antirretrovirais-diante-de-crise-de-financiamento.jpeg175268500891810512025-07-16T16:56:49.001Z"53e0cb7f28bdd2d1425100eafebd93e4"178305ias-2025-destaca-avanços-e-desafios-no-cuidado-contínuo-de-pessoas-vivendo-com-hiv.png175286772605375712025-07-18T19:42:06.097Z"8950862403b8b51c68d8462b5df61768"1117711ias-2025-destaca-como-autotestes-de-hiv-podem-superar-barreiras-de-acesso-à-prep-para-grupos-prioritários.jpeg175259117164260512025-07-15T14:52:51.710Z"6ef0c499881b89921247f8901444c44a"159640ias-2025-destaca-papel-estratégico-do-autoteste-de-hiv-na-expansão-da-prep-em-contextos-de-difícil-acesso.png175259093446865212025-07-15T14:48:54.523Z"6f6915c49a09dc274680ef1f3d3e120a"922757ias-2025-no-ar!-veja-os-destaques-iniciais-da-maior-conferência-mundial-sobre-hiv.jpeg175259019675312712025-07-15T14:36:36.815Z"121a1ad6f0f93cbc556c7cb7c475a654"216968ias-2025:-abertura-oficial-do-congresso-reforça-alerta-sobre-risco-de-retrocesso-global-no-combate-ao-hiv.png175260801854792712025-07-15T19:33:38.587Z"7c6df04f70cbbb35dd83ab0fb927e8ce"1115701ias-2025:-avanços-em-prevenção-e-acesso-marcam-o-segundo-dia-do-congresso.png175260716723799112025-07-15T19:19:27.288Z"66f0497c94ee3ccc687f23bc3799e101"1151592icfer-2026--as-4-colunas-da-terapia-e-como-otimizar-na-prática.png177799006486507512026-05-05T14:07:44.927Z"d20b6f976a079422999fe88406f8e813"831398icml-2025:-principais-avanços-no-tratamento-de-linfoma-difuso-de-grandes-células-b-(ldgcb).png175104338353792412025-06-27T16:56:23.583Z"9156727158c5ba9730c8e84609f2a5e2"2152237icosapent-ethyl-lowers-cardiovascular-risk-across-insulin-resistance-spectrum.jpeg175822205607456012025-09-18T19:00:56.135Z"9bc06512ef3990e19a6c68eff9161aa7"395515icosapent-ethyl-reduce-el-riesgo-cardiovascular-en-todos-los-niveles-de-resistencia-a-la-insulina.jpeg175830711806453612025-09-19T18:38:38.106Z"e42253e98f45dda5407d953239a0a878"87514icosapent-ethyl-reduz-risco-cardiovascular-em-diferentes-nveis-de-resistncia-insulnica.jpeg175822647376437512025-09-18T20:14:33.828Z"83bb57e4a7da9970469260e0e7830f32"395316ighg-issues-harmonized-ctrcd-riskequivalence-ratios-for-anthracyclines-and-mitoxantrone-in-childhood-cancer-survivors.png175745750639944312025-09-09T22:38:26.441Z"35953e2217e7003e3cb18e9d79213225"2940431imagemfinalteste-hero-banner.png177342398399319912026-03-13T17:46:24.037Z"7a3fc90c40655acf10b9b47241fe6b5a"696740impacto-da-melhor-resposta-ao-ibrutinibe-associado-a-bendamustina-e-rituximabe-na-slp-no-lcm-anlise-secundria-do-estudo-shine.jpeg177308968095848712026-03-09T20:54:40.999Z"1a3336e62609579261b6ca54c07806c6"1898218impacto-da-melhor-resposta-ao-ibrutinibe-associado-a-bendamustina-e-rituximabe-na-sobrevida-livre-de-progresso-no-linfoma-de-clulas-do-manto-anlise-secundria-do-estudo-shine.jpeg177308947300708712026-03-09T20:51:13.131Z"1a3336e62609579261b6ca54c07806c6"1898218impacto-da-terapia-gnica-com-exagamglogene-autotemcel-na-qualidade-de-vida-relacionada--sade-em-pacientes-com-anemia-.jpeg177273394320411912026-03-05T18:05:43.267Z"d51c7a3d8e9e98d15e677e1de62925a5"3253089impacto-da-terapia-gnica-com-exagamglogene-autotemcel-na-qualidade-de-vida-relacionada--sade-em-pacientes-com-anemia-falciforme-grave.jpeg177273309002790412026-03-05T17:51:30.091Z"d51c7a3d8e9e98d15e677e1de62925a5"3253089impacto-dos-surtos-de-neuromielite-ptica-a-importncia-do-reconhecimento-precoce-6327.jpeg177576323735628912026-04-09T19:33:57.413Z"558c7c3624326b925c231806490fde93"145931import-low-confirma-eficácia-da-radioterapia-parcial-após-10-anos-de-seguimento-.jpeg175007916531192012025-06-16T13:06:05.360Z"c8bc9686284cc0fc5e70457d4e1274db"7843125importancia-do-check-up-anual-na-pratica-medica-a1aa09cce71245c297193e4fd6c3896b.jpeg176916931589140522026-01-23T11:55:15.947Z"4197fc661d1c77fe1d3d25eb9684e8bf"449708importncia-de-uso-de-mtricas-na-avaliao-e-manejo-do-paciente-com-miastenia-gravis-2923.jpeg177393045774337712026-03-19T14:27:37.780Z"7eeca4e130f8e8bba209131e27342d2a"299365importância-de-uso-de-métricas-na-avaliação-e-manejo-do-paciente-com-miastenia-gravis-1.png177393045627847412026-03-19T14:27:36.316Z"a146f8471648fd23942893d1c31770d9"562459imunização-contra-herpes-zóster:-avanços-na-proteção-de-grupos-de-risco.jpeg174861403376932512025-05-30T14:07:13.822Z"82186819dc60c9bbf2859387d0231564"18474741imunoterapia-adjuvante-se-destaca-no-tratamento-do-carcinoma-cutâneo-de-alto-risco.jpeg175588652120363912025-08-22T18:15:21.247Z"12e1f4bc6a8c564b0075a53065a46527"9150932imunoterapia-combinada-mostra-resultados-promissores-em-cânceres-ginecológicos-de-células-claras-avançados.jpeg175198441306010912025-07-08T14:20:13.104Z"dfcfee7bacbc48df60446804ea088f85"10609663imunoterapia-em-câncer-endometrial-avançado:-evidências-reforçam-benefício-da-terapia-anti-pd-1.png175078886759677412025-06-24T18:14:27.641Z"863537baa1bfe5a01d6053dcdd96a5e2"1602895imunoterapia-em-paciente-transplantado-com-carcinoma-espinocelular-de-pele-avançado--relato-de-caso-com-cemiplimabe.png175457043276674412025-08-07T12:40:32.806Z"6a5b2352f312406bb7c309aced7206dc"1561095imunoterapia-no-cncer-de-pulmo-metasttico-escolhas-clnicas-e-novos-desafios.png176358412098982312025-11-19T20:28:41.049Z"752ed3cf71e2df8750adb3711d5a5abb"861588imunoterapia-perioperatória-com-pembrolizumabe-mostra-benefício-em-carcinoma-espinocelular-de-cabeça-e-pescoço-localmente-avançado.jpeg175164030350414512025-07-04T14:45:03.555Z"05364ce06af023ea6312f6087a9742d4"2233965inavolisib-extends-overall-survival-in-pik3ca-mutated-advanced-breast-cancer..png175253262276860212025-07-14T22:37:02.815Z"346f4ef2cdb453f371dbc1dea46e5a43"1296488incb161734-new-oral-kras-g12d-inhibitor-shows-promising-signals-in-advanced-pancreatic-cancer.png176797527701243612026-01-09T16:14:37.053Z"db8e0631cac7893d2f7970f13ab7f100"2135244incb161734-novo-inibidor-oral-de-kras-g12d-mostra-sinais-promissores-em-cncer-de-pncreas-avanado.jpeg176796195014345112026-01-09T12:32:30.184Z"9fc6eb430c467da65ac916490cbe85f8"310782incb161734-nuevo-inhibidor-oral-de-kras-g12d-muestra-seales-prometedoras-en-cncer-de-pncreas-avanzado.png176797501459292512026-01-09T16:10:14.633Z"c29ed49e30aa587c321b66db2b60af44"2133687inclisiran-recebe-aprovação-do-fda-para-uso-como-monoterapia-na-redução-do-ldl-c.jpeg175499179447411512025-08-12T09:43:14.515Z"52e26ea2b66ee6a7ebaecfd56568e98a"4857371incorporação-inédita-do-zolgensma®-no-sus:-terapia-gênica-revolucionária-para-atrofia-muscular-espinhal-tipo-1-disponível-na-rede-pública.jpeg174922973040468412025-06-06T17:08:50.447Z"3b6a0281b21f59aa601a6d91d24bbdd1"104612infeces-respiratrias-e-sndrome-gripal-o-papel-do-otorrino.png176357333028244312025-11-19T17:28:50.328Z"f18d4f9866b7edc284e68f4864883839"852814infeces-respiratrias-no-brasil-epidemiologia-impacto-clnico-e-estratgias-vacinais.jpeg177334082462813512026-03-12T18:40:24.670Z"b35063c32d38b3b0551462a6c9150db7"265226